1 |
Plazomicin injection 500 mg/10mL |
M/s Cipla Limited |
New Drugs |
2024-Sep-29 |
|
2261 KB |
2 |
PY test Kit Carbon 14 Urea Capsule |
M/s 3BMS diagnostics Pvt Ltd |
New Drugs |
2024-Sep-18 |
|
898 KB |
3 |
Gefapixant tablets |
M/s Sun Pharma Laboratories Limited |
New Drugs |
2024-Sep-18 |
|
1109 KB |
4 |
Asciminib tablets |
M/s Novartis Healthcare Private Limited |
New Drugs |
2024-Sep-18 |
|
572 KB |
5 |
Relugolix Tablets |
M/s Sun Pharmaceutical Industries Limited |
New Drugs |
2024-Sep-18 |
|
874 KB |
6 |
Clascosterone and minoxidil Topical Solution Clascosterone and latanoprost Topical Solution |
M/s Glenmark Pharmaceuticals Ltd |
New Drugs |
2024-Sep-18 |
|
10385 kb |
7 |
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT) |
M/s Novo Medi Sciences Private Limited |
Vaccine |
2024-Sep-11 |
|
218 KB |
8 |
Remifentanil Hydrochloride 1mg/2mg for injection |
M/s Themis Medicare Ltd |
New Drugs |
2024-Aug-28 |
|
1018 KB |
9 |
CT-08-2024 GSK |
M/s GSK Pharma India Private Limited |
Vaccine |
2024-Aug-19 |
|
1668 KB |
10 |
MORF-057 |
M/s PSI CRO |
GCT |
2024-Aug-02 |
|
704 KB |
11 |
CT-07-2024 Zydus |
M/s Zydus Lifesciences Limited |
Vaccine |
2024-Jul-31 |
|
213 KB |
12 |
LEE011 |
M/s Novartis Healthcare |
GCT |
2024-Jul-30 |
|
656 KB |
13 |
Live-Attenuated Respiratory Syncytial Virus (RSV) âNS2/â1313/I1314L vaccine (RSVt vaccine) |
M/s PPD Pharmaceutical |
GCT |
2024-Jul-30 |
|
672 KB |
14 |
Zanidatamab (ZW25 and JZP598) |
M/s PPD Pharmaceutical |
GCT |
2024-Jul-26 |
|
669 KB |
15 |
LOU064 (Remibrutinib) |
M/s Novartis Healthcare |
GCT |
2024-Jul-26 |
|
664 KB |
16 |
CT-06 2024 Bio.E |
M/s Biological E. Limited |
Vaccine |
2024-Jul-23 |
|
414 KB |
17 |
Dexamethasone (1.5% w/v) |
M/s Pharmaceutical Research |
GCT |
2024-Jul-19 |
|
574 KB |
18 |
Tafenoquine 50mg and 150 mg Tablets |
M/s Glaxosmithkline Pharmaceuticals Limited |
New Drugs |
2024-Jul-15 |
|
2205 KB |
19 |
Polmacoxib Capsules 2mg |
M/s Hetero Labs Limited |
New Drugs |
2024-Jul-05 |
|
2293 KB |
20 |
CT-05 2024 TB |
M/s Bharat Biotech International Limited |
Vaccine |
2024-Jun-25 |
|
714 KB |
21 |
Omalizumab |
M/s CuraTeQ Biologics Pvt. Ltd |
New Drugs |
2024-Jun-14 |
|
649 KB |
22 |
REGN3500 (Itepekimab) 300 mg (150 mg/mL) Solution |
M/s SANOFI HEALTHCARE INDIA PRIVATE LIMITED |
GCT |
2024-Jun-04 |
|
654 KB |
23 |
ALT-803 (N-803) |
M/s CBCC Global Research LLP |
GCT |
2024-Jun-04 |
|
680 KB |
24 |
Leuprolide acetate for injectable suspension |
M/s CBCC Global Research LLP |
GCT |
2024-Jun-04 |
|
782 KB |
25 |
VAY736 (Ianalumab) |
M/s Novartis Healthcare Private Limited |
GCT |
2024-Jun-04 |
|
639 KB |
26 |
GSK4057190A/Dostarlimab |
M/s GSK Pharma India Private Limited |
GCT |
2024-Jun-03 |
|
696 KB |
27 |
Osivelotor |
M/s Pfizer Limited |
GCT |
2024-Jun-03 |
|
671 KB |
28 |
PF 06463922 Lorlatinib 25mg Tablets |
M/s Pfizer Limited |
GCT |
2024-Jun-03 |
|
634 KB |
29 |
Bedaquiline, Rifampicin, Clofazimine, Dapsone |
M/s Johnson & Johnson Pvt. Ltd |
GCT |
2024-May-30 |
|
674 KB |
30 |
Baxdrostat Tablets, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg |
M/s AstraZeneca Pharma India Limited |
GCT |
2024-May-29 |
|
697 KB |
31 |
Cannabidiol 100mg/ml Oral Solution |
M/s Zenera Pharma Pvt Ltd |
New Drugs |
2024-May-21 |
|
1051 KB |
32 |
Ziltivekimab C 30 mg/ml / placebo |
M/s. Novo Nordisk India Pvt Ltd |
GCT |
2024-May-20 |
|
831 KB |
33 |
Entrectinib Capsules 100mg and 200mg |
M/s Roche Products (India) Pvt Ltd |
New Drugs |
2024-May-16 |
|
1063 KB |
34 |
Crisaborole Ointment 2% |
M/s Pfizer products India Ltd |
New Drugs |
2024-May-08 |
|
1285 KB |
35 |
Lobeglitazone Sulfate 0.5mg + Glimepiride 1mg Tablets |
M/s Glenmark Pharmaceuticals Ltd |
New Drugs |
2024-May-08 |
|
1083 KB |
36 |
Ravulizumab 10mg/mL (300mg/ 30mL) or Placebo |
M/s. AstraZeneca |
GCT |
2024-May-07 |
|
692 KB |
37 |
AP063 |
M/s. Inventive |
GCT |
2024-May-07 |
|
456 KB |
38 |
Insulin icodec 700 U/ml |
M/s. Novo Nordisk India |
GCT |
2024-May-07 |
|
746 KB |
39 |
Luspatercept (ACE-536) |
M/s. Bristol-Myers Squibb India |
GCT |
2024-May-07 |
|
740 KB |
40 |
Volrustomig (MEDI5752) |
M/s. AstraZeneca |
GCT |
2024-May-07 |
|
758 KB |
41 |
SAR445229 / amlitelimab |
M/s. Sanofi Healthcare India |
GCT |
2024-May-07 |
|
746 KB |
42 |
Relugolix,Estradiol and Norethindrone Acetate Tablets |
M/sSun Pharmaceutical industries Limited |
New Drugs |
2024-Apr-25 |
|
1904 KB |
43 |
Inclisiran solution for injection in Prefilled syringe 284mg/1.5ml |
M/S Novartis Healthcare Private Limited |
New Drugs |
2024-Apr-24 |
|
1334 KB |
44 |
DRL_AB |
M/s. Dr. Reddys |
GCT |
2024-Apr-22 |
|
547 KB |
45 |
Tildrakizumab |
M/s. Sun Pharma |
GCT |
2024-Apr-15 |
|
520 KB |
46 |
Tildrakizumab Injection 100 mg/ ml |
M/s. Sun Pharma |
GCT |
2024-Apr-15 |
|
502 KB |
47 |
RITLECITINIB |
M/s. Pfizer |
GCT |
2024-Apr-12 |
|
657 KB |
48 |
Durvalumab versus Sunitinib |
M/s. Fortrea |
GCT |
2024-Apr-12 |
|
554 KB |
49 |
ISB 2001 |
M/s. Glenmark |
GCT |
2024-Apr-05 |
|
655 KB |
50 |
AZD5305 |
M/s. AstraZeneca |
GCT |
2024-Mar-26 |
|
689 KB |
51 |
AKP02G2 |
M/s. Cliantha |
GCT |
2024-Mar-20 |
|
657 KB |
52 |
Typhoid Vi Conjugate Vaccine (Typhoid (Vi Capsular Polysaccharide) - Tetanus Toxoid Conjugate Vaccine) |
M/s Bharat Biotech International Ltd |
Vaccine |
2024-Mar-19 |
|
284 KB |
53 |
Fluticasone Furoate 100mcg + Glycopyrronium Bromide Ph. Eur eq. to Glycopyrronium 50mcg + Vilanterol Trifenatate |
M/sLupin Limited |
FDC |
2024-Mar-08 |
|
215 KB |
54 |
Romiplostim 250µg/0.5mL |
M/s Levim Biotech LLP |
rDNA |
2024-Mar-08 |
|
568 KB |
55 |
Ustekinumab 45mg/0.5mL |
M/s Biocon Biologics Limited |
rDNA |
2024-Mar-06 |
|
700 KB |
56 |
Filgrastim 300mcg/0.5ml |
M/s CuraTeQ Biologics Private Limited |
rDNA |
2024-Mar-06 |
|
698 KB |
57 |
Brexpiprazole 1mg/2mg/3mg/4mg Tablets |
M/s Torrent Pharmaceuticals Limited |
New Drugs |
2024-Mar-04 |
|
1310 KB |
58 |
iptacopan (LNP023) |
M/s. Novartis |
GCT |
2024-Mar-01 |
|
654 KB |
59 |
Belantamab Mafodotin |
M/s. GSK |
GCT |
2024-Mar-01 |
|
569 KB |
60 |
cagrilintide and semaglutide (CagriSema) 2.4mg/2.4mg s.c. |
M/s. Novo-Nordisk |
GCT |
2024-Mar-01 |
|
749 KB |
61 |
Bevacizumab 25 mg/mL |
M/s. CuraTeQ Biologics Private Limited |
rDNA |
2024-Mar-01 |
|
706 KB |
62 |
Sisunatovir |
M/s. Pfizer |
GCT |
2024-Mar-01 |
|
666 KB |
63 |
BION-1301 |
M/s. PPD |
GCT |
2024-Feb-29 |
|
685 KB |
64 |
ziltivekimab |
M/s. Novo-Nordisk |
GCT |
2024-Feb-28 |
|
805 KB |
65 |
Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized) |
M/s Panacea Biotec Ltd |
Vaccine |
2024-Feb-28 |
|
350 KB |
66 |
Rusfertide (PTG-300) |
M/s. JSS |
GCT |
2024-Feb-28 |
|
652 KB |
67 |
ALXN1850 |
M/s. AstraZeneca |
GCT |
2024-Feb-22 |
|
657 KB |
68 |
AZD4604 |
M/s. AstraZeneca |
GCT |
2024-Feb-22 |
|
672 KB |
69 |
Varicella Zoster Virus (VZV) Vaccine |
M/s Cadila Pharmaceuticals Limited |
Vaccine |
2024-Feb-21 |
|
283 KB |
70 |
Bevacizumab Injection 1.25 mg |
M/s. Gennova Biopharmaceuticals Limited |
rDNA |
2024-Feb-20 |
|
719 KB |
71 |
CEFEPIME-ZIDEBACTAM (FEP-ZID) WCK5222 |
M/s. Wockhardt |
GCT |
2024-Feb-20 |
|
660 KB |
72 |
KLU156 with Coartem® |
M/s. Novartis |
GCT |
2024-Feb-20 |
|
655 KB |
73 |
PANTOPRAZOLE |
M/s. Pfizer |
GCT |
2024-Feb-16 |
|
659 KB |
74 |
Vilanterol Trifenatate eq. to Vilanterol 25mcg + Glycopyrrolate IP eq. to Glycopyrronium 50mcg + Fluticasone Furoate 200mcg powder for inhalation in capsule |
M/sZydus Healthcare Limited |
FDC |
2024-Feb-16 |
|
358 KB |
75 |
Test Formulation A: Dutasteride 0.05% w/w + Minoxidil 5% w/w & Test Formulation B: Dutasteride 0.05% w/w + Latanoprost 0.03% w/w |
M/sGlenmark Pharmaceuticals Limited |
FDC |
2024-Feb-16 |
|
361 KB |
76 |
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) |
M/s Biological E |
Vaccine |
2024-Feb-16 |
|
311 KB |
77 |
Pembrolizumab |
M/s. AstraZeneca |
GCT |
2024-Feb-15 |
|
684 KB |
78 |
ISB 1442 |
M/s. Glenmark |
GCT |
2024-Feb-14 |
|
713 KB |
79 |
Curcumin (Biocurcumax capsule) |
M/s. ICMR |
GCT |
2024-Feb-14 |
|
875 KB |
80 |
tocilizumab biosimilar (DRL_Tocilizumab) |
M/sDr. Reddys |
GCT |
2024-Feb-14 |
|
662 KB |
81 |
Denosumab (Bmab 1000) 120mg/1.7mL |
M/s Biocon Biologics Limited |
rDNA |
2024-Feb-13 |
|
668 KB |
82 |
Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF) |
M/s. AstraZeneca |
GCT |
2024-Feb-13 |
|
671 KB |
83 |
Camizestrant (AZD9833 |
M/s. Fortea |
GCT |
2024-Feb-13 |
|
695 KB |
84 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg +10mg) film coated tablets |
M/sTorrent Pharmaceuticals Limited |
FDC |
2024-Feb-02 |
|
294 KB |
85 |
GIREDESTRANT |
M/s. Roche |
GCT |
2024-Feb-02 |
|
671 KB |
86 |
Dupilumab 150 mg/mL |
M/s Sanofi Healthcare India Pvt. Ltd |
rDNA |
2024-Feb-02 |
|
995 KB |
87 |
Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5%w/v + Nepafenac 0.1%w/v + Benzalkonium Chloride Solution IP 0.01%v/v |
M/sAkums Drugs and Pharmaceutical Ltd |
FDC |
2024-Feb-02 |
|
285 KB |
88 |
Fexuprazan Tablets |
M/s Sun Pharmaceuticals Industries Limited |
New Drugs |
2024-Feb-02 |
|
1408 KB |
89 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg + Sacubitril and Valsartan as Sodium salt complex 200mg (97mg and 103mg) |
M/sExemed Pharmaceuticals |
FDC |
2024-Jan-29 |
|
425 KB |
90 |
Brentuximab Vedotin 50mg |
M/s Takeda Biopharmaceuticals India Pvt. Ltd |
rDNA |
2024-Jan-29 |
|
562 KB |
91 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Linagliptin + Metformin Hydrochloride IP(10mg + 5mg + 500mg & 10mg + 5mg + 1000mg film coated tabletss |
M/sOptimus Pharma Pvt. Ltd |
FDC |
2024-Jan-29 |
|
340 KB |
92 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IPd |
M/sExemed Pharmaceuticals |
FDC |
2024-Jan-29 |
|
339 KB |
93 |
Lupin Denosumab 60mg/mL |
M/s Lupin Limited |
rDNA |
2024-Jan-29 |
|
883 KB |
94 |
Vonoprazan Fumarate 20 mg Tablets |
M/s BDR Pharmaceuticals |
New Drugs |
2024-Jan-25 |
|
1085 KB |
95 |
IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IBERDD) |
M/s. PPD |
GCT |
2024-Jan-19 |
|
668 KB |
96 |
Eluxadoline Tablets |
M/s Sun Pharmaceuticals Industries Limited |
New Drugs |
2024-Jan-19 |
|
1999 KB |
97 |
Insulin Aspart Mix 30, 100IU/mL |
M/s BioGenomics Limited |
rDNA |
2024-Jan-18 |
|
735 KB |
98 |
Efonidipine Hydrochloride Ethanolate 40mg + Telmisartan IP 40mg uncoated bilayered tablets |
M/sZuventus Healthcare Limited |
FDC |
2024-Jan-18 |
|
280 KB |
99 |
Triafarotene 50 µg/g Cream |
M/s Galderma |
New Drugs |
2024-Jan-15 |
|
1812 KB |
100 |
Upadacitinib Extednded Release Tablets |
M/s MSN Laboratories |
New Drugs |
2024-Jan-15 |
|
1972 KB |
101 |
Niraparib Tablets 100 mg |
M/s GSK Pharma India Pvt Ltd |
New Drugs |
2024-Jan-15 |
|
1940 KB |
102 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP |
M/sDr. Reddy's Laboratories Limited |
FDC |
2024-Jan-11 |
|
278 KB |
103 |
Gabapentin IP (as sustained release) + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptylinefilm coated bilayered tablets (Phase III) |
M/sRavenbhel Healthcare Pvt. Ltd |
FDC |
2024-Jan-11 |
|
311 KB |
104 |
Gabapentin IP (as film coated tablets) + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) (300mg + 30mg & 200mg + 20mg) |
M/sSynokem Pharmaceuticals Ltd |
FDC |
2024-Jan-11 |
|
282 KB |
105 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Telmisartan IP (10mg + 40mg & 10mg + 80mg tablets |
M/sExemed Pharmaceuticals |
FDC |
2024-Jan-11 |
|
280 KB |
106 |
Silodosin JP 8mg (as film coated tablet) + Tadalafil IP 5mg (as film coated tablet) hard gelatin capsules (Phase III) |
M/sAkums Drugs and Pharmaceutical Ltd |
FDC |
2024-Jan-11 |
|
301 KB |
107 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (10mg + 100mg & 25mg + 100mg) film coated tablets |
M/sZydus Healthcare Limited |
FDC |
2024-Jan-11 |
|
295 KB |
108 |
Dostarlimab, 500mg/10mL |
M/s. GSK Pharma India Private Limited |
rDNA |
2024-Jan-10 |
|
814 KB |
109 |
PHESGO |
M/s. Roche |
GCT |
2024-Jan-10 |
|
790 KB |
110 |
Mim8 |
M/s. Novo Nordisk |
GCT |
2024-Jan-08 |
|
672 KB |
111 |
Ambrisentan |
M/s. Nextvel |
GCT |
2024-Jan-08 |
|
272 KB |
112 |
Remibrutinib 25 mg b.i.d. |
M/s. Novartis |
GCT |
2024-Jan-08 |
|
681 KB |
113 |
DEGLUSTEROL ON FASTING GLUCOSE |
M/s. CBCC |
GCT |
2024-Jan-08 |
|
652 KB |
114 |
BI456906 |
M/s. IQVIA |
GCT |
2024-Jan-08 |
|
675 KB |
115 |
Abatacept biosimilar (DRL_AB) with Orencia |
M/s. Dr. Reddys |
GCT |
2024-Jan-08 |
|
671 KB |
116 |
SB27 (proposed pembrolizumab biosimilar) and Keytruda |
M/s Fortrea Development India Private Limited |
GCT |
2024-Jan-08 |
|
662 KB |
117 |
abeLacimab |
M/s Fortrea |
GCT |
2024-Jan-08 |
|
690 KB |
118 |
Sibeprenlimab |
M/s George Clinical |
GCT |
2024-Jan-08 |
|
684 KB |
119 |
Capivasertib plus CDK4/6 |
M/s. Astra Zeneca |
GCT |
2024-Jan-08 |
|
693 KB |
120 |
DEGLUSTEROL |
M/s. CBCC |
GCT |
2024-Jan-03 |
|
657 KB |
121 |
Linagliptin + Metformin Hydrochloride IP (as extended release) (2.5mg + 1000mg & 5mg + 1000mg) film coated bilayered tablet |
M/sSynokem Pharmaceuticals Ltd |
FDC |
2024-Jan-02 |
|
331 KB |
122 |
SARS-CoV-2 (Covid-19) Vaccine (Variant XBB.1.5) |
M/s Biological E Limited |
Vaccine |
2024-Jan-01 |
|
324 KB |
123 |
Mycobacterium Tuberculosis (Live, Attenuated) Vaccine |
M/s Bharat Biotech International Limited |
Vaccine |
2024-Jan-01 |
|
414 KB |
124 |
Golimumab 50mg/0.5mL |
M/s Reliance Life Sciences Pvt. Ltd |
rDNA |
2023-Dec-29 |
|
1098 KB |
125 |
Biphasic Isophane Insulin Injection IP 100IU/ml (30% soluble insulin/ 70% isophane insulin) |
M/s Regenix Biosciences Limited |
rDNA |
2023-Dec-29 |
|
718 KB |
126 |
101-PGC-005005CT/ND/45/2023 |
Laxai Life Sciences Pvt. Ltd |
New Drugs |
2023-Dec-28 |
|
883 KB |
127 |
101-PGC-005 |
Laxai Life Sciences Pvt. Ltd. |
New Drugs |
2023-Dec-28 |
|
829 KB |
128 |
CagriSema s.c. in doses 2.4/2.4 mg |
M/s. Novo Nordisk |
GCT |
2023-Dec-28 |
|
844 KB |
129 |
Cilnidipine IP 10mg + Bisoprolol Fumarate IP 5mg film coated tablet |
M/sAkums Drugs & Pharmaceuticals |
FDC |
2023-Dec-27 |
|
206 KB |
130 |
Vilanterol Trifenatate eq. to Vilanterol 12.5mcg + Glycopyrrolate IP eq. to Glycopyrronium 25mcg + Fluticasone Furoate 100mcg metered dose inhalation |
M/sZydus Healthcare |
FDC |
2023-Dec-27 |
|
275 KB |
131 |
Zinc chloride Ph. Eur. 1050 mcg + Sodium fluoride Ph. Eur. 210.0 mcg + Potassium iodide Ph. Eur. 16.60 mcg |
M/sFresenius Kabi |
FDC |
2023-Dec-27 |
|
2187 KB |
132 |
Iberdomidebri |
M/s Bristol-Myers Squibb |
GCT |
2023-Dec-27 |
|
674 KB |
133 |
spesolimab i.v |
M/s. IQVIA |
GCT |
2023-Dec-27 |
|
657 KB |
134 |
AnifrolumabAs |
M/s. Astra Zeneca |
GCT |
2023-Dec-27 |
|
687 KB |
135 |
Yellow Fever Vaccine (Live) I.P. |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2023-Dec-27 |
|
284 KB |
136 |
Afimetoran |
M/s Bristol-Myers Squibb |
GCT |
2023-Dec-27 |
|
657 KB |
137 |
Volrustomig |
M/s. Astra Zeneca |
GCT |
2023-Dec-26 |
|
687 KB |
138 |
iptacopan |
M/s. Novartis |
GCT |
2023-Dec-22 |
|
657 KB |
139 |
CBT-001 |
M/s. IQVIA |
GCT |
2023-Dec-22 |
|
673 KB |
140 |
JNJ-77242113 |
M/s. J&J |
GCT |
2023-Dec-22 |
|
658 KB |
141 |
Rusfertide PTG-300 |
M/s. Medpace |
GCT |
2023-Dec-22 |
|
670 KB |
142 |
Pretomanid BJ |
M/s B J Govt Medical College |
GCT |
2023-Dec-22 |
|
652 KB |
143 |
Dengue Tetravalent Vaccine (Live, Attenuated) Serum |
M/s Serum Institute of India Pvt |
Vaccine |
2023-Dec-21 |
|
319 KB |
144 |
FXIa inhibitor asundexianBAY 2433334 |
M/s. Bayer |
GCT |
2023-Dec-21 |
|
562 KB |
145 |
Varicella Vaccine (Live, Attenuated) |
M/s NOVO MEDI SCIENCES PRIVATE LIMITED |
Vaccine |
2023-Dec-21 |
|
427 KB |
146 |
Tozorakimabdec |
M/s. Astra Zeneca |
GCT |
2023-Dec-21 |
|
674 KB |
147 |
Gabapentin USP 6.0%w/w + Lidocaine HCl IP eq. to Lidocaine 5.0%w/w gel |
M/sAkums Drugs & Pharmaceuticals |
FDC |
2023-Dec-20 |
|
289 KB |
148 |
Acebrophylline 100mg + Erdosteine 300mg film coated tablets |
M/sMacleods Pharmaceuticals |
FDC |
2023-Dec-20 |
|
305 KB |
149 |
CRN04894dec |
M/s. PPD |
GCT |
2023-Dec-19 |
|
660 KB |
150 |
Zetomipzomib KZR-616 30 mg or 60 |
M/s. PPD |
GCT |
2023-Dec-19 |
|
802 KB |
151 |
Pegozafermin |
M/s. Medpace |
GCT |
2023-Dec-18 |
|
677 KB |
152 |
Pregabalin IP (as granules) + Duloxetine hydrochloride IP+ Methylcobalamin IP (as granules)hard gelatin capsule |
M/sRavenbhel Healthcare |
FDC |
2023-Dec-18 |
|
305 KB |
153 |
Camizestrant AZD9833 |
M/s. Labcorp |
GCT |
2023-Dec-14 |
|
695 KB |
154 |
EYU688 |
M/s. Novartis |
GCT |
2023-Dec-08 |
|
654 KB |
155 |
Baxdrostat |
M/s. Astra Zeneca |
GCT |
2023-Dec-08 |
|
695 KB |
156 |
Cefepime-Tazobactam WCK 4282 vs. Meropenem |
M/s. Wockhardt |
GCT |
2023-Dec-08 |
|
658 KB |
157 |
Denosumab 120mg/1.7mL |
M/s. Virchow Biotech Pvt. Ltd |
rDNA |
2023-Dec-08 |
|
736 KB |
158 |
Bempedoic Acid 180mg + Ezetimibe 10mg film coated tablets |
M/sOptimus Pharma |
FDC |
2023-Dec-07 |
|
337 KB |
159 |
Metformin Hydrochloride IP (SR) + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Linagliptin |
M/sMascot Health Serie |
FDC |
2023-Dec-07 |
|
326 KB |
160 |
RO7200220 |
M/s. Roche Products |
GCT |
2023-Dec-07 |
|
812 KB |
161 |
Dapagliflozin propanediol Monohydrate eq. to Dapagliflozin 10mg + Telmisartan 80mg film coated tablets |
M/sEris Life Sciences |
FDC |
2023-Dec-05 |
|
275 KB |
162 |
Cetuximab 100 mg/20 ml |
M/s. Enzene Biosciences Limited |
rDNA |
2023-Dec-05 |
|
807 KB |
163 |
Tedizolid Phosphate 200mg Tablet |
Exemed Pharmaceuticals |
New Drugs |
2023-Dec-05 |
|
1090 KB |
164 |
ianalumabdec |
M/s. Novartis |
GCT |
2023-Dec-05 |
|
658 KB |
165 |
Efruxifermindec |
M/s. Klinera |
GCT |
2023-Dec-05 |
|
703 KB |
166 |
SAR443765 |
M/s. Sanofi |
GCT |
2023-Dec-04 |
|
515 KB |
167 |
Tislelizumab |
M/s B10 HEALTH |
GCT |
2023-Dec-04 |
|
653 KB |
168 |
Ustekinumab Solution for Injection |
M/s Reliance Life Sciences Pvt. Ltd |
rDNA |
2023-Dec-01 |
|
1014 KB |
169 |
Olezarsen (ISIS 678354) |
M/s. Medpace |
GCT |
2023-Nov-30 |
|
682 KB |
170 |
Tropicamide 0.2mg + Phenylephrine Hydrochloride IP 3.1mg + Lidocaine Hydrochloride IP 10mg per ml Injection (Phase IV) |
M/sAppasamy Ocular |
FDC |
2023-Nov-29 |
|
296 KB |
171 |
Pregabalin IP 75mg + Duloxetine hydrochloride IP eq. to Duloxetine 30mg + Mecobalamin IP 1500mcg hard gelatin capsule |
M/sSynokem Pharmaceuticals |
FDC |
2023-Nov-29 |
|
333 KB |
172 |
Zetomipzomib (KZR-616) |
M/s. PPD |
GCT |
2023-Nov-29 |
|
801 KB |
173 |
Glimepiride IP + Linagliptin + Metformin HCL (As ER) IP (1mg + 2.5mg + 1000mg & 2mg + 2.5mg + 1000mg) film coated bilayered tablet |
M/sSynokem Pharmaceuticals |
FDC |
2023-Nov-29 |
|
325 KB |
174 |
Tenalisib 400mg Tablet |
Syngene International Ltd |
New Drugs |
2023-Nov-29 |
|
938 KB |
175 |
Sitagliptin Phosphate IP 100mg + Lobeglitazone Sulfate 0.5mg film coated tablet |
M/sSynokem Pharmaceuticals |
FDC |
2023-Nov-29 |
|
306 KB |
176 |
Suplatast Tosilate 100mg Capsule |
Syngene International Ltd |
New Drugs |
2023-Nov-28 |
|
1290 KB |
177 |
Typhoid Vi Conjugate Vaccine I.P. |
M/s Zydus Lifesciences Limited |
Vaccine |
2023-Nov-23 |
|
421 KB |
178 |
POZELIMAB AND CEMDISIRAN23 |
M/s. Parexel |
GCT |
2023-Nov-23 |
|
665 KB |
179 |
TIN816 |
M/s. Novartis |
GCT |
2023-Nov-22 |
|
654 KB |
180 |
LY3502970 Compared with Placebo |
M/s. Eli Lilly |
GCT |
2023-Nov-22 |
|
674 KB |
181 |
20-valent Pneumococcal Conjugate vaccine |
M/s. Pfizer |
GCT |
2023-Nov-22 |
|
669 KB |
182 |
Tezepelumab |
M/s. Astra Zeneca |
GCT |
2023-Nov-22 |
|
677 KB |
183 |
Serpin PCInven |
M/s. Inventiv |
GCT |
2023-Nov-22 |
|
652 KB |
184 |
CRN04894 |
M/s. PPD |
GCT |
2023-Nov-22 |
|
660 KB |
185 |
LY3502970l |
M/s. Eli Lilly |
GCT |
2023-Nov-22 |
|
670 KB |
186 |
BLU-5937IQVIA |
M/s. IQVIA |
GCT |
2023-Nov-17 |
|
666 KB |
187 |
ESK-001 |
M/s. Inventiv |
GCT |
2023-Nov-17 |
|
680 KB |
188 |
PEGylated Factor VIII(BAX 855) |
M/s. IQVIA |
GCT |
2023-Nov-17 |
|
673 KB |
189 |
LY3871801 |
M/s. Eli Lilly |
GCT |
2023-Nov-17 |
|
659 KB |
190 |
JDQ443 |
M/s. Novartis |
GCT |
2023-Nov-17 |
|
658 KB |
191 |
Efruxifermin |
M/s. Klinera |
GCT |
2023-Nov-17 |
|
673 KB |
192 |
Glimepiride IP + Metformin Hydrochloride IP (As sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1mg + 1000mg + 100mg & 2mg + 1000mg + 10mg) film coated bilayer tablets (Phase III) |
M/sMascot Health Series |
FDC |
2023-Nov-15 |
|
312 KB |
193 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Lobeglitazone Sulfate 0.5mg film coated tablets (Phase III) |
M/sAkums Drugs & Pharmaceuticals |
FDC |
2023-Nov-15 |
|
270 KB |
194 |
Pacritinib |
M/s. PSI CRO |
GCT |
2023-Nov-03 |
|
615 KB |
195 |
Parenteral TK-112690 |
M/s. Biosphere |
GCT |
2023-Nov-03 |
|
659 KB |
196 |
Combined tetanus toxoid, reduced diphtheria toxoid, reduced recombinant pertussis vaccine. (Tdapgen) |
M/s TechInvention Lifecare Pvt. Ltd |
Vaccine |
2023-Nov-03 |
|
274 KB |
197 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg + 10mg) film coated tablets (Phase III) |
M/sSynokem Pharmaceuticals |
FDC |
2023-Nov-02 |
|
345 KB |
198 |
Bilastine IP 3.3mg + Phenylephrine Hydrochloride IP 5mg + Dextromethorphan Hydrobromide IP 10mg syrup (Phase III) |
M/sSynokem Pharmaceuticals |
FDC |
2023-Nov-02 |
|
353 KB |
199 |
Montelukast Sodium IP 10mg + Fexofenadine hydrochloride IP 180mg Uncoated bilayered tablet (Phase III) |
M/sSynokem Pharmaceuticals |
FDC |
2023-Nov-02 |
|
319 KB |
200 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (25mg + 100mg & 10mg + 100mg) film coated tablet (Phase III) |
M/sExemed Pharmaceuticals |
FDC |
2023-Nov-02 |
|
336 KB |
201 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Metoprolol Succinate IP eq. to Metoprolol TartrateExtended Release50mg film coated bilayered tablet |
M/sExemed Pharmaceuticals |
FDC |
2023-Nov-02 |
|
250 KB |
202 |
Oral NRC-2694-A |
M/s. Natco Pharma |
GCT |
2023-Oct-31 |
|
654 KB |
203 |
BEMNIFOSBUVIR (BEM) AND RUZASVIR (RZR) |
M/s. IQVIA |
GCT |
2023-Oct-26 |
|
654 KB |
204 |
LY3502970lily |
M/s. Eli Lilly |
GCT |
2023-Oct-26 |
|
678 KB |
205 |
LY3437943eli |
M/s. Eli Lilly |
GCT |
2023-Oct-26 |
|
690 KB |
206 |
PF-06823859 |
M/s. Pfizer |
GCT |
2023-Oct-25 |
|
657 KB |
207 |
IcoSema and daily insulin glargine 100 units/mL |
M/s. Novo-Nordisk |
GCT |
2023-Oct-23 |
|
678 KB |
208 |
MK-7684 with Pembrolizumab |
M/s. MSD |
GCT |
2023-Oct-23 |
|
661 KB |
209 |
NAPTUMOMAB ESTAFENATOX |
M/s. PFC Pharma |
GCT |
2023-Oct-23 |
|
512 KB |
210 |
TP-102 |
M/s. JSS |
GCT |
2023-Oct-23 |
|
656 KB |
211 |
POZELIMAB AND CEMDISIRAN |
M/s. Parexel |
GCT |
2023-Oct-20 |
|
665 KB |
212 |
RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) |
M/s. IQVIA |
GCT |
2023-Oct-19 |
|
704 KB |
213 |
ASTEGOLIMAB |
M/s. PPD |
GCT |
2023-Oct-18 |
|
697 KB |
214 |
Benralizumab 100mg |
M/s. AstraZeneca |
GCT |
2023-Oct-17 |
|
677 KB |
215 |
Mavacamten |
M/s. BMS |
GCT |
2023-Oct-17 |
|
663 KB |
216 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Pioglitazone Hydrochloride IP 15mg film coated tablets (Phase III) |
M/sEris Life Sciences |
FDC |
2023-Oct-17 |
|
282 KB |
217 |
Insulin Injection IP 100 IU/mL |
M/s Regenix BiosciencesLimited |
rDNA |
2023-Oct-16 |
|
578 KB |
218 |
Vonoprazan Fumarate 20mg tablet |
Dr. Reddy's Laboratories Ltd |
New Drugs |
2023-Oct-12 |
|
1994 KB |
219 |
Polmacoxib 2mg + Paracetamol IP 325 mg (Phase III) |
M/sHetero Labs |
FDC |
2023-Oct-10 |
|
299 KB |
220 |
Glimepiride IP + Metformin Hydrochloride IP (as extended release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1mg + 1000mg + 100mg & 2mg + 1000mg + 100mg) tablets (Phase III) |
M/sInnova Captab |
FDC |
2023-Oct-10 |
|
308 KB |
221 |
Denosumabcura |
M/s CuraTeQ Biologics Private Ltd |
rDNA |
2023-Oct-09 |
|
697 KB |
222 |
Divozilimab |
M/s. Invitro Research |
GCT |
2023-Oct-06 |
|
558 KB |
223 |
LY3437943 |
M/s. Eli Lilly |
GCT |
2023-Sep-26 |
|
672 KB |
224 |
SerpinPC |
M/s. Inventiv |
GCT |
2023-Sep-26 |
|
641 KB |
225 |
Dengue Tetravalent Vaccine (Live, Attenuated) |
M/s IQVIA RDS (India) Private Limited |
Vaccine |
2023-Sep-19 |
|
298 KB |
226 |
Insulin Lispro Ultrarapid(UR) Injection |
M/s. Eli Lilly and Company (India) Pvt. Ltd |
rDNA |
2023-Sep-18 |
|
669 KB |
227 |
Atacicept |
M/s. Medpace |
GCT |
2023-Sep-16 |
|
683 KB |
228 |
Lumateperone Tosylate 42mg capsule |
Sun Pharma Laboratories Ltd. |
New Drugs |
2023-Sep-15 |
|
1137 KB |
229 |
Milvexian, an Oral Factor XIa Inhibitor |
M/s. IQVIA |
GCT |
2023-Sep-13 |
|
739 KB |
230 |
Metformin Hydrochloride IP (as ER) + Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1000mg + 1mg + 100mg & 1000mg + 2mg + 100mg) film coated bilayered tablets (Phase III) |
M/sExemed Pharmaceuticals |
FDC |
2023-Sep-12 |
|
350 KB |
231 |
Crovalimab |
M/s. Roche |
GCT |
2023-Sep-06 |
|
641 KB |
232 |
Denosumab Injection |
M/s. Reliance Life Sciences Pvt Ltd |
rDNA |
2023-Sep-06 |
|
820 KB |
233 |
Benralizumab |
M/s. Labcorp |
GCT |
2023-Sep-06 |
|
648 KB |
234 |
Insulin Glargine Injection |
M/s. Regenix BiosciencesLimited |
rDNA |
2023-Sep-01 |
|
578 KB |
235 |
Denosumabrdna |
M/s. Hetero Biopharma Limited |
rDNA |
2023-Aug-31 |
|
733 KB |
236 |
PB016 and Entyvio |
M/s. Woldwide |
GCT |
2023-Aug-30 |
|
723 KB |
237 |
Fexofenadine Hydrochloride IP 180mg + Montelukast Sodium IP eq. to Montelukast 10mg tablets (Phase III) |
M/sExemed Pharmaceuticals |
FDC |
2023-Aug-30 |
|
316 KB |
238 |
Tadalafil IP 5mg (as film coated tablet) + Tamsulosin Hydrochloride IP 0.4mg (Prolonged release tablet) hard gelatin capsules (Phase IV) |
M/sAkums Drugs & Pharmaceuticals |
FDC |
2023-Aug-30 |
|
305 KB |
239 |
Varespladib |
M/s. Inventiv |
GCT |
2023-Aug-29 |
|
648 KB |
240 |
Tozorakimab (MEDI3506) |
M/s. AstraZeneca |
GCT |
2023-Aug-29 |
|
672 KB |
241 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Metoprolol Succinate IP eq. to Metoprolol Tartrate (as extended release) 50mg film coated bilayered tablet (Phase III) |
M/sExemed Pharmaceuticals |
FDC |
2023-Aug-25 |
|
583 KB |
242 |
RSVPreF3 |
M/s. GSK |
GCT |
2023-Aug-25 |
|
615 KB |
243 |
FXIa inhibitor asundexian (BAY 2433334) |
M/s. Bayer |
GCT |
2023-Aug-25 |
|
547 KB |
244 |
nebulized PC945 |
M/s. PSI CRO |
GCT |
2023-Aug-25 |
|
654 KB |
245 |
Bilastine 40mg + Montelukast Sodium IP eq. to Montelukast 10mg tablets (Phase III) |
M/sExemed Pharmaceuticals |
FDC |
2023-Aug-25 |
|
291 KB |
246 |
Trinbelimab Injection |
M/s. Syngene International Limited |
rDNA |
2023-Aug-24 |
|
734 KB |
247 |
Quadrivalent Human Papillomavirus (Serotypes 6, 11, 16 & 18) Vaccine |
M/s. Serum Institute of India Pvt. Ltd |
Vaccine |
2023-Aug-24 |
|
441 KB |
248 |
Denosumab |
M/s. Lupin |
GCT |
2023-Aug-24 |
|
643 KB |
249 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14 Valent) |
M/s Biological E |
Vaccine |
2023-Aug-21 |
|
341 KB |
250 |
BI1015550 |
M/s. IQVIA |
GCT |
2023-Aug-19 |
|
643 KB |
251 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Bisoprolol Fumarate IP (10mg + 5mg & 10mg +10mg) tablet (Phase III) |
M/s Eris Life Sciences |
SND |
2023-Aug-11 |
|
508 KB |
252 |
Bempedoic Acid + Rosuvastatin Calcium IP eq. to Rosuvastatin (180mg + 5mg, 180mg + 10mg & 180mg + 20mg) tablets (Phase III) |
M/sExemed Pharmaceuticals |
FDC |
2023-Aug-11 |
|
587 KB |
253 |
Dapagliflozin propanediol Monohydrate eq. to Dapagliflozin + Linagliptin + Metformin Hydrochloride IP (as sustained release) tablets (Phase III) |
Theon Pharmaceuticals Ltd |
FDC |
2023-Aug-09 |
|
406 KB |
254 |
WD1905 Tablets with SINEMET |
M/s. Cliantha |
GCT |
2023-Aug-04 |
|
637 KB |
255 |
Indacaterol (as acetate) eq. to Indacaterol + Glycopyrrolate IP eq. to Glycopyrronium + Mometasone Furoate IP powder for inhalation (Phase IV) |
Glenmark Pharmaceuticals |
FDC |
2023-Aug-04 |
|
348 KB |
256 |
LY3502970 |
M/s. Eli Lilly |
GCT |
2023-Aug-03 |
|
681 KB |
257 |
HT-6184 |
M/s. CBCC |
GCT |
2023-Aug-03 |
|
636 KB |
258 |
Tenecteplase |
M/s. Hetero Biopharma Limited |
rDNA |
2023-Aug-01 |
|
732 KB |
259 |
Bilastine + Dextromethorphan Hydrobromide + Phenylephrine Hydrochloride syrup (Phase III) |
Glenmark Pharmaceuticals |
FDC |
2023-Jul-28 |
|
414 KB |
260 |
Budesonide IP + Formoterol Fumarate IP + Glycopyrronium Ph. Eur inhalation powder (Phase IV |
)Lupin Ltd |
FDC |
2023-Jul-28 |
|
435 KB |
261 |
RLS Protein Subunit Vaccine against SARS CoV 2 Virus |
M/s Reliance Life Sciences |
Vaccine |
2023-Jul-27 |
|
612 KB |
262 |
Afliberceptz |
M/s Zydus Lifesciences Ltd |
rDNA |
2023-Jul-26 |
|
624 KB |
263 |
PZN-128 powder for solution |
M/s. GCT Pharma |
GCT |
2023-Jul-25 |
|
480 KB |
264 |
Gedatolisib |
M/s. PSI CRO |
GCT |
2023-Jul-19 |
|
657 KB |
265 |
IPV vaccine |
M/s Biological E Hyderabad |
Vaccine |
2023-Jul-19 |
|
410 KB |
266 |
Milvexian, an Oral Factor XIa |
M/s. IQVIA |
GCT |
2023-Jul-17 |
|
684 KB |
267 |
NM8074 |
M/s. Ablenio Sciences Pvt. Ltd |
rDNA |
2023-Jul-17 |
|
692 KB |
268 |
CC-92480 (BMS-986348) |
M/s. BMS |
GCT |
2023-Jul-17 |
|
663 KB |
269 |
ExPEC9V |
M/s. PRA |
GCT |
2023-Jul-14 |
|
668 KB |
270 |
Metformin Hydrochloride IP (As Extended release form) + Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin tablets (Phase IV) |
Akums Drugs & Pharmaceuticals |
FDC |
2023-Jul-13 |
|
314 KB |
271 |
Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase IV |
Synokem Pharmaceuticals |
FDC |
2023-Jul-13 |
|
329 KB |
272 |
Mirabegron (as extended release form) + Silodosin tablets (Phase III) |
Pure & Cure Healthcare |
FDC |
2023-Jul-13 |
|
313 KB |
273 |
Tegoprazan |
M/s. Dr. Reddys |
GCT |
2023-Jul-12 |
|
535 KB |
274 |
AZD2693 |
M/s. AstraZeneca |
GCT |
2023-Jul-12 |
|
405 KB |
275 |
ianalumab (VAY736)g |
M/s. Novartis |
GCT |
2023-Jul-04 |
|
636 KB |
276 |
HRF-10071 and Lamivudine |
M/s Synapse Labs Pvt. Ltd |
IND |
2023-Jul-03 |
|
1753 KB |
277 |
Levormeloxifene |
M/s Cipla Limited |
IND |
2023-Jul-03 |
|
2039 KB |
278 |
Indacaterol Acetate eq. to Indacaterol IH+ Glycopyrronium Bromide eq. to Glycopyrronium Ph Eur + Mometasone Furoate eq. to Mometasone Furoate IP inhalation powder (Phase IV) |
M/s. Lupin Ltd |
FDC |
2023-Jul-03 |
|
313 KB |
279 |
LtdLNP3693 |
M/s Lupin |
IND |
2023-Jul-03 |
|
2170 KB |
280 |
BI 685509 |
M/s. IQVIA |
GCT |
2023-Jun-30 |
|
645 KB |
281 |
cagrilintide 2.4 mg s.c. |
M/s. Novo-Nordisk |
GCT |
2023-Jun-30 |
|
695 KB |
282 |
Varicella Vaccine |
M/s Techinvention Lifecare |
Vaccine |
2023-Jun-28 |
|
391 KB |
283 |
Diltiazem Hydrochloride 2% Gel |
M/s. Cliantha |
GCT |
2023-Jun-26 |
|
385 KB |
284 |
TeriparatideI |
M/s Intas Pharmaceuticals Ltd |
rDNA |
2023-Jun-21 |
|
772 KB |
285 |
Pegfilgrastim Injection |
M/s. CuraTeQ Biologics Private Limited |
rDNA |
2023-Jun-21 |
|
660 KB |
286 |
Pertuzumab And Trastuzumab |
M/s. Roche |
GCT |
2023-Jun-16 |
|
653 KB |
287 |
MK-7684A (Vibostolimab with Pembrolizumab) |
M/s. MSD |
GCT |
2023-Jun-16 |
|
640 KB |
288 |
Imeglimin 500mg and 1000mg tablets |
M/s Synokem Pharmaceuticals Ltd |
New Drugs |
2023-Jun-16 |
|
2234 KB |
289 |
BI 1015550 |
M/s. IQVIA |
GCT |
2023-Jun-16 |
|
393 KB |
290 |
TAR-200 |
M/s. J&J |
GCT |
2023-Jun-13 |
|
648 KB |
291 |
Insulin Aspart Mix 70/30 Injection |
M/s Mankind Pharma Ltd |
rDNA |
2023-Jun-13 |
|
749 KB |
292 |
AUR107, |
M/s Aurigene Discovery Technologies Limited |
New Drugs |
2023-Jun-13 |
|
3145 KB |
293 |
ianalumab (VAY736) |
M/s. Novartis |
GCT |
2023-Jun-12 |
|
640 KB |
294 |
Anti-COVID-19 AKS-452 |
M/s. Veeda |
GCT |
2023-Jun-12 |
|
644 KB |
295 |
VTX958 |
M/s. Psi CRO |
GCT |
2023-Jun-12 |
|
642 KB |
296 |
Mino-Lok Therapy (MLT) |
M/s. Biorasi |
GCT |
2023-Jun-12 |
|
668 KB |
297 |
ADL-018 150 mg and 300 mg |
M/s. Kashiv Biosciences |
GCT |
2023-Jun-12 |
|
454 KB |
298 |
Montelukast Sodium IP + Bilastine orodispersible tablets (Phase IV) |
M/s. Synokem Pharmaceuticals Ltd |
FDC |
2023-Jun-07 |
|
322 KB |
299 |
finerenone plus empagliflozin |
M/s. Labcorp |
GCT |
2023-Jun-07 |
|
655 KB |
300 |
Gabapentin IP + Nortriptyline HCl IP eq. to Nortriptyline film coated tablets (Phase IV) |
M/s. Synokem Pharmaceuticals Ltd |
FDC |
2023-Jun-07 |
|
271 KB |
301 |
Vedolizumab injection |
M/s Takeda Biopharmaceuticals India Pvt. Ltd |
rDNA |
2023-Jun-06 |
|
696 KB |
302 |
Asciminib |
M/s. Novartis |
GCT |
2023-Jun-06 |
|
641 KB |
303 |
BevacizumabRLS |
M/s Reliance Life Sciences Pvt. Ltd. |
rDNA |
2023-Jun-06 |
|
651 KB |
304 |
BLU-5937 |
M/s. IQVIA |
GCT |
2023-Jun-03 |
|
405 KB |
305 |
PertuzumabA |
M/s Accutest ResearchLaboratories (I) Pvt. Ltd |
rDNA |
2023-Jun-01 |
|
915 KB |
306 |
Sovateltide injection 30μg |
M/s Pharmazz India Private Limited |
IND |
2023-May-31 |
|
2837 KB |
307 |
CKJX839D12302inclisiran |
M/s. Novartis |
GCT |
2023-May-26 |
|
689 KB |
308 |
Darbepoetin alfa |
M/s Dr. Reddyâs Laboratories Limited |
rDNA |
2023-May-25 |
|
763 KB |
309 |
Idursulfase |
M/s Takeda Biopharmaceuticals India Pvt. Ltd |
rDNA |
2023-May-24 |
|
672 KB |
310 |
Tofacitinib Gel 2% w/w |
M/s. Precise Biopharma Pvt. Ltd |
SND |
2023-May-23 |
|
438 KB |
311 |
Nor-Ursodeoxycholic Acid 1500mg |
M/s Shilpa Medicare Limited |
IND |
2023-May-23 |
|
2575 KB |
312 |
Glycopyrronium (As Glycopyrrolate IP) + Budesonide IP + Formoterol Fumarate (As Formoterol Fumarate Dihydrate IP) powder for inhalation (in capsule) (Phase IV) |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2023-May-23 |
|
325 KB |
313 |
Japanese Encephalitis Vaccine |
M/s Biological E Hyderabad |
Vaccine |
2023-May-23 |
|
139 KB |
314 |
SAR408701 versus docetaxel |
M/s. Sanofi |
GCT |
2023-May-23 |
|
507 KB |
315 |
(+)-Alpha- Dihydrotetrabenazine ({+})-α-DHTBZ) Powder |
M/s Synapse Labs Pvt. Ltd. |
IND |
2023-May-23 |
|
2205 KB |
316 |
Bemnifosbuvir |
M/s. IQVIA |
GCT |
2023-May-19 |
|
672 KB |
317 |
Auxora |
M/s. JSS |
GCT |
2023-May-19 |
|
639 KB |
318 |
Ustekinumab |
M/s Johnson and Johnson Private Limited |
rDNA |
2023-May-19 |
|
681 KB |
319 |
Amoxycillin Trihydrate IP eq. to Amoxycillin + Potassium Clavulanate diluted IP eq. to Clavulanic Acid of the reconstituted suspension (Phase IV) |
M/s. Sun Pharmaceuticals Industries Ltd |
FDC |
2023-May-16 |
|
362 KB |
320 |
ABX464 |
M/s. IQVIA |
GCT |
2023-May-12 |
|
676 KB |
321 |
ABX464 once daily |
M/s. IQVIA |
GCT |
2023-May-12 |
|
667 KB |
322 |
ABX464 25 mg or 50 mg |
M/s. IQVIA |
GCT |
2023-May-10 |
|
727 KB |
323 |
Fluconazole (MARIO) |
M/s. PSI CRO |
GCT |
2023-May-10 |
|
651 KB |
324 |
Guselkumab and Golimumab |
M/s. Parexel |
GCT |
2023-May-09 |
|
649 KB |
325 |
Guselkumab and Golimumab in Participants |
M/s. Parexel |
GCT |
2023-May-09 |
|
644 KB |
326 |
ARV-471 (PF-07850327) |
M/s. Pfizer |
GCT |
2023-May-08 |
|
661 KB |
327 |
Aztreonam- Avibactam ± Metronidazole |
M/s. Pfizer |
GCT |
2023-May-08 |
|
638 KB |
328 |
Daratumumab SC and Lenalidomide (Tec-DR) |
M/s. J&J |
GCT |
2023-May-04 |
|
645 KB |
329 |
Adalimumab Injection |
M/s Enzene Biosciences Ltd |
rDNA |
2023-Apr-28 |
|
731 KB |
330 |
Oral Ozanimod |
M/s. PSI CRO |
GCT |
2023-Apr-26 |
|
662 KB |
331 |
Glycopyrrolate IP + Budesonide IP + Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate per actuation delivers (ex-actuator) inhalation aerosol (Phase IV) |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2023-Apr-24 |
|
311 KB |
332 |
Bupropion Hydrochloride IP (as extended release) + Dextromethorphan Hydrobromide IP tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2023-Apr-24 |
|
365 KB |
333 |
Hexavalent DtwP-HepB-IPV-Heb Liq.Hexa vaccine |
M/s Biological E Hyderabad |
Vaccine |
2023-Apr-24 |
|
127 KB |
334 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Pioglitazone Hydrochloride IP Eq. to Pioglitazone tablets (Phase III) |
M/s. Akums Drugs and Pharmaceutical Ltd |
FDC |
2023-Apr-24 |
|
289 KB |
335 |
Guselkmab |
M/s. J&J |
GCT |
2023-Apr-21 |
|
650 KB |
336 |
Fluticasone Propionate HFA ,Pressurized Metered Dose Inhaler 110mcg ex-actuator dose (125rncg ex-valve dose) |
M/s Cipla Limited |
New Drugs |
2023-Apr-21 |
|
1256 KB |
337 |
FluticasonePropionate HFA Pressurized Metered Dose Inhaler 110mcg ex-actuator dose (125rncg ex-valve dose) |
M/s Cipla Limited |
IND |
2023-Apr-21 |
|
2510 KB |
338 |
Faricimab (RO686746 |
M/s. Roche |
GCT |
2023-Apr-20 |
|
656 KB |
339 |
Vonoprazan 20 Mg. Tablets/ Pantoprazole 40 Mg |
M/s Optimus Pharma Private Limited |
New Drugs |
2023-Apr-20 |
|
125 KB |
340 |
Vonoprazan 20 Mg Tablets/ Pantoprazole 40 Mg |
M/s Optimus Pharma Private Limited |
IND |
2023-Apr-20 |
|
2421 KB |
341 |
Datopotamab Deruxtecan (Dato-DXd) |
M/s. AstraZeneca |
GCT |
2023-Apr-19 |
|
657 KB |
342 |
Ozanimod |
M/s. PSI CRO |
GCT |
2023-Apr-18 |
|
662 KB |
343 |
AUR108 |
M/s Aurigene Oncology Limited |
IND |
2023-Apr-18 |
|
2378 KB |
344 |
Lumateperone |
M/s. IQVIA |
GCT |
2023-Apr-17 |
|
677 KB |
345 |
filgotinib |
M/s. PRA |
GCT |
2023-Apr-17 |
|
655 KB |
346 |
AUR107 |
M/s Aurigene Discovery Technologies Limited |
IND |
2023-Apr-13 |
|
2418 KB |
347 |
Topical 1% AKP-11 |
M/sICBio Clinical Research Pvt. Ltd |
IND |
2023-Apr-13 |
|
2339 KB |
348 |
Lumateperone as Adjunctive Therapy |
M/s. IQVIA |
GCT |
2023-Apr-12 |
|
677 KB |
349 |
Imlunestrant |
M/s. Eli Lilly |
GCT |
2023-Apr-12 |
|
674 KB |
350 |
Basimglurant |
M/s. CliniRx |
GCT |
2023-Apr-12 |
|
667 KB |
351 |
Agalsidase alfa |
M/s Takeda Biopharmaceuticals India Pvt. Ltd |
rDNA |
2023-Apr-12 |
|
567 KB |
352 |
Ranibizumab r-dna |
M/s. Lupin Limited |
rDNA |
2023-Apr-11 |
|
693 KB |
353 |
Pertuzumabf |
M/s Enzene Biosciences Ltd |
rDNA |
2023-Apr-10 |
|
832 KB |
354 |
Pegfilgrastimn |
M/s. Virchow Biotech Pvt. Ltd |
rDNA |
2023-Apr-09 |
|
699 KB |
355 |
Imeglimin Hydrochloride sustend release tablets 1000 mg |
M/s Synokem Pharmaceuticals Ltd |
IND |
2023-Apr-06 |
|
2277 KB |
356 |
Coagulation Factor VIII (Recombinant) rFVIII |
M/s Takeda Biopharmaceuticals India Pvt. Ltd |
rDNA |
2023-Apr-03 |
|
840 KB |
357 |
ARO-APOC3 |
M/s Medpace |
GCT |
2023-Apr-03 |
|
771 KB |
358 |
Ocrelizumab |
M/s. PPD |
GCT |
2023-Apr-03 |
|
675 KB |
359 |
cagrilintide s.c. 2.4 mg |
M/s. Novo-Nordisk |
GCT |
2023-Mar-31 |
|
675 KB |
360 |
Aflibercept |
M/s Shilpa Biologicals Private Limited |
rDNA |
2023-Mar-31 |
|
1115 KB |
361 |
Sodium Zirconium Cyclosilicatec |
M/s. AstraZeneca |
GCT |
2023-Mar-31 |
|
378 KB |
362 |
xevinapant |
M/s. IQVIA |
GCT |
2023-Mar-31 |
|
645 KB |
363 |
Teclistamab |
M/s. J&J |
GCT |
2023-Mar-28 |
|
653 KB |
364 |
JNJ-63723283 |
M/s. J&J |
GCT |
2023-Mar-28 |
|
657 KB |
365 |
Dydrogesterone Extended Release Tablet 20 mgM |
M/s.Synokem Pharmaceuticals Ltd |
SND |
2023-Mar-27 |
|
358 KB |
366 |
Tozorakimab |
M/s. AstraZeneca |
GCT |
2023-Mar-27 |
|
660 KB |
367 |
EPX-100 |
M/s. GCT Pharma |
GCT |
2023-Mar-23 |
|
749 KB |
368 |
AUR106 |
M/s Synapse Labs Pvt. Ltd. |
IND |
2023-Mar-17 |
|
2112 KB |
369 |
HRF-10071 tablet 120 mg and Metformin 500mg IR Tablet |
M/s Aurigene Discovery Technologies Limited |
IND |
2023-Mar-17 |
|
2048 KB |
370 |
Glimepiride IP + Linagliptin film coated tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2023-Mar-17 |
|
354 KB |
371 |
Pioglitazone Hydrochloride IP Eq. to Pioglitazone Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2023-Mar-17 |
|
327 KB |
372 |
Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2023-Mar-17 |
|
367 KB |
373 |
Rosuvastatin Calcium IP eq. to Rosuvastatin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2023-Mar-16 |
|
395 KB |
374 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Pioglitazone HCl IP eq. to Pioglitazone film coated tablets (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2023-Mar-13 |
|
308 KB |
375 |
Chlorthalidone IP + Cilnidipine IP + Bisoprolol Fumarate IP film coated tablets |
M/s. Windlas Biotech Ltd |
FDC |
2023-Mar-13 |
|
298 KB |
376 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablets |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2023-Mar-13 |
|
329 KB |
377 |
Vildagliptin + Dapagliflozin + Metformin Hydrochloride IP tablets (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2023-Mar-13 |
|
304 KB |
378 |
Dydrogesterone Extended Release Tablet 20 mg |
M/s. Zydus Healthcare Limited |
SND |
2023-Mar-07 |
|
411 KB |
379 |
FS118 |
M/s. Star Genomics |
GCT |
2023-Mar-03 |
|
699 KB |
380 |
17β-Hydroxysteroid Dehydrogenase type 13 |
M/s. GSk |
GCT |
2023-Mar-03 |
|
654 KB |
381 |
LY3209590 |
M/s. Eli Lilly |
GCT |
2023-Mar-03 |
|
644 KB |
382 |
HBI-8000 Combined with Nivolumab |
M/s. Novotech |
GCT |
2023-Mar-03 |
|
661 KB |
383 |
Ranibizumab |
M/s Enzene Biosciences Ltd. |
rDNA |
2023-Mar-01 |
|
715 KB |
384 |
Faricimab (RO6867461) |
M/s. Roche |
GCT |
2023-Feb-22 |
|
640 KB |
385 |
JDQ443 versus docetaxel |
M/s. Novartis |
GCT |
2023-Feb-22 |
|
651 KB |
386 |
Pertuzumab |
M/s Intas Pharmaceuticals Ltd |
rDNA |
2023-Feb-21 |
|
780 KB |
387 |
Vilanterol Trifenatate eq. to Vilanterol + Glycopyrrolate IP eq. to Glycopyrronium metered dose inhalation (Phase III) |
M/s. Zydus Healthcare Limited |
FDC |
2023-Feb-15 |
|
380 KB |
388 |
Ianalumab CT/22/000006 |
M/s. Novartis |
GCT |
2023-Feb-15 |
|
657 KB |
389 |
Elagolix Tablets ,150 mg & 200mg |
M/s MSN Laboratories Pvt. Ltd |
New Drugs |
2023-Feb-14 |
|
2413 KB |
390 |
Elagolix Tablets 150 mg & 200mg |
M/s MSN Laboratories Pvt. Ltd |
IND |
2023-Feb-14 |
|
2413 KB |
391 |
Sodium Zirconium Cyclosilicate |
M/s. Astra Zeneca |
GCT |
2023-Feb-13 |
|
671 KB |
392 |
Bepirovirsen |
M/s. GSk |
GCT |
2023-Feb-13 |
|
680 KB |
393 |
Bepirovirsen in HBeAg-negative |
M/s. GSk |
GCT |
2023-Feb-13 |
|
682 KB |
394 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Metoprolol Succinate IP eq. to Metoprolol Tartrate (As sustained release) film coated bilayered tablets (Phase III) |
M/s. Eris Lifesciences Ltd |
FDC |
2023-Feb-09 |
|
349 KB |
395 |
Liquid Nasal Spray (Nitric oxide) (100 ppm) |
M/s.Meril Diagnostics Pvt. Ltd |
SND |
2023-Feb-08 |
|
351 KB |
396 |
Fosnetupitant 235 mg and Palonosetron 0.25mg |
M/s Glenmark Pharmaceuticals Ltd |
IND |
2023-Feb-06 |
|
2476 KB |
397 |
Vildagliptin IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Ltd |
FDC |
2023-Feb-06 |
|
351 KB |
398 |
Imeglimi.n Hydrochloride sustend release tablets 1000 mg |
M/s Synokem Pharmaceuticals Ltd. |
New Drugs |
2023-Feb-06 |
|
2277 KB |
399 |
Fosnetupitant, 235 mg and Palonosetron 0.25mg |
M/s Glenmark Pharmaceuticals Ltd. |
New Drugs |
2023-Feb-06 |
|
2472 KB |
400 |
Recombinant Rabies G protein Vaccine |
M/s Cadila Pharma Ltd |
Vaccine |
2023-Feb-03 |
|
94 KB |
401 |
VTX002 |
M/s. PSI CRO |
GCT |
2023-Jan-30 |
|
661 KB |
402 |
sImeglimin Hydrochloride 500 tablets |
M/s Exmed Pharmaceutical |
IND |
2023-Jan-27 |
|
2545 KB |
403 |
Bisoprolol Fumarate IP 5mg + Cilnidipine IP film coated tablets (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2023-Jan-27 |
|
346 KB |
404 |
Imeglimin. Hydrochloride 1000 tablets |
M/s Exmed Pharmaceuticals |
New Drugs |
2023-Jan-27 |
|
2845 KB |
405 |
sImeglimin Hydrochloride 1000 tablets |
M/s Exmed Pharmaceuticals |
IND |
2023-Jan-27 |
|
2845 KB |
406 |
Prolectin-I Injection |
M/s. Samahitha Research Solutions |
IND |
2023-Jan-27 |
|
1915 KB |
407 |
Hydrochloride, 500 tablets |
M/s Exmed PharmaceuticalsImeglimin |
New Drugs |
2023-Jan-27 |
|
2545 KB |
408 |
NV-CoV-2 Oral Syrup Oral Gummy(Chewable gel) |
M/s. Karveer Meditech Private Limited |
IND |
2023-Jan-27 |
|
2202 KB |
409 |
(Research Park)LNP7457 |
M/s. Lupin Limited |
IND |
2023-Jan-27 |
|
2397 KB |
410 |
Vonoprazan, Tablets 10mg/20mg |
M/s. Hetero Labs Limited |
New Drugs |
2023-Jan-27 |
|
2768 KB |
411 |
Vonoprazan Tablets 10mg/20mg |
M/s. Hetero Labs Limited |
IND |
2023-Jan-27 |
|
2786 KB |
412 |
Polmacoxib Capsules 2 mg |
M/s. Presise Biopharma Pvt. Ltd |
IND |
2023-Jan-20 |
|
2399 KB |
413 |
Polmacoxib. Capsules 2 mg |
M/s. Presise Biopharma Pvt. Ltd. |
New Drugs |
2023-Jan-20 |
|
2399 KB |
414 |
Tegoprazan .50 mg tablets |
Dr. Reddys Laboratories |
New Drugs |
2023-Jan-20 |
|
2016 KB |
415 |
AZD9977 and Dapagliflozin |
M/s. Parexel |
GCT |
2023-Jan-17 |
|
669 KB |
416 |
Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Ltd |
FDC |
2023-Jan-13 |
|
440 KB |
417 |
Lorlatinib |
M/s. Pfizer |
GCT |
2023-Jan-13 |
|
658 KB |
418 |
20-valent Pneumococcal Conjugate (20vPnC) Vaccine |
M/s Pfizer Limited |
Vaccine |
2023-Jan-12 |
|
556 KB |
419 |
Norditropin® |
M/s. Novo Nordisk |
GCT |
2023-Jan-12 |
|
507 KB |
420 |
Macitentan 75 mg |
M/s. J&J |
GCT |
2023-Jan-11 |
|
516 KB |
421 |
Marstacimab Prophylaxi |
M/s. Pfizer |
GCT |
2023-Jan-11 |
|
654 KB |
422 |
Trastuzumab Emtasine |
M/s Zydus Lifesciences Limited |
rDNA |
2023-Jan-09 |
|
698 KB |
423 |
Tegoprazan 50 mg tablets |
Dr. Reddys Laboratories |
IND |
2023-Jan-06 |
|
2016 KB |
424 |
Vilanterol trifenatate eq. to Vilanterol + Glycopyrrolate IP eq. to Glycopyrronium + Flucticasone Furoate Ph. Eur metered dose inhalation (Phase III) |
M/s. Zydus Healthcare Limited |
FDC |
2023-Jan-06 |
|
318 KB |
425 |
Cannabidol Oral Solution 150 mg/ml |
M/s Zenera Pharma Pvt. LTD |
IND |
2023-Jan-06 |
|
2629 KB |
426 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd. |
FDC |
2023-Jan-06 |
|
287 KB |
427 |
Cannabidol Oral. Solution 150 mg/ml |
M/s Zenera Pharma Pvt. LTD |
New Drugs |
2023-Jan-06 |
|
2629 KB |
428 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP film coated tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2023-Jan-06 |
|
324 KB |
429 |
Tildrakizumab23jan |
M/s. Sun Pharma |
GCT |
2023-Jan-03 |
|
664 KB |
430 |
ianalumab |
M/s. Novartis |
GCT |
2023-Jan-03 |
|
657 KB |
431 |
FB2001 |
M/s. IQVIA |
GCT |
2022-Dec-30 |
|
528 KB |
432 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Sitagliptin Phosphate Monohydrochloride IP eq. to Sitagliptin tablet (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-Dec-30 |
|
307 KB |
433 |
Ibrutinib |
M/s. J&J |
GCT |
2022-Dec-30 |
|
514 KB |
434 |
Romosozumab |
M/s Amgen Technology Pvt. Ltd |
rDNA |
2022-Dec-29 |
|
842 KB |
435 |
LYT-100 |
M/s Novotech |
GCT |
2022-Dec-27 |
|
681 KB |
436 |
S-217622 |
M/s. IQVIA |
GCT |
2022-Dec-27 |
|
588 KB |
437 |
NNC 0365-3769 (Mim8) prophylaxis |
M/s. Novo Nordisk |
GCT |
2022-Dec-27 |
|
514 KB |
438 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Glimperide IP + Metformin Hydrochloride IP (as extended release) film coated tablets |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2022-Dec-16 |
|
376 KB |
439 |
Metformin Hydrochloride IP (As extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet |
M/s. Innova Captab Pvt. Ltd |
FDC |
2022-Dec-16 |
|
334 KB |
440 |
Prolectin M |
M/s Murali Krishna Pharma Pvt. Ltd |
New Drugs |
2022-Dec-16 |
|
2190 KB |
441 |
Gliclazide IP (As sustained release) + Dapagliflozin film coated bilayered tablets (Phase III) |
M/s. Eris Lifesciences Ltd |
FDC |
2022-Dec-16 |
|
307 KB |
442 |
TEV-45779 |
M/s Lotus Labs Pvt |
GCT |
2022-Dec-16 |
|
770 KB |
443 |
Ursodiol Injection 625 mg/25ml (25mg/ml |
M/s Shilpa Medicare |
SND |
2022-Dec-16 |
|
404 KB |
444 |
Glycopyrroinum Bromide Ph. Eur + Fluticasone Furoate + Vilanterol Trifenatate inhalation powder |
M/s. JSS Medical Research Asia Pacific Pvt. Ltd |
FDC |
2022-Dec-15 |
|
293 KB |
445 |
Tildrakizumab Injection |
M/s Sun Pharmaceutical Industries Limited |
rDNA |
2022-Dec-15 |
|
720 KB |
446 |
Trelagliptin tablets 25mg/50mg/100mg |
M/s Zuventus Healthcare Limited |
New Drugs |
2022-Dec-15 |
|
2552 KB |
447 |
Human Albumin (r-DNA origin) |
Ms. Lazuline Biotech Private Limited |
rDNA |
2022-Dec-14 |
|
705 KB |
448 |
STN1010904 |
M/s InVentiv |
GCT |
2022-Dec-14 |
|
401 KB |
449 |
Recombinant human FSH |
M/s Zydus Lifesciences Limited |
rDNA |
2022-Dec-14 |
|
699 KB |
450 |
decitabine-tetrahydrouridine |
M/s. Novo Nordisk |
New Drugs |
2022-Dec-13 |
|
345 KB |
451 |
Pimavenserin Capsules 34 mg |
M/s Pure and Cure Healthcare Pvt. Ltd |
New Drugs |
2022-Dec-09 |
|
2383 KB |
452 |
Imeglimin Hydrochloride Sustained Relase Tablet 1000 mg |
M/s Exemed Pharmaceuticals |
SND |
2022-Dec-09 |
|
482 KB |
453 |
Glycopyrroinum Bromide Ph. Eur + Vilanterol Trifenatate inhalation powder |
M/s. JSS Medical Research Asia Pacific Pvt. Ltd |
FDC |
2022-Dec-09 |
|
328 KB |
454 |
Dapagliflozin Propanediol monohydrate + Linagliptin film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Ltd |
FDC |
2022-Dec-09 |
|
4371 KB |
455 |
Lasmiditan tablets 50 mg / 100 mg |
M/s Pure and Cure Healthcare Pvt. Ltd |
New Drugs |
2022-Dec-09 |
|
2304 KB |
456 |
Ranibizumab Solution for Injection, 10 mg/mL vial |
M/s Intas Pharmaceuticals Ltd |
rDNA |
2022-Dec-09 |
|
696 KB |
457 |
Mesenchymal Stem Cell |
M/s Biorasi |
GCT |
2022-Dec-08 |
|
663 KB |
458 |
Luspatercept powder for solution for injection: 25 mg and 75 mg |
M/s Bristol-Myers Squibb India Pvt. Ltd |
rDNA |
2022-Dec-06 |
|
796 KB |
459 |
Paracetamol Injection 1000 mg/4ml iv use |
M/s Troikaa Pharmaceuticals |
SND |
2022-Dec-06 |
|
501 KB |
460 |
Docetaxel |
M/s. Parexel |
GCT |
2022-Dec-05 |
|
788 KB |
461 |
101-PGC-005â¦20mg |
M/s Laxi Life Science |
New Drugs |
2022-Dec-02 |
|
2347 KB |
462 |
Asunercept |
M/s Pharm-Olam |
GCT |
2022-Dec-02 |
|
791 KB |
463 |
Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2022-Dec-02 |
|
320 KB |
464 |
LL-BMT1 |
M/s. CBCC |
GCT |
2022-Dec-01 |
|
701 KB |
465 |
Recombinant Hepatits E |
M/s Zydus Life Sciences Ltd |
Vaccine |
2022-Nov-29 |
|
228 KB |
466 |
QIV Vaccine |
M/s IQVIA |
Vaccine |
2022-Nov-29 |
|
438 KB |
467 |
HRF-10071 -120 mg |
M/s. Synapse Labs Pvt. Ltd |
IND |
2022-Nov-28 |
|
2200 KB |
468 |
BCD-201 (JSC BIOCAD) and Keytruda® |
M/s.IR Innovate |
GCT |
2022-Nov-28 |
|
797 KB |
469 |
HRF-100071- 20 mg/40mg/ 100mg |
M/s Veeda Clinical Research Private Limited |
IND |
2022-Nov-25 |
|
2576 KB |
470 |
NBTXR3 |
M/s. PRA |
GCT |
2022-Nov-23 |
|
668 KB |
471 |
SAR440340/REGN3500/itepekimabd |
M/s.Sanofi |
GCT |
2022-Nov-22 |
|
333 KB |
472 |
Hexavalent Vaccine |
M/s Serum Institute India Pvt Ltd |
Vaccine |
2022-Nov-21 |
|
561 KB |
473 |
Alcohol IP + Ketoprofen IP gel (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Nov-21 |
|
271 KB |
474 |
Pregabalin IP (as prolonged release) + Etoricoxib IP film coated bilayered tablets (Phase IV) |
M/s.. Ajanta Pharma Ltd |
FDC |
2022-Nov-21 |
|
348 KB |
475 |
Vildagliptin + Pioglitazone Hcl IP eq. Pioglitazone uncoated tablet (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2022-Nov-21 |
|
326 KB |
476 |
Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin + Pioglitazone Hydrochloride IP equivalent to Pioglitazone film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2022-Nov-18 |
|
393 KB |
477 |
Metformin Hydrochloride IP + Glimepiride IP + Dapagliflozin Propanediol Monohydrate tablets (Phase III). |
M/s. Windlas Biotech Ltd. (Plant-2) |
FDC |
2022-Nov-18 |
|
303 KB |
478 |
BCD-217 (Nurulimab + Prolgolimab) |
M/s.IR Innovate |
GCT |
2022-Nov-14 |
|
667 KB |
479 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP (as sustained release) IP tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Nov-11 |
|
286 KB |
480 |
Etifoxine HCl 50 mg |
M/s Sun Pharmaceuticals |
New Drugs |
2022-Nov-11 |
|
2623 KB |
481 |
Liothyronine Sodium Tablets 5mcg & 20 mcg |
M/s Acme GenericsLIP |
New Drugs |
2022-Nov-09 |
|
2533 KB |
482 |
Dulaglutide solution for injection 0.75mg and 1.5mg prefilled pen |
M/s Eli Lilly And Company |
rDNA |
2022-Nov-07 |
|
712 KB |
483 |
Gliclazide IP (As sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III) |
M/s. Eris Lifesciences Ltd |
FDC |
2022-Nov-07 |
|
367 KB |
484 |
Linagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2022-Nov-04 |
|
307 KB |
485 |
mepolizumab 100 mg SC |
M/s. PPD |
GCT |
2022-Oct-28 |
|
688 KB |
486 |
Ivermectin cutaneous solution 0.5% |
M/s. Veeda Clinical |
GCT |
2022-Oct-28 |
|
665 KB |
487 |
Durvalumab plus Olaparib |
M/s. Labcorp |
GCT |
2022-Oct-27 |
|
679 KB |
488 |
Diphtheria and Tetanus vaccine for Adults and Adolescents I.P (Td Vaccine) |
M/s Panacea Biotec Ltd |
Vaccine |
2022-Oct-26 |
|
91 KB |
489 |
Pneumococcal Conjugate Vaccine (2+1 schedule) |
M/s Serum Institute of India |
Vaccine |
2022-Oct-20 |
|
141 KB |
490 |
Montelukast IP + Fexofenadine Hydrochloride IP suspension (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2022-Oct-14 |
|
323 KB |
491 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2022-Oct-14 |
|
410 KB |
492 |
Thymosin Alpha 1 for injection 1.6mg |
M/s Gufic Bioscience |
SND |
2022-Oct-14 |
|
420 KB |
493 |
Elagolix tablets 150 mg |
M/s Sun Pharmaceuticals |
New Drugs |
2022-Oct-14 |
|
2471 KB |
494 |
Latanoprost IP + Netarsudil Mesylate eq. to Netarsudil + Benzalkonium Chloride IP (As preservative) per ml ophthalmic solution (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-Oct-14 |
|
287 KB |
495 |
Brilaroxazine (RP5063) |
M/s. PRA |
GCT |
2022-Oct-11 |
|
671 KB |
496 |
C-TB, Tubercullin PPD RT23 SSI |
ICMR-Regional Medical research |
New Drugs |
2022-Oct-07 |
|
1988 KB |
497 |
AVT06 Compared with EU-Eylea |
M/s. IQVIA |
GCT |
2022-Oct-07 |
|
813 KB |
498 |
Aflibercept with Eylea |
M/s. Lupin |
GCT |
2022-Oct-07 |
|
789 KB |
499 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP film coated tablet (Phase III). |
M/s. Ajanta Pharma Ltd |
FDC |
2022-Oct-06 |
|
325 KB |
500 |
Itolizumab for Injection 100 mg/vial |
M/s Biocon Limited |
rDNA |
2022-Oct-03 |
|
574 KB |
501 |
Lyophilized mRNA Vaccine for Injection (COVID-19 |
M/sGennova Biopharmaceuticals Limited |
Vaccine |
2022-Oct-03 |
|
234 KB |
502 |
Liraglutide injection 6mg/ml |
M/s Virchow Biotech Private Limited |
rDNA |
2022-Oct-03 |
|
724 KB |
503 |
Desidustat 50 mg |
Zydus Lifesciences |
IND |
2022-Sep-30 |
|
2107 KB |
504 |
Solifenacin Succinate IP + Silodosin film coated bilayered tablets (Phase III) |
M/s. Savi Health Science |
FDC |
2022-Sep-30 |
|
279 KB |
505 |
Nivolumab |
M/s Zydus Lifesciences Limited |
rDNA |
2022-Sep-29 |
|
1158 KB |
506 |
Proxalutamide (GT0918) |
M/s. Siro Clinpharm |
GCT |
2022-Sep-28 |
|
656 KB |
507 |
Vildagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablet (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2022-Sep-24 |
|
242 KB |
508 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP (As extended release form) tablets (Phase III), |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Sep-24 |
|
284 KB |
509 |
Sitagliptin Phosphate Monohydrate eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Metformin Hydrochloride IP (As extended release) film coated bilayered tablet (Phase III), |
M/s. Synokem Pharmaceuticals Pvt |
FDC |
2022-Sep-24 |
|
334 KB |
510 |
[+]-α-dihydrotetrabenazine [ -α- DHTB -5mg/7.5mg/10mg/15mg/22.5mg |
M/s. Synapse Labs Pvt. Ltd. |
IND |
2022-Sep-23 |
|
2181 KB |
511 |
Pseudoephedrine Hydrochloride IP + Fexofenadine Hydrochloride IP extended release tablet (Phase IV |
)M/s. Sanofi India Ltd |
FDC |
2022-Sep-19 |
|
292 KB |
512 |
Pantoprazole Sodium IP eq. to Pantoprazole (as gastro-resistant tablet) + Acotiamide Hydrochloride Hydrate (as 3 extended release tablets of each) hard gelatin capsules (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Sep-19 |
|
308 KB |
513 |
Lifitegrast Opthalamic Solution 5% |
M/s. Ajanta Pharma Limited |
New Drugs |
2022-Sep-16 |
|
2753 KB |
514 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Glimepiride IP + Metformin Hydrochloride IP (As sustained release form) film coated bilayered tablet (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Sep-16 |
|
318 KB |
515 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP (as extended release form) tablet (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2022-Sep-16 |
|
312 KB |
516 |
Bisoprolol Fumarate IP + Telmisartan IP film coated bilayered tablet (Phase III) |
M/s. Ajanta Pharma Ltd |
FDC |
2022-Sep-16 |
|
353 KB |
517 |
Pneumococcal Polysaccharide Conjugate Vaccine (adsorbed), I.P. (15 valent |
M/s Tergene Biotech Private Limited |
Vaccine |
2022-Sep-15 |
|
429 KB |
518 |
Carboplatin and Paclitaxel |
M/s. Labcorp |
GCT |
2022-Sep-13 |
|
673 KB |
519 |
SAR440340/REGN3500/itepekimab |
M/s. Sanofi |
GCT |
2022-Sep-13 |
|
511 KB |
520 |
Adenoviral-Vector Based Vaccine (VXA-CoV2-1.1-S) (Enteric Coated Tablet) |
M/s Syngene International Limited |
Vaccine |
2022-Sep-12 |
|
397 KB |
521 |
Live Attenuated Tetravalent Recombinant Dengue Vaccine |
M/s Indian Immunological Limited |
Vaccine |
2022-Sep-09 |
|
194 KB |
522 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP film coated bilayered tablet (Phase IV) |
M/s. Ajanta Pharma Ltd |
FDC |
2022-Sep-09 |
|
306 KB |
523 |
Ticagrelor 180 mg Tablet |
M/s MSN Laboratories Pvt. Ltd. |
SND |
2022-Sep-09 |
|
3675 KB |
524 |
Silodosin + Mirabegron (SR) film coated bilayered tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2022-Sep-09 |
|
296 KB |
525 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14 |
M/s BiologicalE Limited |
Vaccine |
2022-Sep-07 |
|
226 KB |
526 |
Insulin Injection,Biphasic Isophane Ph.Eur 100IU/ml |
M/s Hinge Clinica Pvt. Ltd |
rDNA |
2022-Sep-05 |
|
851 KB |
527 |
Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2022-Sep-02 |
|
307 KB |
528 |
Metformin Hydrochloride IP eq. to Metformin (as extended release form) + Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated tablets (Phase III) |
M/s. Theon Pharmaceuticals Ltd |
FDC |
2022-Sep-02 |
|
297 KB |
529 |
Metformin Hydrochloride IP (As extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet (Phase 3 |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Sep-02 |
|
300 KB |
530 |
Metformin Hydrochloride IP (Extended release) + Glimepiride IP 1mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated bilayered tablet (Phase III) |
M/s. Macleods Pharmaceuticals Limited |
FDC |
2022-Aug-31 |
|
314 KB |
531 |
Triamcinolone Acetonide Cream 0.1% w/w |
Abbott Helathcare |
SND |
2022-Aug-31 |
|
548 KB |
532 |
Metformin Hydrochloride IP (as extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablet (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2022-Aug-31 |
|
363 KB |
533 |
Tinofovir Pivafen Fumarate 50 mg |
M/s Cipla Ltd. |
IND |
2022-Aug-31 |
|
1982 KB |
534 |
Metformin Hydrochloride IP (as sustained release) + Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III) |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2022-Aug-30 |
|
360 KB |
535 |
Dapagliflozin + Pioglitazone Hydrochloride IP eq. to Pioglitazone film coated tablets (Phase III) |
M/s. USV Pvt. Ltd |
FDC |
2022-Aug-30 |
|
309 KB |
536 |
HRF-10071tablets 120 mg and Rifampicin 600 mg capsules |
M/s Synergen Bio Pvt. Ltd |
IND |
2022-Aug-29 |
|
2183 KB |
537 |
HRF-10071tablets 120 mg and Pravastatin 40 mg |
M/s Synergen Bio Pvt. Ltd |
IND |
2022-Aug-29 |
|
2028 KB |
538 |
Mino-Lok Therapy (MLT |
M/s. Biorasi |
GCT |
2022-Aug-24 |
|
649 KB |
539 |
Finerenone 10 mg and 20 mg |
M/s Bayers |
New Drugs |
2022-Aug-24 |
|
2588 KB |
540 |
SRP-4045 and SRP-4053 |
M/s. PPD |
GCT |
2022-Aug-18 |
|
659 KB |
541 |
AZD1222 Vaccine |
M/s. IQVIA |
GCT |
2022-Aug-18 |
|
674 KB |
542 |
AB001 400mg Tablets |
M/s Vopec Pharmaceuticals Pvt. Ltd |
New Drugs |
2022-Aug-18 |
|
2052 KB |
543 |
ZY19489 |
M/s Zydus Lifesciences |
New Drugs |
2022-Aug-18 |
|
2030 KB |
544 |
Eteplirsen |
M/s. PPD |
GCT |
2022-Aug-17 |
|
667 KB |
545 |
PNB001 |
M/s Biosphere |
New Drugs |
2022-Aug-17 |
|
2240 KB |
546 |
Clotrimazole Vaginal Film 50 mg |
Hetero Healthcare |
SND |
2022-Aug-17 |
|
437 KB |
547 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (ER) + Telmisartan IP + Amlodipine Besilate IP eq. to Amlodipine Film Coated Bilayered tablet (Phase III) |
M/s. Ajanta Pharma Ltd |
FDC |
2022-Aug-16 |
|
414 KB |
548 |
LNP023gc |
M/s. Novartis Healthcare Private Limited |
GCT |
2022-Aug-12 |
|
659 KB |
549 |
Thymosin Alpha 1 for injection 1.6 mg |
Gufic Bioscience |
SND |
2022-Aug-12 |
|
411 KB |
550 |
Sovateltide |
M/s Pharmazz India Private Limited |
New Drugs |
2022-Aug-10 |
|
2118 KB |
551 |
Dupilumabr |
M/s. Sanofi |
GCT |
2022-Aug-10 |
|
792 KB |
552 |
Ramatroban tablets 75 mg |
M/s JSS Medical Research Asia |
New Drugs |
2022-Aug-10 |
|
1855 KB |
553 |
Pantoprazole Dual Release Gastro-Resistant Tablet 80 mg |
Sun Pharma |
SND |
2022-Aug-04 |
|
372 KB |
554 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride As sustained release formIP uncoated bilayered tablets (Phase III |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-Aug-04 |
|
182 KB |
555 |
Inhaled Itracoanzole Dry Powder for inhalation 10 mg capsule (PUR 1900) |
Cipla Limited |
SND |
2022-Aug-02 |
|
471 KB |
556 |
Glycopyrrolate IP + Formoterol Fumarate dehydrate IP eq. to Formoterol Fumarate + Budesonide IP Per actuation deliver (Phase IV) |
M/s. Zydus Healthcare Ltd |
FDC |
2022-Aug-02 |
|
184 KB |
557 |
ES16001 |
M/s. Cliantha |
GCT |
2022-Jul-27 |
|
645 KB |
558 |
inclisiran |
M/s. Novartis |
GCT |
2022-Jul-25 |
|
645 KB |
559 |
Telmisartan IP + Bisoprolol Fumarate IP tablets (Phase III) |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2022-Jul-23 |
|
256 KB |
560 |
Azelastine Hydrohloride 1 mg/ml Nasal Spray |
M/s Ursapharm India |
SND |
2022-Jul-15 |
|
423 KB |
561 |
Guselkumab |
M/s. Parexel |
GCT |
2022-Jul-11 |
|
788 KB |
562 |
HRF-10071, Darunavir and Ritonavir |
M/s Veeda Clinical research Private limited |
New Drugs |
2022-Jul-08 |
|
2004 KB |
563 |
NRC-1111 |
M/s Natco pharma Limited |
New Drugs |
2022-Jul-08 |
|
2198 KB |
564 |
Fosfomycin Trometamol Powder 3 gm |
M/s Clinexel Life Science |
SND |
2022-Jul-08 |
|
477 KB |
565 |
remibrutinib versus teriflunomide |
M/s. Novartis |
GCT |
2022-Jul-08 |
|
661 KB |
566 |
Pneumococcal Polysaccharide Conjugate Vaccine I.P. (PCV13-TT |
M/s G.C. Chemie Pharmie Ltd |
Vaccine |
2022-Jul-07 |
|
562 KB |
567 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablet (Phase III) |
M/s. Alkem Health Science |
FDC |
2022-Jul-06 |
|
283 KB |
568 |
Mirabegron (ER) + Solifenacin Succinate IP film coated bilayered tablet (Phase IV |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-Jul-06 |
|
186 KB |
569 |
Teriparatide 20microgram/80 micro litre solution for injection in prefilled pen |
M/s Alkem Laboratories Ltd |
rDNA |
2022-Jul-05 |
|
828 KB |
570 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tabletPhase III) |
M/s. Glenmark Phramaceuticals Ltd |
FDC |
2022-Jul-04 |
|
195 KB |
571 |
Vildagliptin IP (as sustained release)Pioglitazone Hydrochloride IP eq. to Pioglitazone tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2022-Jul-04 |
|
229 KB |
572 |
Vericiguat therapy |
M/s Bayers pharmaceuticals Pvt. Ltd. |
New Drugs |
2022-Jun-30 |
|
2443 KB |
573 |
Dapagliflozin IP +Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP bilayered tablet (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2022-Jun-28 |
|
192 KB |
574 |
Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP + Sitagliptin Phosphate IP eq. to Sitagliptin film coated bilayered tablet (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2022-Jun-24 |
|
206 KB |
575 |
Rabies Vaccine, Human I.P. [Purified Inactivated Vero Cell Rabies vaccine â Lyophilized |
M/s Cadila Healthcare Limited |
Vaccine |
2022-Jun-24 |
|
484 KB |
576 |
Paclitaxel-Carboplatin-Oregovomab) |
M/s. Raptim |
GCT |
2022-Jun-23 |
|
673 KB |
577 |
Dupilumabn |
M/s. Sanofi |
GCT |
2022-Jun-23 |
|
691 KB |
578 |
Ondansetron Extended Relese Injectable Supension 100mg/ml |
Shilpa |
SND |
2022-Jun-22 |
|
400 KB |
579 |
Typhoid Conjugate Vaccine (Bivalent) |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2022-Jun-17 |
|
235 KB |
580 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone uncoated tabletsPhase III) |
M/s. Windlas Biotech Ltd.(Plant-2) |
FDC |
2022-Jun-15 |
|
211 KB |
581 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) + Amlodipine Besilate IP eq. to Amlodipine + Chlorthalidone IP film coated bilayered tablets (Phase III) |
M/s. Ajanta Pharma Ltd |
FDC |
2022-Jun-14 |
|
206 KB |
582 |
Trelagliptin |
M/s Hetero Labs Limited |
New Drugs |
2022-Jun-13 |
|
2481 KB |
583 |
remibrutinib versus teriflunomidegc |
M/s. Novartis |
GCT |
2022-Jun-13 |
|
654 KB |
584 |
HRF-10071 and Dolutegravir |
M/s Lambda Therapeutics Research Limited |
New Drugs |
2022-Jun-10 |
|
2256 KB |
585 |
Oral AUR105 |
M/s Aurigene Discovery Technologies Limited |
New Drugs |
2022-Jun-10 |
|
2312 KB |
586 |
Durvalumabgct |
M/s. AstraZeneca |
GCT |
2022-Jun-10 |
|
668 KB |
587 |
Capivasertib + Docetaxel |
M/s. Labcorp |
GCT |
2022-Jun-08 |
|
657 KB |
588 |
Durvalumab plus Domvanalimab (AB154 |
M/s. AstraZeneca |
GCT |
2022-Jun-08 |
|
684 KB |
589 |
Cefepime Zidebactam vs. Meropenem |
M/s. Wockhardt |
GCT |
2022-Jun-06 |
|
661 KB |
590 |
Biphasic Insulin Aspart Injection IP 100 IU/mL |
M/s Wockhardt Limited |
rDNA |
2022-Jun-06 |
|
700 KB |
591 |
Novel Corona virus-2019-nCoV Vaccine |
M/s Zydus Lifesciences Ltd |
Vaccine |
2022-Jun-03 |
|
572 KB |
592 |
Tremelimumab ± Lenvatinib |
M/s. AstraZeneca |
GCT |
2022-Jun-02 |
|
676 KB |
593 |
IcoSema and once weekly insulin icodec |
M/s. Novo-Nordisk |
GCT |
2022-Jun-02 |
|
687 KB |
594 |
Omalizumab Injection |
M/s Veeda Clinical Research Private Limited |
rDNA |
2022-May-31 |
|
693 KB |
595 |
Bucillamine tablets 100mg |
M/s Optimus Pharma Private Limited |
New Drugs |
2022-May-31 |
|
2592 KB |
596 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated tablets (Phase III) |
M/s. Theon Pharmaceuticals Ltd |
FDC |
2022-May-31 |
|
192 KB |
597 |
Linagliptin + Dapagliflozin tablets (Phase III) |
M/s. Micro Labs Ltd |
FDC |
2022-May-31 |
|
260 KB |
598 |
Triamcinolone Hexacetonide Injectable Suspension 20 mg/ml |
M/s Abbott healthcare Pvt. Ltd |
New Drugs |
2022-May-30 |
|
2426 KB |
599 |
Tofacitinib Ointment 2% |
Intas Pharma |
SND |
2022-May-27 |
|
491 KB |
600 |
Vildagliptin (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2022-May-27 |
|
206 KB |
601 |
Virion Inactivated Corona Virus Vaccine |
M/s Post Graduate Institute Of Medical Education And Research |
Vaccine |
2022-May-24 |
|
320 KB |
602 |
Omalizumab 150 mg/ml |
M/s Synchron Research Services Pvt. Ltd. |
rDNA |
2022-May-23 |
|
560 KB |
603 |
Teriperatide Injection solution for injection in a pre-filled pen 600mcg/2.4ml (Synthetic Origin) |
Sun Pharma |
SND |
2022-May-23 |
|
538 KB |
604 |
EMPAgliflozin |
M/s. Labcorp |
GCT |
2022-May-19 |
|
800 KB |
605 |
Dapagliflozin Propanedilol Monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film Coated Tablets (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-May-19 |
|
294 KB |
606 |
Pregabalin IP (As Prolonged Release) + Etoricoxib IP film coated bilayered tablets (Phase IV) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2022-May-18 |
|
309 KB |
607 |
Lyka Labs |
Tofacitinib Ointment 2% |
SND |
2022-May-17 |
|
426 KB |
608 |
Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablets (Phase III) |
M/s. Macleods Pharmaceuticals Ltd |
FDC |
2022-May-13 |
|
291 KB |
609 |
HRF-10071, Tenofovir, Dolutegravir |
M/s Lambda |
New Drugs |
2022-May-13 |
|
2031 KB |
610 |
Glycopyrrolate IP eq. to Glycopyrronium _+ Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate + Budesonide inhalation powder (Phase IV) |
M/s. Zydus Healthcare Limited |
FDC |
2022-May-13 |
|
319 KB |
611 |
Ajanta Pharma |
Loteprednol Etabonate Ophthalmic Supension 1% w/v |
SND |
2022-May-11 |
|
365 KB |
612 |
f GSK S. aureus candidate vaccine |
M/s. GSK |
GCT |
2022-May-11 |
|
673 KB |
613 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (Phase II |
M/s. Windlas Biotech Ltd |
FDC |
2022-May-09 |
|
275 KB |
614 |
Nor-ursodeoxycholic acid |
M/s Shilpa Medicare Limited |
New Drugs |
2022-May-09 |
|
2242 KB |
615 |
Chlorthalidone IP + Efonidipine Hydrochloride Ethanolate IP tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-May-06 |
|
266 KB |
616 |
HRF-10071, Tenofovir alafenamide and Ripivirine |
M/s Lambda |
New Drugs |
2022-May-06 |
|
2175 KB |
617 |
MS/ Veeda |
HRF-10071, Tenofovir, Lamivudine |
New Drugs |
2022-May-06 |
|
2124 KB |
618 |
HRF-10071, Tenofovir alafenamide and Emtricitabin |
MS/ Veeda |
New Drugs |
2022-May-06 |
|
2148 KB |
619 |
HRF-10071, Ripivirine |
M/s Lambda |
New Drugs |
2022-May-06 |
|
2165 KB |
620 |
AUR103 Calciumin |
M/s Aurigene |
New Drugs |
2022-May-06 |
|
2392 KB |
621 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III) |
M/s Mascot Health Series Pvt. Ltd |
FDC |
2022-May-06 |
|
293 KB |
622 |
Varicella Vaccine Live, Attenuated IP(VARIVAX) 2000 PFU |
M/s VHB Life Sciences Limited |
Vaccine |
2022-May-05 |
|
146 KB |
623 |
Human Insulin Short acting |
M/s Hinge ClinicaPvt. Ltd |
rDNA |
2022-May-05 |
|
706 KB |
624 |
Paltusotine |
M/s. Pharm-Olam |
GCT |
2022-May-05 |
|
674 KB |
625 |
Insulin Glargine (r-DNA origin) Injection 100 units/mL |
M/s GeneSys Biologics Pvt. Ltd |
rDNA |
2022-May-05 |
|
702 KB |
626 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP Tablets (Phase III) |
M/s Mascot Health Series Pvt. Ltd |
FDC |
2022-May-04 |
|
319 KB |
627 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Dapagliflozin (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2022-May-02 |
|
248 KB |
628 |
Elobixibat |
M/s Dr. Reddy |
New Drugs |
2022-Apr-29 |
|
2497 KB |
629 |
concizumab prophylaxis |
M/s. Novo-Nordisk |
GCT |
2022-Apr-29 |
|
653 KB |
630 |
SCO-120 |
M/s. Sun Pharma |
GCT |
2022-Apr-27 |
|
487 KB |
631 |
Brinzolamide IP + Timolol Maleate IP eq. to Timolol + Potassium Sorbate IP (as preservative) Ophthalmic suspension (Phase IV) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2022-Apr-25 |
|
308 KB |
632 |
Silodosin + Tdalafil IP hard gelatin capsule (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2022-Apr-25 |
|
277 KB |
633 |
Linaclotide Capsules |
M/s Dr. reddy's laboraotories limited |
New Drugs |
2022-Apr-25 |
|
2258 KB |
634 |
Fosravuconazole capsules |
M/s Dr. reddy's laboraotories limited |
New Drugs |
2022-Apr-25 |
|
2338 KB |
635 |
Umifenovir Tablet |
M/s Medizest Pharmaceuticals |
New Drugs |
2022-Apr-25 |
|
2240 KB |
636 |
Montelukast Sodium IP eq. to Montelukast + Bilastine Orodispersible tablet (Phase IV) |
M/s. Akums Drugs & Pharmaceutical Ltd |
FDC |
2022-Apr-24 |
|
301 KB |
637 |
Atrasentan |
M/s. IQVIA |
GCT |
2022-Apr-22 |
|
662 KB |
638 |
Inactivated Influenza Vaccine (Split Virion) I.P. (Tetravalent) |
M/s Cadila Healthcare Limited |
Vaccine |
2022-Apr-21 |
|
330 KB |
639 |
TOPOTECAN AND CYCLOPHOSPHAMIDE |
M/s. Pfizer |
GCT |
2022-Apr-20 |
|
653 KB |
640 |
IRINOTECAN AND TEMOZOLOMIDE |
M/s. Pfizer |
GCT |
2022-Apr-20 |
|
653 KB |
641 |
Tislelizuma |
M/s. PPD |
GCT |
2022-Apr-20 |
|
673 KB |
642 |
Savolitinib plus Durvalumab |
M/s. Labcorp |
GCT |
2022-Apr-20 |
|
806 KB |
643 |
MYL-1701P |
Ms/s. Cliantha |
GCT |
2022-Apr-19 |
|
655 KB |
644 |
Naftifine hydrochloride cream 2% b |
M/s Synokem Pharamceutical Ltd |
New Drugs |
2022-Apr-18 |
|
2544 KB |
645 |
ASLAN004 |
M/s. IQVIA |
GCT |
2022-Apr-13 |
|
672 KB |
646 |
LY3484356 |
M/s. Eli Lilly |
GCT |
2022-Apr-13 |
|
669 KB |
647 |
osimertinib |
M/s. Novartis |
GCT |
2022-Apr-11 |
|
707 KB |
648 |
Efonidipine Hydrochloride Ethanolate IP + Telmisartan IP film coated tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Apr-11 |
|
290 KB |
649 |
Polmacoxib Capsules |
M/s Hetero labs Limited |
New Drugs |
2022-Apr-11 |
|
3066 KB |
650 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (13- valent) |
M/s Pfizer Limited |
Vaccine |
2022-Apr-07 |
|
588 KB |
651 |
Semaglutide on functional capacity |
M/s. Novo-Nordisk |
GCT |
2022-Apr-07 |
|
652 KB |
652 |
Pegfilgrastim |
M/s Accutest Research Laboratories (I) |
rDNA |
2022-Apr-04 |
|
674 KB |
653 |
GRC 54276 |
M/s Glenmark Pharmaceuticals ltd |
New Drugs |
2022-Apr-04 |
|
2658 KB |
654 |
AUR-101 |
M/s Aurigene Discovery Technologies Limited |
New Drugs |
2022-Apr-04 |
|
2296 KB |
655 |
TK-90M/s. SiRO |
M/s. SiRO |
GCT |
2022-Apr-04 |
|
627 KB |
656 |
Sitagliptin Phosphate monohydrate eq. to Sitagliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Lt |
FDC |
2022-Apr-04 |
|
366 KB |
657 |
HGCO19 Lyophilized mRNA Vaccine for Injection |
M/s Gennova Biopharmaceuticals Limited |
Vaccine |
2022-Mar-29 |
|
568 KB |
658 |
Hepatitis A (Live) Vaccine, Freeze-Dried |
M/s Joint Force Pharamchem Pvt. Ltd |
Vaccine |
2022-Mar-25 |
|
497 KB |
659 |
Inactivated Salk Polio Vaccine |
M/s Serum Institute Of India Pvt. Ltd |
Vaccine |
2022-Mar-25 |
|
333 KB |
660 |
Pneumococcal Polysaccharide Conjugate Vaccine |
M/s Biological E Limited, Shameerpet Mandal |
Vaccine |
2022-Mar-25 |
|
327 KB |
661 |
Metformin Hydrochloride IP (as sustained release) + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin tablets (Phase III |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2022-Mar-24 |
|
306 KB |
662 |
Belantamab Mafodotin (GSK2857916) |
M/s. GSK |
GCT |
2022-Mar-22 |
|
649 KB |
663 |
SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine [COVOVAX] |
M/s Serum Institute Of India Pvt. Ltd |
Vaccine |
2022-Mar-22 |
|
300 KB |
664 |
A vector vaccine for the prevention of the coronavirus infection |
M/s Dr Reddyâs Laboratories Limited |
Vaccine |
2022-Mar-22 |
|
302 KB |
665 |
TK-90 |
M/s. SIRO |
GCT |
2022-Mar-22 |
|
626 KB |
666 |
Sodium Hyaluronate BP + Chontroitin Sulfate Sodium BP + Poloxamer IP per 10ml oral liquid (Phase IV) |
M/s. Micro Labs Ltd. |
FDC |
2022-Mar-21 |
|
311 KB |
667 |
SAR442168 to placebo |
M.s. Sanofi Healthcare |
GCT |
2022-Mar-17 |
|
671 KB |
668 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III) |
M/s. Theon Pharmaceuticals Ltd. |
FDC |
2022-Mar-17 |
|
317 KB |
669 |
Vildagliptin (as sustained release) + Pioglitazone Hydrochloride eq. to Pioglitazone IP uncoated bilayered tablets (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd. |
FDC |
2022-Mar-16 |
|
304 KB |
670 |
NUCALA |
M/s. GSK |
GCT |
2022-Mar-16 |
|
2527 KB |
671 |
Dapagliflozin Propanediol eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to to Sitagliptin film coated tablet (Phase III) |
M/s. Theon Pharmaceuticals Ltd |
FDC |
2022-Mar-16 |
|
320 KB |
672 |
Sun Pharma |
Favipiravir 400 mg Tablet SND/CT/21/000093 |
SND |
2022-Mar-16 |
|
416 KB |
673 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III |
M/s. Macleods Pharmaceuticals Ltd. |
FDC |
2022-Mar-16 |
|
326 KB |
674 |
CRIZOTINIB |
M/s. Roche |
GCT |
2022-Mar-14 |
|
422 KB |
675 |
Teriparatide |
M/s Enzene Biosciences Limited |
rDNA |
2022-Mar-11 |
|
545 KB |
676 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP uncoated bilayered tablets (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-Mar-11 |
|
290 KB |
677 |
Revefenacin |
M/s Mylan Pharmaceuticals .Ltd |
New Drugs |
2022-Mar-11 |
|
2350 KB |
678 |
Chlorpheniramine Maleate IP + Noscapine IP per 5ml oral liquid (Phase III) |
M/s. Biological E Ltd |
FDC |
2022-Mar-11 |
|
392 KB |
679 |
Vildagliptin (as sustained release) + Dapagliflozin (100mg+5mg & 100mg + 10mg) tablets (Phase III)M/s. Ravenbhel Healthcare Pvt. Ltd |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2022-Mar-11 |
|
281 KB |
680 |
Pegfilgrastim Solution for Injection |
M/s Intas Pharmaceuticals Limited |
rDNA |
2022-Mar-09 |
|
393 KB |
681 |
Remogliflozin Etabonate + Vildagliptin + Metformin Hydrochloride IP Film coated tablet (Phase IV) |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2022-Mar-09 |
|
329 KB |
682 |
TOFACITINIB |
Ms. Pfizer |
GCT |
2022-Mar-08 |
|
663 KB |
683 |
Whole Virion Inactivated Corona Virus Vaccine |
M/s National Institute Of Epidemiology, Indian Council Of Medical Research, Chennai |
Vaccine |
2022-Mar-08 |
|
337 KB |
684 |
Tamsulosin Hydrochloride IP (as prolonged release pellets) + Tadalafil IP (as film coated tablet) capsules (Phase IV) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2022-Mar-04 |
|
352 KB |
685 |
Teneligliptin IP + Dapagliflozin tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd. |
FDC |
2022-Mar-03 |
|
271 KB |
686 |
ELRANATAMAB |
Ms. Pfizer |
GCT |
2022-Mar-03 |
|
665 KB |
687 |
AT-752 |
M/s. PPD |
GCT |
2022-Mar-03 |
|
787 KB |
688 |
Nitazoxanide Tablets 500 mg |
M/s. Rapti |
GCT |
2022-Mar-02 |
|
656 KB |
689 |
dupilumab |
M.s. Sanofi Healthcare |
GCT |
2022-Mar-02 |
|
667 KB |
690 |
Lifeviro treat inhalation |
M/s Supreme Drugs pvt. Ltd |
New Drugs |
2022-Mar-02 |
|
2497 KB |
691 |
Acalabrutinib1 |
M/s. Labcorp |
GCT |
2022-Feb-28 |
|
665 KB |
692 |
Atropine Sulphate Ophthalmic Solution 0.05% w/v0.05 % w/v Ophthalmic Solution |
Entod Pharmaceuticals |
SND |
2022-Feb-28 |
|
466 KB |
693 |
Metoprolol IP + Chlorthalidone IP + Cilnidipine IP tablets (Phase III) |
M/s. Pure & Cure Healthcare Pvt. Ltd |
FDC |
2022-Feb-27 |
|
276 KB |
694 |
Abrocitinib |
M/s. Pfizer Products India Pvt. Ltd |
New Drugs |
2022-Feb-25 |
|
30383KB |
695 |
Follicle Stimulating Hormone (Human Recombinant) |
M/s Veeda Clinical Research Limited |
rDNA |
2022-Feb-25 |
|
564 KB |
696 |
Imeglimin tabletsv |
M/s Synokem Pharamceutical Ltd |
New Drugs |
2022-Feb-25 |
|
2952 KB |
697 |
BI 690517 |
M/s. Parexel |
GCT |
2022-Feb-25 |
|
677 KB |
698 |
SAR442168 |
M.s. Sanofi Healthcare |
GCT |
2022-Feb-25 |
|
849 KB |
699 |
tofacitinib |
Ms. Pfizer |
GCT |
2022-Feb-24 |
|
390 kB |
700 |
secukinumab (Cosentyx) |
M/s. Novartis |
GCT |
2022-Feb-24 |
|
661 KB |
701 |
SATRALIZUMAB |
M/s. Roche |
GCT |
2022-Feb-24 |
|
653 KB |
702 |
alteplase |
M/s. Parexel |
GCT |
2022-Feb-23 |
|
671 KB |
703 |
fitusiran prophylaxis |
M/s. Sanofi Healthcare |
GCT |
2022-Feb-21 |
|
657 KB |
704 |
Elranatamab (PF-06863135 |
M/sPfizer |
GCT |
2022-Feb-21 |
|
670 KB |
705 |
Intraversial SN-38 Lipid Suspension |
M/s Intas Pharmaceutical Ltd |
New Drugs |
2022-Feb-18 |
|
2587 KB |
706 |
ligelizumab (QGE031) |
M/s. Novartis |
GCT |
2022-Feb-18 |
|
664 KB |
707 |
Picrorhiza kurroa |
M/sCSIR-CDRI |
New Drugs |
2022-Feb-18 |
|
2654 KB |
708 |
Intravenous Allogeneic Mesenchymal |
M/s. Biorasi |
GCT |
2022-Feb-18 |
|
654 KB |
709 |
Amlodipine Besylate IP eq. to Amlodipine + Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2022-Feb-17 |
|
316 KB |
710 |
fluticasone propionate |
M/s. Glenmark |
GCT |
2022-Feb-16 |
|
771 KB |
711 |
Tofacetinib Gel 2% |
Macleods Pharmacuticals |
SND |
2022-Feb-15 |
|
425 KB |
712 |
hydrogen peroxide |
M/s. IQVIA |
GCT |
2022-Feb-14 |
|
509 KB |
713 |
Dapagliflozin + Sitagliptin film coated tablet (Phase III)M/s. Glenmark Pharmaceuticals Ltd |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2022-Feb-09 |
|
286 KB |
714 |
Dapagliflozin + Sitagliptin film coated tablet (Phase IIIg |
M/s. Glenmark Pharmaceuticals Ltd. |
FDC |
2022-Feb-09 |
|
286 KB |
715 |
Tranexamic Acid Spray 10% w/v Acid Spray 10% w/v Acid Spray 10% w/v |
Shilpa |
SND |
2022-Feb-09 |
|
394 KB |
716 |
SAR442168 to teriflunomide (Aubagio®) |
M.s. Sanofi Healthcare |
GCT |
2022-Feb-08 |
|
663 KB |
717 |
Mepolizumab |
M/s Glaxosmithkline Pharmaceuticals Limited |
rDNA |
2022-Feb-07 |
|
325 KB |
718 |
Imeglimin tablets |
M/s Exemed Pharmaceuticals |
New Drugs |
2022-Feb-03 |
|
2592 KB |
719 |
Dapagliflozin + Metformin Hydrochloride IP + Vildagliptin film coated tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd. |
FDC |
2022-Feb-03 |
|
297 KB |
720 |
Naftifine hydrochloride cream 2% |
M/s Zydus Coroporate Park |
New Drugs |
2022-Feb-03 |
|
2682 KB |
721 |
Quadrivalent Meningococcal Conjugate Vaccine |
M/s Sanofi Healthcare |
GCT |
2022-Feb-01 |
|
667 KB |
722 |
Bioactive concentrate from small marine fish + water for injection (WFI) solution for injection (Phase III) |
M/s. Biotehnos Pvt. Ltd. |
FDC |
2022-Jan-28 |
|
296 KB |
723 |
Pimavenserin Capsules |
M/s Sun paharma laboratories limited |
New Drugs |
2022-Jan-28 |
|
2375 KB |
724 |
Vildagliptin SR + Dapagliflozin + film coated bilayered tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd. |
FDC |
2022-Jan-27 |
|
286 KB |
725 |
Chimpanzee Adenovirus Vectored COVID-19 Vaccine (BBV154) |
M/s Bharat Biotech International Limited, Hyderabad |
Vaccine |
2022-Jan-27 |
|
232 KB |
726 |
Chimpanzee Adenovirus Vectored COVID-19 Vaccine |
M/s Bharat Biotech International Limited, Hyderabad |
Vaccine |
2022-Jan-27 |
|
424 KB |
727 |
Ferric Pyrophosphate citrate |
M/s Sun paharma laboratories limited |
New Drugs |
2022-Jan-24 |
|
2622 KB |
728 |
tocilizumab |
M/s Dr Reddys Laboratories |
GCT |
2022-Jan-21 |
|
653 KB |
729 |
Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 |
M/s. Cipla |
GCT |
2022-Jan-21 |
|
659 KB |
730 |
Nano Carrier Entrapped Vitamin D3 Oral Dispersion 60000IU |
M/s Pulse Pharmaceuticals |
SND |
2022-Jan-20 |
|
490 KB |
731 |
Vildagliptin + Dapagliflozin + Metformin hydrochloride IP tablets (Phase III) |
M/s. USV Pvt. Ltd. |
FDC |
2022-Jan-20 |
|
341 KB |
732 |
(r-hFSH) 900 IU (66.0 μg)/1.5 mL Solution |
M/s. Bharat Serum |
GCT |
2022-Jan-17 |
|
657 KB |
733 |
PROphylaxis |
M/s George Institute |
GCT |
2022-Jan-17 |
|
347 KB |
734 |
Dapagliflozin + Metformin XR versus Metformin XR |
M/s. Novartis |
GCT |
2022-Jan-14 |
|
548 KB |
735 |
IMM-101 |
M/s. JSS |
GCT |
2022-Jan-12 |
|
654 KB |
736 |
PCV-20 Valent |
M/s Pfizer Ltd |
Vaccine |
2022-Jan-12 |
|
556 KB |
737 |
Wosulin R, Wosulin N and Wosulin 30/70 |
M/s Wockhardt Limited |
rDNA |
2022-Jan-11 |
|
742 KB |
738 |
LXE408 |
M/s. Qascent |
GCT |
2022-Jan-11 |
|
652 KB |
739 |
Anifrolumab |
M/s. AstraZeneca |
GCT |
2022-Jan-11 |
|
657 KB |
740 |
Amantadine Extended Release Tablet 129/193 mg |
M/s Sun Pharma |
SND |
2022-Jan-07 |
|
446 KB |
741 |
INO-4800 |
M/s. Inovio Clinical Trials |
GCT |
2022-Jan-07 |
|
685 KB |
742 |
IcoSema and Daily Insulin Glargine 100 units/mL |
M/s. Novo-Norisk |
GCT |
2022-Jan-06 |
|
733 KB |
743 |
LTX-109 3% gel |
M/s. Parexel |
GCT |
2022-Jan-05 |
|
323 KB |
744 |
Dapagliflozin + Metformin Hydrochloride IP (Extended Release) + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2022-Jan-04 |
|
331 KB |
745 |
Pertuzumab 420 mg/14mL Injection |
M/s Cadila Healthcare Limited |
rDNA |
2021-Dec-31 |
|
693 KB |
746 |
Cholera Vaccine (Inactivated, Oral), I.P. |
M/s Bharat Biotech International Limited, Genome Valley, Shameerpet |
Vaccine |
2021-Dec-31 |
|
306 KB |
747 |
MEDI3506 |
M/s. AstraZeneca |
GCT |
2021-Dec-30 |
|
667 KB |
748 |
Anti-HIV microbicide gel |
M/s HLL lifecare limited |
New Drugs |
2021-Dec-29 |
|
2139 KB |
749 |
Alpelisib plus Fulvestrant |
M/s Sandoz private limited |
New Drugs |
2021-Dec-29 |
|
2590 KB |
750 |
SARS-CoV-2 (Covid-19) Vaccine (RBD antigen of SARS CoV-2(Covid-19 |
M/s Biological E Limited, Shameerpet Mandal, Hyderabad |
Vaccine |
2021-Dec-28 |
|
234 KB |
751 |
Measles (Edmonston Zagreb) and Rubella (RA27/3) Vaccine Live, Attenuated (Freeze Dried), IP |
M/s Biological E Limited, Shameerpet Mandal, Hyderabad |
Vaccine |
2021-Dec-28 |
|
329 KB |
752 |
OMS721 |
M/s. Kendle |
GCT |
2021-Dec-27 |
|
675 KB |
753 |
Mupirocin 2% w/w Ointment |
Apex Laboratories |
SND |
2021-Dec-24 |
|
428 KB |
754 |
Dato-DXd |
M/s. AstraZeneca |
GCT |
2021-Dec-22 |
|
782 KB |
755 |
remibrutinib LOU064 |
M/s. Novartis |
GCT |
2021-Dec-22 |
|
675 KB |
756 |
COVID-19 (Adapt Out COVID) |
M/s. PPD |
GCT |
2021-Dec-20 |
|
748 KB |
757 |
Metformin Hydrochloride IP (as prolonged release) + Teneligliptin IP + Dapagliflozin tablets (Phase III) |
M/s. Macleods Pharmaceuticals Ltd |
FDC |
2021-Dec-20 |
|
190 KB |
758 |
Trastuzumab Deruxtecanas |
M/s. AstraZeneca |
GCT |
2021-Dec-17 |
|
771 KB |
759 |
Lemborexant |
M/s Eisai Pharmaceuticals india Private limited |
New Drugs |
2021-Dec-16 |
|
23275 KB |
760 |
Bempedoic acid |
M/s Akums Drugs and pharmaceutical Ltd |
New Drugs |
2021-Dec-16 |
|
24271 KB |
761 |
Mirabegron (As extended release) + Silodosin film coated bilayered tablets (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2021-Dec-16 |
|
184 KB |
762 |
Darolutamide |
M/s Bayer pharmaceuticals pvt. Ltd |
New Drugs |
2021-Dec-16 |
|
2994 KB |
763 |
Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2021-Dec-14 |
|
258 KB |
764 |
Ozenoxacin Lotion 2% w/v |
Optimus |
SND |
2021-Dec-13 |
|
1196 KB |
765 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP tablets (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2021-Dec-13 |
|
247 KB |
766 |
CKD-314 |
M/s. Kendle |
GCT |
2021-Dec-13 |
|
689 KB |
767 |
Esmprazole Dual release Gastro Resistant Tablets 80 mg |
Sun Pharma |
SND |
2021-Dec-09 |
|
515 KB |
768 |
Adjuvant Giredestrant |
M/s. Roche |
GCT |
2021-Dec-08 |
|
739 KB |
769 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2021-Dec-08 |
|
234 KB |
770 |
Metoprolol Succinate IP (ER) + Azelnidipine IP film coated bilayered tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2021-Dec-07 |
|
184 KB |
771 |
Plecanatide |
M/s MSN Laborotories Pvt. Limited |
New Drugs |
2021-Dec-07 |
|
23335 KB |
772 |
brequinar combined dipyridamole |
M/s. Veeda |
GCT |
2021-Dec-07 |
|
657 KB |
773 |
remibrutinib (LOU064) |
M/s. Novartis |
GCT |
2021-Dec-07 |
|
671 KB |
774 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml oral suspension (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2021-Dec-07 |
|
168 KB |
775 |
IMU-838 versus Placebo |
M/s Bioinnovat |
GCT |
2021-Dec-06 |
|
656 KB |
776 |
Cariprazine |
M/s Sun Pharmaceuticals Industries Limited |
New Drugs |
2021-Dec-06 |
|
2129 KB |
777 |
IMU-838 |
M/s Bioinnovat |
GCT |
2021-Dec-03 |
|
657 KB |
778 |
Peptide Receptor Radionuclide Therapy (PRRT) |
M/s PSI CRO |
GCT |
2021-Dec-02 |
|
765 KB |
779 |
dabrafenib plus trametinib |
M/s. Novartis |
GCT |
2021-Dec-01 |
|
660 KB |
780 |
asciminib |
M/s. Novartis |
GCT |
2021-Dec-01 |
|
656 KB |
781 |
Typhoid Conjugate Vaccine (Monovalent) [Typhoid Vi ConjugateVaccine] |
M/s Biological E Limited, Shameerpet Mandal, Hyderabad |
Vaccine |
2021-Dec-01 |
|
583 KB |
782 |
Amivantamab and Lazertinib |
M/s. Johnson & Johnson |
GCT |
2021-Nov-29 |
|
668 KB |
783 |
cccc |
M/s Akums Drugs and pharmaceutical Ltd |
New Drugs |
2021-Nov-29 |
|
2368 KB |
784 |
INTP24 Against Avastin® |
M/s. INTAS |
GCT |
2021-Nov-29 |
|
661 KB |
785 |
Teneligliptin IP + Rosuvastatin Calcium IP tablets (Phase III) |
M/s. Theon Pharmaceuticals Ltd |
FDC |
2021-Nov-29 |
|
253 KB |
786 |
Dapagliflozin + Vildagliptin tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2021-Nov-25 |
|
198 KB |
787 |
triptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Tablets (Phase III) |
M/s. Theon Pharmaceuticals Ltd |
FDC |
2021-Nov-25 |
|
231 KB |
788 |
Trastuzumab Deruxtecan (T-DXd) |
M/s. AstraZeneca |
GCT |
2021-Nov-24 |
|
521 KB |
789 |
LIB003 in Heterozygous |
M/s. Medpace |
GCT |
2021-Nov-24 |
|
659 KB |
790 |
Tirzepatiden |
M/s. Eli Lilly |
GCT |
2021-Nov-24 |
|
680 KB |
791 |
Lastacaft |
M/s Alkem Laboratorties |
SND |
2021-Nov-23 |
|
389 KB |
792 |
Alcaftadine Nasal Spray CT NOC |
M/s Alkem Laboratorties |
SND |
2021-Nov-23 |
|
404 KB |
793 |
Alcaftadine Nasal Spray ALDP001 |
M/s Alkem Laboratorties |
SND |
2021-Nov-23 |
|
389 KB |
794 |
Alcaftadine Nasal Spray |
M/s Alkem Laboratorties |
SND |
2021-Nov-23 |
|
400 KB |
795 |
Rilematovir (JNJ-53718678) |
M/s. Johnson & Johnson |
GCT |
2021-Nov-22 |
|
505 KB |
796 |
CSJ117 |
M/s. Novartis |
GCT |
2021-Nov-22 |
|
653 KB |
797 |
MSP008-22c |
M/s Clinixel Life Sciences Pvt. Ltd |
New Drugs |
2021-Nov-16 |
|
2128 KB |
798 |
Bisoprolol Fumarate IP + Telmisartan IP uncoated bilayered tablets (Phase III) |
M/s. Windlas Biotech Ltd |
FDC |
2021-Nov-15 |
|
172 KB |
799 |
Zinc Citrate Trihydrate eq. to Zinc IP +Ascorbic Acid IP effervescent tablets (Phase IV) |
M/s. Kusum Healthcare Pvt. Ltd |
FDC |
2021-Nov-15 |
|
187 KB |
800 |
LIB003n |
M/s. Medpace |
GCT |
2021-Nov-12 |
|
650 KB |
801 |
LIB003 (Low density lipoprotein) |
M/s. Medpace |
GCT |
2021-Nov-11 |
|
650 KB |
802 |
Itolizumab |
M/s. Biocon |
GCT |
2021-Nov-10 |
|
670 KB |
803 |
Marstacimab Prophylaxis |
M/s. Pfizer |
GCT |
2021-Nov-03 |
|
645 KB |
804 |
Pharmacokinetics of Remdesivir |
M/s Lupin Limited |
SND |
2021-Nov-02 |
|
2831 KB |
805 |
Brazikumabn |
M/s. AstraZeneca |
GCT |
2021-Nov-02 |
|
665 KB |
806 |
antiviral therapies |
M/s Qascent Research Solution Pvt ltd |
SND |
2021-Nov-02 |
|
4141 KB |
807 |
ADG20 |
M.s, PPD |
GCT |
2021-Nov-02 |
|
514 KB |
808 |
Capmatinib film coated tablet 150 mg/200 mg |
M/s Novartis Healthcare Private Limited |
New Drugs |
2021-Nov-02 |
|
2260 KB |
809 |
Proxalutamide (GT0918 |
)M/s. CBCC |
GCT |
2021-Nov-01 |
|
518 KB |
810 |
Deupirfenidone (LYT-100) |
M/s. Syngene |
GCT |
2021-Oct-27 |
|
501 KB |
811 |
Finerenone |
M/s. Bayer |
GCT |
2021-Oct-27 |
|
508 KB |
812 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP (as extended release) Film coated bilayered tablets (Phase III) |
M/s. Sun Pharma Laboratories Ltd. |
FDC |
2021-Oct-26 |
|
245 KB |
813 |
NNC0194-0499 |
M/s. Novo-Nordisk |
GCT |
2021-Oct-26 |
|
529 KB |
814 |
OAV101 |
M/s. Novartis |
GCT |
2021-Oct-25 |
|
496 KB |
815 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (11-valent) |
M/s Panacea Biotec Ltd., New Delhi |
Vaccine |
2021-Oct-22 |
|
324 KB |
816 |
Letrozole Tablet 5 mg |
M/s Akums Drugs |
SND |
2021-Oct-21 |
|
2846 KB |
817 |
Inactivated Hepatitis A Vaccine (Adsorbed |
M/s Biological E Limited, Shameerpet Mandal, Hyderabad |
Vaccine |
2021-Oct-21 |
|
315 KB |
818 |
Brinzolamide IP + Brimonidine Tartrate IP Ophthalmic suspension (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2021-Oct-20 |
|
184 KB |
819 |
Urosodiol Injection 625 mg/25ml 925mg/ml) |
Shilpa Medicare |
SND |
2021-Oct-18 |
|
3072 KB |
820 |
Remdesivir for injection 100mg/vial |
M/s Syngene International |
SND |
2021-Oct-14 |
|
2819 KB |
821 |
Study (NEST) |
M/s. GSK |
GCT |
2021-Oct-14 |
|
652 KB |
822 |
Intravitreal OPT-302 |
M/s. IQVIA |
GCT |
2021-Oct-14 |
|
338 KB |
823 |
Loeglitazone sulphate 0.5 mg tablets |
M/s Glenmark Pharmaceuticals ltd |
New Drugs |
2021-Oct-13 |
|
2617 KB |
824 |
Ad26.COV2.S |
M/s. Johnson & Johnson |
GCT |
2021-Oct-13 |
|
664 KB |
825 |
Typhoid Vi Conjugate Vaccine I. |
M/s Cadila Healthcare Limited, Ahmedabad |
Vaccine |
2021-Oct-13 |
|
232 KB |
826 |
Quadrivalent Influenza vaccine (Split Virion, Inactivated) |
M/s Sanofi Healthcare India Private LimitedMumbai |
Vaccine |
2021-Oct-12 |
|
306 KB |
827 |
OPT-302 |
M/s. IQVIA |
GCT |
2021-Oct-11 |
|
672 KB |
828 |
PF-07321332/Ritonavir |
M/s. Pfizer |
GCT |
2021-Oct-11 |
|
410 KB |
829 |
Vilanterol Trifenatate eq. to Vilanterol + Fluticasone Furoate per actuation delivers metered dose inhalation (Phase III) |
M/s. Zydus Healthcare Ltd. |
FDC |
2021-Oct-08 |
|
224 KB |
830 |
HRF-10071 |
M/s Veeda Clinicial research private Limited |
New Drugs |
2021-Oct-08 |
|
2295 KB |
831 |
Peg-filgrastim Injection 6 mg/0.6ml |
M/s Reliance Life Sciences Pvt. Ltd |
rDNA |
2021-Oct-07 |
|
684 KB |
832 |
Insulin Aspart Injection (100 IU/mL) |
M/s Wockhardt Limited |
rDNA |
2021-Oct-07 |
|
695 KB |
833 |
PDP-1 17 |
M/s Norwich Clinical Services Pvt. Ltd |
New Drugs |
2021-Oct-07 |
|
2303 KB |
834 |
MRG-001, |
M/s. Navitas |
GCT |
2021-Oct-05 |
|
646 KB |
835 |
ISTH0036 |
M.s, Cliantha |
GCT |
2021-Oct-05 |
|
476 KB |
836 |
ziltivekimab1 |
M/s. Novo Nordisk |
GCT |
2021-Oct-05 |
|
646 KB |
837 |
FP-025 |
M/s. Medpace |
GCT |
2021-Oct-05 |
|
483 KB |
838 |
Gadoteridol 279.3mg/ml Injection |
M/s Imaging products India pvt. Ltd |
New Drugs |
2021-Oct-05 |
|
2210 KB |
839 |
Acalabrutinibz |
M/s. Covance |
GCT |
2021-Oct-04 |
|
967 KB |
840 |
Nortriptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Film Coated Tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2021-Oct-04 |
|
203 KB |
841 |
Anti-COVID-19 AKS-452 vaccine |
M/s. Veeda |
GCT |
2021-Oct-04 |
|
671 KB |
842 |
Naltrexone Hydrochloride + Zonisamide sustained release capsules (Phase II) |
M/s. Dr. Reddyâs Laboratories Ltd |
FDC |
2021-Oct-01 |
|
242 KB |
843 |
Teneligliptin Hydrobromide IP + Dapagliflozin tablets (Phase III) |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2021-Oct-01 |
|
131 KB |
844 |
Novel Corona virus-2019-nCoV Vaccine (recombinant) |
M/s Cadila Healthcare LtdAhmedabad |
Vaccine |
2021-Sep-30 |
|
229 KB |
845 |
Insulin Aspart Injection 100 U/mL |
M/s GeneSys Biologics Pvt. Ltd |
rDNA |
2021-Sep-30 |
|
697 KB |
846 |
Varespladib-Methyl |
Ms. Premier Research |
GCT |
2021-Sep-29 |
|
650 KB |
847 |
Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin |
M/s. ICMR |
GCT |
2021-Sep-29 |
|
502 KB |
848 |
Imetelstat (GRN163L) |
M/s. Parexel |
GCT |
2021-Sep-28 |
|
514 KB |
849 |
Angiotensin Receptor Blocker (ARB) |
M/s. George Institute |
GCT |
2021-Sep-28 |
|
651 KB |
850 |
Favipiravir Tablet 200/800 m |
M/s Mylan |
SND |
2021-Sep-27 |
|
675 KB |
851 |
Apremilast Topcial Gel 2% |
M/s Aizant Drugs |
SND |
2021-Sep-27 |
|
3225 KB |
852 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP tablets (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2021-Sep-27 |
|
230 KB |
853 |
BP01 (Bevacizumab) |
M/s. Curateq |
GCT |
2021-Sep-24 |
|
656 KB |
854 |
Betamethasone dipropionate Ph. Eur + Calcipotriol anhydrous Ph. Eur. Cutaneous spray (Phase III) |
M/s. Cadila Pharmaceuticals Ltd |
FDC |
2021-Sep-24 |
|
220 KB |
855 |
Polatuzumab Vedotin |
M/s. Roche |
GCT |
2021-Sep-23 |
|
649 KB |
856 |
unadjuvanted RSV Maternal vaccine |
M/s. GSK |
GCT |
2021-Sep-22 |
|
657 KB |
857 |
Azelnidipine + Telmisartan IP tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2021-Sep-21 |
|
215 KB |
858 |
Bisoprolol IP + Telmisartan IP tablets (Phase III) |
M/s. Micro Labs Ltd |
FDC |
2021-Sep-21 |
|
208 KB |
859 |
Bempedoic acid 180 mg tabletct |
M/s Ajanta Pharma Limited |
New Drugs |
2021-Sep-21 |
|
239 KB |
860 |
Inhaled Ampion |
M/s. QED |
GCT |
2021-Sep-20 |
|
668 KB |
861 |
Saroglitazar Tablet 4 mg |
M/s Cadila Healthcare |
SND |
2021-Sep-17 |
|
2782 KB |
862 |
Bempedoic acid 180 mg tablet |
M/s Exemed Pharmaceuticals |
New Drugs |
2021-Sep-17 |
|
2853 KB |
863 |
Silodosin + Tadalafil capsules (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2021-Sep-17 |
|
287 KB |
864 |
Bilastine + Montelukast Sodium IP eq. to Montelukast oral suspension (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2021-Sep-17 |
|
197 KB |
865 |
Tirzepatide |
M/s Eli Lilly |
GCT |
2021-Sep-16 |
|
660 KB |
866 |
Herpes Zoster vaccine |
M/s GlaxoSmithKline Pharmaceuticals Limited, Mumbai |
Vaccine |
2021-Sep-16 |
|
219 KB |
867 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP(as sustained release) tablets (Phase III) |
M/s. Alkem Health Science |
FDC |
2021-Sep-15 |
|
233 KB |
868 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP Phase III) |
M/s. Macleods Pharmaceuticals Ltd |
FDC |
2021-Sep-14 |
|
192 KB |
869 |
Hydroxyprogesterone Caproate Intramuscular Injection |
M/s. CBCC |
GCT |
2021-Sep-14 |
|
651 KB |
870 |
Iptacopan (LNP023) |
M/s. Novartis |
GCT |
2021-Sep-14 |
|
651 KB |
871 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP per actuation delivers metered dose inhaler (Phase III) |
M/s. Zydus Healthcare Ltd |
FDC |
2021-Sep-13 |
|
197 KB |
872 |
Pioglitazone Hydrochloride IP + Teneligliptin Hydrobromide Hydrate IP tablets (Phase III) |
M/s. Macleods Pharmaceuticals Ltd |
FDC |
2021-Sep-13 |
|
185 KB |
873 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP dry powder for inhalation (capsules) (Phase III) |
M/s. Zydus Healthcare Ltd |
FDC |
2021-Sep-13 |
|
207 KB |
874 |
Fesoteroduine Fumarate Extend release tabklet 4 mg/8 mg and Solifenacin sucinate tablets 5 mg/10 mg |
M/s MSN Laborotories Pvt. Limited |
New Drugs |
2021-Sep-10 |
|
2540 KB |
875 |
Typhoid Conjugate |
M/sCadila Healthcare |
Vaccine |
2021-Sep-08 |
|
567 KB |
876 |
Fimasartan Potassium + Chlorthalidone IP tablets (Phase III) |
M/s. Windlas |
FDC |
2021-Sep-07 |
|
176 KB |
877 |
BP05 Versus EU-Approved Lucentis® |
M/s. Curateq |
GCT |
2021-Sep-06 |
|
674 KB |
878 |
Nucleocapsid |
M/s Reliance Life Sciences |
Vaccine |
2021-Sep-03 |
|
326 KB |
879 |
Cetrelimab |
M/s. PRA |
GCT |
2021-Sep-03 |
|
689 KB |
880 |
Acalabrutinib |
M/s. Covance |
GCT |
2021-Sep-02 |
|
404 KB |
881 |
SARS-CoV-2Vaccine |
M/s Biological E limited |
Vaccine |
2021-Sep-01 |
|
323 KB |
882 |
Favipiravir Tablet 200/400/800 mg |
M/s Mylan |
SND |
2021-Sep-01 |
|
2852 KB |
883 |
(KAE609) |
M/s. Novartis |
GCT |
2021-Aug-31 |
|
653 KB |
884 |
Ozenoxacin Lotion 2% W/v |
M/s Precise Biopharma |
SND |
2021-Aug-27 |
|
3467 KB |
885 |
Efonidipine hydrochloride Ethanolate + Telmisartan IP Film coated bilayered tablet (Phase III) |
M/s. Ajanta Pharma Ltd |
FDC |
2021-Aug-27 |
|
215 KB |
886 |
Remdesivir 100 mgb |
M/s Dr Reddy's Laboratories Limited |
New Drugs |
2021-Aug-27 |
|
2180 KB |
887 |
Tapentadol Hydrochloride Nasal Spray 225 mg/ml |
M/s Torrent Pharma |
SND |
2021-Aug-27 |
|
3553 KB |
888 |
Favipiravir tablet 200 mg/400 mg/800 mg |
M/s Cipla Ltd |
New Drugs |
2021-Aug-27 |
|
2836 KB |
889 |
Amoxicillin Trihydrate 759.04 mg eq. to Amoxicillin free acid 652.78 mg* + Potassium Clavulanate 61.48 mg eq. to Clavulanic acid 50.41mg |
M/s. GlaxoSmithKline Pharmaceuticals Ltd |
FDC |
2021-Aug-27 |
|
176 KB |
890 |
Cipargamin |
M/s. Novartis |
GCT |
2021-Aug-26 |
|
543 KB |
891 |
PTG-300 |
M/s. JSS |
GCT |
2021-Aug-24 |
|
2593 KB |
892 |
Lenvatinib 4/10 mg Capsule |
M/s Sun Pharma |
SND |
2021-Aug-23 |
|
3239 KB |
893 |
HGCO19 |
M/sGennova Biopharmaceuticals Limited |
Vaccine |
2021-Aug-22 |
|
313 KB |
894 |
SARS-CoV-2V |
M/s Biological E Limited |
Vaccine |
2021-Aug-20 |
|
669 KB |
895 |
Favipiravir tablet 400 mg |
M/s Optimus Pharma Pvt. Ltd |
New Drugs |
2021-Aug-19 |
|
2337 KB |
896 |
Favipiravir tablet 800 mg |
M/s Optimus Pharma Pvt. Ltd |
New Drugs |
2021-Aug-19 |
|
2285 KB |
897 |
Teneligliptin Hydrobromide hydrate eq. to Teneligliptin + Dapagliflozin tablets (Phase III) |
M/s. Alkem Health Science |
FDC |
2021-Aug-19 |
|
170 KB |
898 |
Vildagliptin SR + Metformin Hydrochloride (SR) uncoated bilayered tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2021-Aug-19 |
|
199 KB |
899 |
Recombinant Human Parathyroid Hormone (rhPTH1-34) injection (Teriparatide Injection) 750 mcg/3 mL |
M/s Stelis Biopharma Private Limited |
rDNA |
2021-Aug-19 |
|
708 KB |
900 |
Talazoparib With Enzalutamide |
M/s. Pfizer |
GCT |
2021-Aug-17 |
|
654 KB |
901 |
Remdesivir 100 mgh |
M/s Hetero labs Limited |
New Drugs |
2021-Aug-17 |
|
2560 KB |
902 |
LNP023n |
M/s. Novartis |
GCT |
2021-Aug-16 |
|
649 KB |
903 |
Metformin hydrochloride IP (as an extended-release form) + Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III) |
M/s. Alkem Health Science |
FDC |
2021-Aug-13 |
|
216 KB |
904 |
Mifepristone 10/25 mg Tablet |
M/s Akums Drugs |
SND |
2021-Aug-13 |
|
2861 KB |
905 |
Remdesivir 100 mgc |
M/sCipla Limited |
New Drugs |
2021-Aug-13 |
|
2484 KB |
906 |
Cocculus hirsutus |
M/s Sun Pharmaceutical Industries Ltd |
New Drugs |
2021-Aug-13 |
|
3037 KB |
907 |
Remdesivir 100 mgj |
M/s Jubilant Generics ltd |
New Drugs |
2021-Aug-13 |
|
2305 KB |
908 |
Sputnik Light |
M/s Dr Reddy's Laboratories Limited |
Vaccine |
2021-Aug-12 |
|
229 KB |
909 |
Rilematovir |
M/s. J&J |
GCT |
2021-Aug-12 |
|
409 KB |
910 |
C21 |
M/s. QED |
GCT |
2021-Aug-11 |
|
409 KB |
911 |
BBV154 |
M/s Bharat Biotech International Limited |
Vaccine |
2021-Aug-11 |
|
423 KB |
912 |
Remdesivir for Injection 100mg/ml |
M/s Cadila Healthcare |
SND |
2021-Aug-10 |
|
2877 KB |
913 |
2-Deoxy-D-Glucose Oral Powder 2.34 gm & 3.0 gm |
M/s Dr. Reddyâs Laboratories |
SND |
2021-Aug-10 |
|
176 KB |
914 |
Favipiravir tablet 200 mgw |
M/s Zenera Pharma Private Limited |
New Drugs |
2021-Aug-10 |
|
2590 KB |
915 |
Teneligliptin hydrobromide hydrate eq to Teneligliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2021-Aug-10 |
|
236 KB |
916 |
Doxazosin Tablet 2 mg |
M/s Stand Life Sciences |
SND |
2021-Aug-09 |
|
2638 KB |
917 |
Chimpanzee Adenovirus Vectored |
M/sBharat Biotech International Limited |
Vaccine |
2021-Aug-08 |
|
276 KB |
918 |
COVAXIN |
M/sChristian Medical College |
Vaccine |
2021-Aug-07 |
|
308 KB |
919 |
Remdesivir 100 mg |
M/s JSS medical Research Asia Pacific Private Limited |
New Drugs |
2021-Aug-06 |
|
2480 KB |
920 |
Atezolizumab |
M/s. Roche |
GCT |
2021-Aug-06 |
|
680 KB |
921 |
Encorafenib Plus Cetuximab |
M/s. Pfizer |
GCT |
2021-Aug-06 |
|
657 KB |
922 |
Favipiravir tablet 200 mg |
M/s Dr Reddy's Laboratories Limited |
New Drugs |
2021-Aug-05 |
|
2181 KB |
923 |
Lidocaine Spray 10% w/v |
M/s Zydus |
SND |
2021-Aug-05 |
|
175 KB |
924 |
Remdesivir100 mg |
M/s JSS medical Research Asia Pacific Private Limited |
New Drugs |
2021-Aug-05 |
|
248 KB |
925 |
Favipiravir tablet 200 mgdr |
M/s Dr Reddy's Laboratories Limited |
New Drugs |
2021-Aug-05 |
|
2181 KB |
926 |
Favipiravirtablet 200 mg |
M/s Optimus Pharma Pvt. Ltd. |
New Drugs |
2021-Aug-05 |
|
2341 KB |
927 |
Favipiravir tablet 200 mgf |
M/s Optimus Pharma Pvt. Ltd |
New Drugs |
2021-Aug-05 |
|
2341 KB |
928 |
VIB7734 |
M/s. PPD |
GCT |
2021-Aug-04 |
|
655 KB |
929 |
EQ001 |
M/s. Bioinnovat Research |
GCT |
2021-Aug-03 |
|
639 KB |
930 |
Olaparib |
M/s. AstraZeneca |
GCT |
2021-Aug-03 |
|
501 KB |
931 |
Niclosamidee |
M/s. CBCC |
GCT |
2021-Aug-02 |
|
496 KB |
932 |
ensovibep (MP0420) |
M/s. IQVIA |
GCT |
2021-Jul-30 |
|
530 KB |
933 |
Duloxetine (as delayed release pellets) IP + Pregabalin IP hard gelatin capsules (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2021-Jul-30 |
|
217 KB |
934 |
Aspirin (EC) IP + Ticagrelor (SR) IP capsules (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2021-Jul-30 |
|
199 KB |
935 |
Insulin Degludec 100 units/mL |
M/s. Novo-Nordisk |
GCT |
2021-Jul-30 |
|
410 KB |
936 |
RP7214 |
M/s JSS medical Research Asia Pacific Private Limited |
New Drugs |
2021-Jul-29 |
|
2293 KB |
937 |
Azilsartan Medoxomil + Amlodipine tablets (Phase III) |
M/s. Inventia Healthcare Pvt. Ltd |
FDC |
2021-Jul-29 |
|
286 KB |
938 |
Endoxifen |
M/s Intas Pharmaceuticals Ltd |
New Drugs |
2021-Jul-29 |
|
2385 KB |
939 |
Vildagliptin SR + Metformin Hydrochloride SR IP Sustained release tablets (Phase III) |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2021-Jul-29 |
|
192 KB |
940 |
RP7214jss |
M/s JSS medical Research Asia Pacific Private Limited |
GCT |
2021-Jul-29 |
|
2693 KB |
941 |
Levonadifloxacinn |
M/s Wockhardt limited |
New Drugs |
2021-Jul-29 |
|
2474 KB |
942 |
Levonadifloxacinw |
M/s Wockhardt limited |
New Drugs |
2021-Jul-29 |
|
2474 KB |
943 |
CA-170 |
M/s Aurigene Discovery Technologies Limited |
New Drugs |
2021-Jul-28 |
|
2252 KB |
944 |
Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP |
M/s Excel Life Sciences |
GCT |
2021-Jul-27 |
|
405 KB |
945 |
imatinib mesylate |
M/s. Syngene |
GCT |
2021-Jul-27 |
|
458 KB |
946 |
PF-07321332 |
M/s. Pfizer |
GCT |
2021-Jul-26 |
|
506 KB |
947 |
Amikacin Sulphate |
M/s Macleods Pharmaceuticals |
SND |
2021-Jul-23 |
|
386 KB |
948 |
LIB003 |
M/s. Medpace |
GCT |
2021-Jul-22 |
|
498 KB |
949 |
Endoxifen2 |
M/s Intas Pharmaceuticals Ltd |
New Drugs |
2021-Jul-21 |
|
2358 KB |
950 |
Minocycline Hydrochloride Topical Gel 4% |
M/s Glenmark Pharma |
SND |
2021-Jul-20 |
|
2674 KB |
951 |
Atropine Sulfate Ophthalmic Solution USP 0.01% w/v |
M/s SUN Pharma |
SND |
2021-Jul-19 |
|
706 KB |
952 |
C-TB with QuantiFERON-TB Gold Plus and 2.T.U. Tuberculin PPD RT23 |
ICMR- Regional Medical research Centre |
New Drugs |
2021-Jul-16 |
|
2167 KB |
953 |
VPM1002 (rBCG) Vaccine |
M/s Serum Institute of India Ltd |
Vaccine |
2021-Jul-16 |
|
223 KB |
954 |
23-valent Pneumococcal Polysaccharide Vaccine I.P. |
M/s G. C. Chemie Pharmie limited |
Vaccine |
2021-Jul-16 |
|
388 KB |
955 |
LY3471851 |
M/s. Eli Lilly |
GCT |
2021-Jul-16 |
|
638 KB |
956 |
Lifitegrast |
M/s Micro labs Limited |
New Drugs |
2021-Jul-15 |
|
2347 KB |
957 |
Dextromethorphan Polistirex eq. to Dextromethorphan Hydrobromide IP + Chlorpheniramine Polistirex eq. to Chlorpheniramine Maleate + Methylparaben IP + Propylparaben IP per 5ml sustained release oral suspension (Phase IV) |
M/s. Sun Pharmaceuticals Industries Ltd |
FDC |
2021-Jul-14 |
|
222 KB |
958 |
Nitric oxide |
M/s Glenmark Pharmaceuticals Ltd |
New Drugs |
2021-Jul-14 |
|
2443 KB |
959 |
ofatumumab and siponimod versus fingolimod |
M/s. Novartis |
GCT |
2021-Jul-13 |
|
501 KB |
960 |
Coronavirus vaccine (rDNA) â BBV151 |
M/s Bharat Biotech India Pvt Ltd |
Vaccine |
2021-Jul-09 |
|
319 KB |
961 |
Dienogest 2mg Tablet |
M/s Sun Pharma |
SND |
2021-Jul-08 |
|
345 KB |
962 |
Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2021-Jul-07 |
|
266 KB |
963 |
JNJ-42756493 |
M/s. Johnson & Johnson |
GCT |
2021-Jul-07 |
|
492 KB |
964 |
Aqueous chlorine S |
M/s Supreme industries |
New Drugs |
2021-Jul-07 |
|
2399 KB |
965 |
Urosdexycholic Acid Tablet 150/mg/300 mg |
M/s Abbott India |
SND |
2021-Jul-06 |
|
3327 KB |
966 |
Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2021-Jul-01 |
|
233 KB |
967 |
Solidarity trial |
ICMR-National AIDS Research Institute |
New Drugs |
2021-Jul-01 |
|
3455 KB |
968 |
Molnupiravir Mild2 |
M/s Pure & Cure Health Care Ltd |
New Drugs |
2021-Jul-01 |
|
3954 KB |
969 |
NNC0365-3769 |
M/s. Novo-Nordisk |
GCT |
2021-Jun-30 |
|
404 KB |
970 |
OQL011 |
M/s. CBCC |
GCT |
2021-Jun-29 |
|
503 KB |
971 |
Hydrochloroquinee |
M/s Ipca Laboratories Limited |
SND |
2021-Jun-29 |
|
187 KB |
972 |
Anti-Covid-19 mAbs cocktail drug product |
M/s Cadila Healthcare Limited |
rDNA |
2021-Jun-29 |
|
561 KB |
973 |
Multitope Protein/ Peptide-Based SARS-CoV-2 Vaccine (Manufactured by M/s Aurobindo Pharma Limited, Hyderabad) 2. UB-612(Imported from M/s UBI Pharma (UBIP),Taiwan) |
M/s. AXIS Clinicals Limited |
Vaccine |
2021-Jun-28 |
|
302 KB |
974 |
Metoprolol Succinate eq. to Metoprolol Tartrate IP + Azelnidipine IP tablets (Phase III) |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2021-Jun-25 |
|
198 KB |
975 |
Erdafitinib |
M/s. J&J |
GCT |
2021-Jun-23 |
|
497 KB |
976 |
Flupentixol + Melitracen tablets (Phase IV) |
M/s. Mankind Pharma |
FDC |
2021-Jun-22 |
|
139 KB |
977 |
Montelukast Sodium IP eq. to Montelukast + Bilastine orodispersible tablet (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2021-Jun-21 |
|
190 KB |
978 |
ODM-203 |
M/s Aurigene Discovery Technologies Limited |
New Drugs |
2021-Jun-18 |
|
2225 KB |
979 |
GRC 17536 |
M/s Glenmark Pharmaceuticals Ltd |
New Drugs |
2021-Jun-18 |
|
2255 KB |
980 |
MKP-10241 |
M/s Mankind Research Centre |
New Drugs |
2021-Jun-18 |
|
2162 KB |
981 |
AB1001 |
M/s Ahammune Bioscences Private Limited |
New Drugs |
2021-Jun-18 |
|
2037 KB |
982 |
Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate powder for inhalation (Phase IV) |
M/s. GlaxoSmithKline Pharmaceuticals Ltd |
FDC |
2021-Jun-18 |
|
201 KB |
983 |
ZY-19489 |
M/s Cadila Healthcare Limited |
New Drugs |
2021-Jun-18 |
|
2106 KB |
984 |
ZYIL 1 |
M/s Zydus Research Centre |
New Drugs |
2021-Jun-18 |
|
2179 KB |
985 |
SARS-CoV-2 Adjuvanted Recombinant |
M/s. Sanofi |
GCT |
2021-Jun-16 |
|
505 KB |
986 |
Duloxetine Hydrochloride eq. to Duloxetine (as gastro resistant pellets) IP + Pregabalin IP Capsules (Phase III) |
M/s. Pure & Cure Pvt. Ltd |
FDC |
2021-Jun-15 |
|
215 KB |
987 |
Quercetin Nutraceutical bar |
Director, Defence institute of Physiology and Allied Sciences |
New Drugs |
2021-Jun-11 |
|
2159 KB |
988 |
Gam-COVID-Vac combined vector vaccine Component Iand Component II |
M/s Virchow |
Vaccine |
2021-Jun-09 |
|
229 KB |
989 |
Anti-COVID19 Serum [Equine Anti Covid Antibody Fragments F(abâ)2] |
M/s Premium Serums |
Vaccine |
2021-Jun-09 |
|
292 KB |
990 |
Bilastine Tablets 40mg |
M/s Ravenbhel Healthcare pvt ltd |
SND |
2021-Jun-08 |
|
3789 KB |
991 |
Molnupiravir Moderateapl |
M/s APL Research Center-II |
New Drugs |
2021-Jun-08 |
|
2472 KB |
992 |
Palbociclib versus Anastrozole |
M/s. AstraZeneca |
GCT |
2021-Jun-08 |
|
326 KB |
993 |
Aviptadil2 |
M/s MSN Laborotories Pvt. Limited |
New Drugs |
2021-Jun-08 |
|
2481 KB |
994 |
Molnupiravir Mildapl |
M/s APL Research Center-II |
New Drugs |
2021-Jun-08 |
|
2404 KB |
995 |
Larotrectinib |
M/s. Bayer |
GCT |
2021-Jun-07 |
|
392 KB |
996 |
Galcanezumab in Adolescent Patients |
M/s.Eli Lilly |
GCT |
2021-Jun-07 |
|
640 KB |
997 |
Chikungunya vaccine (Inactivated) |
M/s Bharat Biotech International Limited |
Vaccine |
2021-Jun-04 |
|
225 KB |
998 |
Niclosamide |
M/s Daewoong Pharmaceutical |
SND |
2021-Jun-04 |
|
2820 KB |
999 |
Quadrivalent Influenza Seasonal Vaccine (QIV) (Virus Like Particle) |
M/s Cadila Pharmaceuticals Limited |
Vaccine |
2021-Jun-03 |
|
294 KB |
1000 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents IP |
M/s Indian Immunological Limited |
Vaccine |
2021-Jun-02 |
|
86 KB |
1001 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents IP |
M/s Indian Immunological Limited |
Vaccine |
2021-Jun-02 |
|
95 KB |
1002 |
Molnupiravir Moderatepure |
M/s Pure & Cure Health Care Ltd |
New Drugs |
2021-Jun-01 |
|
3944 KB |
1003 |
Galcanezumab |
M/s. Eli Lilly |
GCT |
2021-Jun-01 |
|
498 KB |
1004 |
Vildagliptin +Dapagliflozin tablets (Phase III) |
M/s. USV Pvt. Ltd |
FDC |
2021-May-25 |
|
292 KB |
1005 |
Oral Cholera Vaccine (Inactivated) |
M/s Techinvention |
Vaccine |
2021-May-25 |
|
305 KB |
1006 |
Molnupiravir Mildm1 |
M/s MSN Laborotories Pvt. Limited |
New Drugs |
2021-May-21 |
|
1872 KB |
1007 |
Molnupiravir Moderateb2 |
M/s BDR Pharmaceuticals International Pvt. Limited |
New Drugs |
2021-May-19 |
|
1763 KB |
1008 |
Molnupiravir Milds1 |
M/s Strides Pharma Science Limited |
New Drugs |
2021-May-19 |
|
2391 KB |
1009 |
Molnupiravir MildB1 |
M/s BDR Pharmaceuticals International Pvt. Limited |
New Drugs |
2021-May-19 |
|
1709 KB |
1010 |
Molnupiravir Moderatem3 |
M/s MSN Laborotories Pvt. Limited |
New Drugs |
2021-May-19 |
|
2003 KB |
1011 |
Adaptive Platform Treatment Trial |
M/s. PPD |
GCT |
2021-May-19 |
|
515 KB |
1012 |
Molnupiravir Mildr |
M/s Dr Reddy's Laboratories Limited |
New Drugs |
2021-May-18 |
|
18881 KB |
1013 |
Molnupiravir Mildh |
M/s Hetero labs Limited |
New Drugs |
2021-May-18 |
|
2557 KB |
1014 |
Molnupiravir Milda |
M/s Ajanta Pharma Limited |
New Drugs |
2021-May-18 |
|
2008 KB |
1015 |
Molnupiravir Moderate2s |
M/s Strides Pharma Science Limited |
New Drugs |
2021-May-18 |
|
2451 KB |
1016 |
Molnupiravir Mild1 |
M/s Natco Pharma Limited |
New Drugs |
2021-May-18 |
|
2417 KB |
1017 |
Molnupiravir Mild |
M/s Optimus pharma Pvt. Ltd |
New Drugs |
2021-May-18 |
|
2203 KB |
1018 |
Molnupiravir Moderater1 |
M/s Dr Reddy's Laboratories Limited |
New Drugs |
2021-May-18 |
|
1955 KB |
1019 |
Molnupiravir Moderaten |
M/s Ajanta Pharma Limited |
New Drugs |
2021-May-18 |
|
1999 KB |
1020 |
Molnupiravir Moderateh2 |
M/s Hetero labs Limited |
New Drugs |
2021-May-18 |
|
2634 KB |
1021 |
ATR-002 |
M/s. Clinexel Life Sciences |
GCT |
2021-May-18 |
|
527 KB |
1022 |
LNP023 in primary IgA nephropathy |
M/s. Novartis |
GCT |
2021-May-18 |
|
497 KB |
1023 |
Molnupiravir Moderate2 |
M/s Natco Pharma Limited |
New Drugs |
2021-May-18 |
|
2469 KB |
1024 |
Molnupiravir Moderate |
M/s Optimus pharma Pvt. Ltd |
New Drugs |
2021-May-18 |
|
3074 KB |
1025 |
Whole-Virion Inactivated SARS-CoV-2 Vaccine |
M/s Bharat Biotech India Pvt Ltd |
Vaccine |
2021-May-12 |
|
566 KB |
1026 |
Inactivated Japanese encephalitis vaccine |
M/s Bharat Biotech India Pvt Ltd |
Vaccine |
2021-May-12 |
|
566 KB |
1027 |
Aceclofenac IP + Linceed Oil (containing predominantly-Linolenic acid) + Methyl Salicylate IP + Capsaicin USP +Menthol IP + Benzyl Alcohol IP (as preservative) ointment (Phase III) |
M/s. Panacea Biotec Ltd |
FDC |
2021-May-07 |
|
298 KB |
1028 |
70% Human Insulin Isophane Suspension and 30% Human Insulin Injection (100 U/mL) |
M/sWockhardt Limited |
rDNA |
2021-May-04 |
|
684 KB |
1029 |
Equine Anti Covid Antibody Fragments F(ab)2 |
M/s JSS Medical Research India Pvt Ltd |
Vaccine |
2021-May-04 |
|
954 KB |
1030 |
Trastuzumab and Pertuzumab |
M/s. AstraZeneca |
GCT |
2021-May-03 |
|
504 KB |
1031 |
ruxolitinib and panobinostat (LBH589) |
M/s. Novartis |
GCT |
2021-Apr-29 |
|
310 KB |
1032 |
Pamrevlumab |
M/s. Novotech |
GCT |
2021-Apr-28 |
|
496 KB |
1033 |
Gam-COVID-Vac combined vector vaccine Component I and Component II) |
M/s Hetero Biopharma Ltd |
Vaccine |
2021-Apr-27 |
|
442 KB |
1034 |
Sodium Hyaluronate + Polyethylene Glycol 400 + Propylene Glycol lubricant eye drops (Phase IV) |
M/s. Alcon Laboratories (I) Pvt. Ltd |
FDC |
2021-Apr-23 |
|
292 KB |
1035 |
Tropicamide IP + Phenylephrine Hydrochloride IP + Lidocaine Hydrochloride IP injection (Phase IV) |
M/s. Sunways (India) Pvt. Ltd |
FDC |
2021-Apr-23 |
|
300 KB |
1036 |
Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 (RBD antigen of SARS CoV-2 (Covid-19)) |
M/s Biological E limited |
Vaccine |
2021-Apr-23 |
|
315 KB |
1037 |
Biapenam Injection 300 mg |
M/s Hetero labs Limited |
New Drugs |
2021-Apr-22 |
|
2411 KB |
1038 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin film coated tablets (Phase III) |
M/s. Inventia Healthcare Ltd |
FDC |
2021-Apr-20 |
|
286 KB |
1039 |
Niclosamide Tablets |
M/s Laxai Life Sciences Pvt Ltd |
SND |
2021-Apr-20 |
|
3263 KB |
1040 |
(TACTIC-E) |
M/s. Spectra |
GCT |
2021-Apr-15 |
|
497 KB |
1041 |
Azelnidipine IP Metoprolol Succinate IP eq. to Metoprolol Tartrate (SR) film coated tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2021-Apr-15 |
|
283 KB |
1042 |
Liraglutide 3.0 mg |
M/s. Novo-Nordisk |
GCT |
2021-Apr-13 |
|
490 KB |
1043 |
osilodrostat (LCI699) |
M/s. IQVIA |
GCT |
2021-Apr-13 |
|
491 KB |
1044 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone film coated tablets (Phase III) |
M/s. USV Pvt. Ltd |
FDC |
2021-Apr-12 |
|
304 KB |
1045 |
Randomized SARS |
CSIR Indian Institute of Chemical Technology |
SND |
2021-Apr-12 |
|
2197 KB |
1046 |
insulin glargine 100 units/m |
LM/s. Novo -Nordisk |
GCT |
2021-Apr-09 |
|
503 KB |
1047 |
AQCH |
M/s Sun Pharma Industries limited |
New Drugs |
2021-Apr-09 |
|
2605 KB |
1048 |
SNG001 |
M/s. Parexel |
GCT |
2021-Apr-09 |
|
507 KB |
1049 |
Ozenoxacin2 |
M/s Optimus Pharma Pvt. Ltd |
New Drugs |
2021-Apr-08 |
|
2351 KB |
1050 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
GCT |
2021-Apr-08 |
|
329 KB |
1051 |
Sugammadex |
M/s BDR Pharmaceuticals International Pvt. Limited |
New Drugs |
2021-Apr-06 |
|
2369 KB |
1052 |
Aqueous chlorine |
M/s Supreme industries |
New Drugs |
2021-Apr-06 |
|
2210 KB |
1053 |
Omalizumab150 mg/ml |
M/s Synchron Research Services Pvt. Ltd. |
rDNA |
2021-Mar-31 |
|
697 KB |
1054 |
MSP008-22 |
M/s Clinixel Life Sciences Pvt. Ltd |
New Drugs |
2021-Mar-26 |
|
2172 KB |
1055 |
SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) |
M/s. Sanofi |
GCT |
2021-Mar-26 |
|
503 KB |
1056 |
Pneumococcal (Polysaccharide Conjugate Vaccine (15-Valent) |
M/s Tergene Biotech Pvt Ltd |
Vaccine |
2021-Mar-25 |
|
339 KB |
1057 |
Bilastine tab |
M/s Akums Drugs and Pharmaceuticals |
SND |
2021-Mar-22 |
|
2423 KB |
1058 |
T4030 |
M/s. IQVIA |
GCT |
2021-Mar-22 |
|
511 KB |
1059 |
A vector vaccine for the prevention of the coronavirus infection induced by the SARSCoV-2 virus |
M/s Dr Reddyâs Laboratories Limited, Hyderabad |
Vaccine |
2021-Mar-22 |
|
337 KB |
1060 |
Isophane Insulin Human suspension (100 IU/mL) |
M/s Wockhardt Limited |
rDNA |
2021-Mar-22 |
|
678 KB |
1061 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml suspension (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2021-Mar-19 |
|
321 KB |
1062 |
Vildagliptin + Metformin Hydrochloride IP Film coated bilayered tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2021-Mar-19 |
|
322 KB |
1063 |
selexipagn |
M/s. J&J |
GCT |
2021-Mar-17 |
|
360 KB |
1064 |
Budesonide, Glycopyrronium |
M/s. AstraZeneca |
GCT |
2021-Mar-15 |
|
326 KB |
1065 |
Novel Corona Virus Vaccine -2019-nCov Vaccine (3mg dose- 28 days Schedule) |
M/s Cadila Healthcare Pvt Ltd |
Vaccine |
2021-Mar-15 |
|
316 KB |
1066 |
fibrinogen concentrate (FIB Grifols) |
M/s. Parexel |
GCT |
2021-Mar-12 |
|
316 KB |
1067 |
Glycopyrrolate IP + Formoterol Fumarate Dihydrate IP eq to Formoterol Fumarate Inhalation Aerosol per actuation deliver (Phase IV) |
M/s. Zydus Healthcare Ltd |
FDC |
2021-Mar-12 |
|
215 KB |
1068 |
SAR443122 |
M/s. Sanofi |
GCT |
2021-Mar-11 |
|
499 KB |
1069 |
Neoadjuvant Osimertinib |
M/s. AstraZeneca |
GCT |
2021-Mar-11 |
|
498 KB |
1070 |
EdoxabaN foR IntraCranial Hemorrhage |
M/s. CBCi Society |
GCT |
2021-Mar-10 |
|
524 KB |
1071 |
CT-P42 |
M/s. Kendle |
GCT |
2021-Mar-09 |
|
519 KB |
1072 |
RSV Maternal Vaccine |
M/s. GSK |
GCT |
2021-Mar-08 |
|
434 KB |
1073 |
Tropicamide IP + Phenylephrine Hydrochloride IP + Lidocaine Hydrochloride IP per ml solution for Injection (Phase IV) |
M/s. ENTOD Pharmaceuticals Ltd |
FDC |
2021-Mar-05 |
|
5090 KB |
1074 |
Pneumococcal (Polysaccharide Conjugate Vaccine (14-Valent) |
M/s Biological E Ltd |
Vaccine |
2021-Mar-05 |
|
327 KB |
1075 |
finerenone |
M/s. Bayer |
GCT |
2021-Mar-05 |
|
394 KB |
1076 |
Fenebrutinib |
M/s. Roche |
GCT |
2021-Mar-04 |
|
592 KB |
1077 |
Tapentadol Hy |
M/s Torrent Pharmaceuticals Limited |
SND |
2021-Mar-02 |
|
5845 KB |
1078 |
Pregabalin IP (as prolonged release) + Etoricoxib IP uncoated bilayered tablets (Phase IV) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2021-Feb-26 |
|
5808 KB |
1079 |
Ozenoxacin |
M/s BDR Pharmaceuticals International Pvt. Limited |
New Drugs |
2021-Feb-26 |
|
2072 KB |
1080 |
Duloxetine Hydrochloride eq. to Duloxetine (as delayed release pellets) + Pregabalin IP Capsules |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2021-Feb-26 |
|
291 KB |
1081 |
Sucroferic oxyhydroxide |
M/s Emcure Pharmaceutical Limited |
New Drugs |
2021-Feb-26 |
|
2340 KB |
1082 |
Brazikumab2 |
M/s. AstraZeneca |
GCT |
2021-Feb-26 |
|
622 KB |
1083 |
Inebilizumab2 |
M/s. Medpace |
GCT |
2021-Feb-24 |
|
495 KB |
1084 |
30 mg bid of evenamide (NW-3509) |
Ms. CliniRx |
GCT |
2021-Feb-23 |
|
502 KB |
1085 |
Trastuzumab Deruxtecan (T-DXd, DS-8201a) |
M/s. AstraZeneca |
GCT |
2021-Feb-22 |
|
489 KB |
1086 |
BG00012 and BIIB017 |
M/s. IQVIA |
GCT |
2021-Feb-22 |
|
|
1087 |
Roxadustat (FG-4592) |
M/s. Parexel |
GCT |
2021-Feb-17 |
|
495 KB |
1088 |
Trastuzumab Deruxtecan |
M/s. AstraZeneca |
GCT |
2021-Feb-17 |
|
498 KB |
1089 |
pasireotide |
M/s. IQVIA |
GCT |
2021-Feb-15 |
|
495 KB |
1090 |
Efgartigimod PH20 SC1 |
M/s. PPD |
GCT |
2021-Feb-15 |
|
494 KB |
1091 |
Chimpanzee Adenovector Corona Virus Vaccine (BBV152) |
M/s Bharat Biotech India Ltd |
Vaccine |
2021-Feb-12 |
|
222 KB |
1092 |
SARS-Cov2-rs Protein recombinant spike protein nanoparticle vaccine |
M/s Serum Institute of India Ltd |
Vaccine |
2021-Feb-11 |
|
235 KB |
1093 |
semaglutide 25 mg compared with 14 mg |
M/s. Novo Nordisk |
GCT |
2021-Feb-10 |
|
423 KB |
1094 |
Semaglutide with alcoholic steatohepatitis |
M/s Novo-Nordisk |
GCT |
2021-Feb-10 |
|
509 KB |
1095 |
Colchicine |
M/s Laxai Life Sciences Provate Limited |
New Drugs |
2021-Feb-05 |
|
2435 KB |
1096 |
Linezolid in combination with Bedaquiline and Pretomanid |
M/s Mylan Laboratories Limited |
New Drugs |
2021-Feb-05 |
|
2517 KB |
1097 |
Pregabalin IP (as sustained release tablet) + Duloxetine HCl IP eq to Duloxetine (as enteric coated tablet) hard gelatin capsule (Phase III) |
M/s. Intas Pharmaceuticals Ltd |
FDC |
2021-Feb-05 |
|
307 KB |
1098 |
Adapalene EP + Benzoyl Peroxide EP per gram topical Gel (Phase IV) |
M/s. Galderma India Pvt. Ltd |
FDC |
2021-Feb-05 |
|
323 KB |
1099 |
darolutamide |
M/s. Bayer |
GCT |
2021-Feb-04 |
|
321 KB |
1100 |
Vildagliptin + Metformin Hydrochloride IP Film coated bilayered sustained release tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2021-Feb-02 |
|
321 KB |
1101 |
Hyperimmune Intravenous Immunoglobulin |
M/s. ICMR |
GCT |
2021-Feb-01 |
|
493 KB |
1102 |
Leuprolide Acetatea |
M/s Bharat Serums and Vaccines limited |
SND |
2021-Jan-28 |
|
4345 KB |
1103 |
Marzeptacog alfae |
M/s. PSI CRO |
GCT |
2021-Jan-28 |
|
498 KB |
1104 |
Aviptadiln |
M/s Dr Reddy's Laboratories Limited |
New Drugs |
2021-Jan-27 |
|
2393 KB |
1105 |
Durvalumab1 |
M/s. AstraZeneca |
GCT |
2021-Jan-27 |
|
490 KB |
1106 |
Aviptadil |
M/s Zuventus healthcare limited |
New Drugs |
2021-Jan-25 |
|
2363 KB |
1107 |
M-RNA Vaccine for Injection (Covid-19) |
M/s Gennova Biopharma Pvt Ltd |
Vaccine |
2021-Jan-25 |
|
405 KB |
1108 |
Equine Covid-19 Antiserum |
M/s Bharat Serums and Vaccines Pvt Ltd |
Vaccine |
2021-Jan-19 |
|
290 KB |
1109 |
Levonadifloxacin |
M/s Wockhardt limited |
New Drugs |
2021-Jan-11 |
|
2507 KB |
1110 |
Inosine Pranobex |
M/s Themis Medicare Limited |
New Drugs |
2021-Jan-08 |
|
2553 KB |
1111 |
Chlorhexidine Gluconate solution + Metronidazole Benzoate BP eq to Metronidazole Gel (Phase III) |
M/s. AGIO Pharmaceuticals Ltd |
FDC |
2021-Jan-08 |
|
276 KB |
1112 |
Tetracosactide |
M/s Sun Pharmaceuticals Limited |
New Drugs |
2021-Jan-08 |
|
2087 KB |
1113 |
Biapenam injection |
M/s GC Chemie Pharmie Limited |
New Drugs |
2021-Jan-08 |
|
2519 KB |
1114 |
S007-1500 |
Director,CSIR |
New Drugs |
2021-Jan-08 |
|
2165 KB |
1115 |
Novel CoronaVirus2019-nCoV Vaccine |
M/s Cadila Healthcare Limited |
Vaccine |
2021-Jan-04 |
|
306 KB |
1116 |
Oral Eflornithine NSRT2020 |
M/s Navin Saxena Research and Technology |
SND |
2020-Dec-30 |
|
2898 KB |
1117 |
Isophane Human Insulin suspension, (100 IU/mL) |
M/s Wockhardt Limited |
rDNA |
2020-Dec-30 |
|
625 KB |
1118 |
Carvedilol _ Ivabradine Hydrochloride eq. to Ivabradine film coated tablets (Phase IV) |
M/s. Serdia Pharmaceuticals (India) Pvt. Ltd |
FDC |
2020-Dec-29 |
|
316 KB |
1119 |
Selexipag |
M/s. Johnson & Johnson |
GCT |
2020-Dec-21 |
|
492 KB |
1120 |
Efgartigimod PH20 SC |
M/s. PPD |
GCT |
2020-Dec-21 |
|
494 KB |
1121 |
Taliglucerase Alfa |
M/s. Novotech |
GCT |
2020-Dec-18 |
|
492 KB |
1122 |
JS016 |
M/s. Parexel |
GCT |
2020-Dec-16 |
|
318 KB |
1123 |
AMT-101 |
M/s. George Clinical |
GCT |
2020-Dec-16 |
|
503 KB |
1124 |
Mirabegron (ER) + Solifenacin Succinate IP tablets (Phase III |
M/s. Pure & Cure Pvt. Ltd |
FDC |
2020-Dec-14 |
|
297 KB |
1125 |
Bepotastine Besilate + Montelukast Sodium IP eq. to Montelukast film coated tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals |
FDC |
2020-Dec-14 |
|
285 KB |
1126 |
Bilastine + Montelukast sodium IP eq. to Montelukast Oral Suspension (Phase III |
M/s. Ravenbhel Healthcare Pvt. Ltd |
FDC |
2020-Dec-14 |
|
318 KB |
1127 |
Pregabalin (as sustained release) IP + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptyline IP tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals |
FDC |
2020-Dec-14 |
|
300 KB |
1128 |
Levobupivacaine Hydrochloride eq. to Levobupivacaine + Dextrose liquid injection (Phase III) |
M/s. Neon Laboratories Ltd |
FDC |
2020-Dec-14 |
|
321 KB |
1129 |
Budesonide + Glycopyrronium + Formoterol Fumarate inhalation Powder (Phase IV) |
M/s. Cipla Limited |
FDC |
2020-Dec-10 |
|
304 KB |
1130 |
noxaparin) in COVID-19 |
M/s. Tech Observer |
GCT |
2020-Dec-09 |
|
501 KB |
1131 |
Metformin HCl (SR) + Myo-Inositol film coated bilayered tablets (Phase III) |
M/s. Eris Life Sciences Pvt. Ltd |
FDC |
2020-Dec-04 |
|
330 KB |
1132 |
RIVACA |
M/s Bayer Zydus Pharma Pvt |
SND |
2020-Dec-02 |
|
3602 KB |
1133 |
Potassium Chloride (K-Lyte) |
M/s. ICBio |
GCT |
2020-Dec-01 |
|
419 KB |
1134 |
Pegylated interferon alfa-2b Cadila |
M/s Cadila Healthcare Limited |
rDNA |
2020-Nov-30 |
|
430 KB |
1135 |
Brimonidine IP + Brinzolamide IP + Timolol eq. to Timolol Maleate IP + Benzalkonium chloride solution IP (as preservative) + Water for injection IP q.s. per ml Ophthalmic Suspension (Phase III) |
M/s. Micro Labs Ltd |
FDC |
2020-Nov-27 |
|
322 KB |
1136 |
Alogliptin Benzoate eq. to Alogliptin + Metformin Hydrochloride IP Film Coated Tablet (Phase IV) |
M/s. Indoco Remedies Ltd |
FDC |
2020-Nov-27 |
|
281 KB |
1137 |
Randomized |
M/s zuventus healthcare limited |
SND |
2020-Nov-27 |
|
2969 KB |
1138 |
Marzeptacog Alfa |
M/s. Medpace |
GCT |
2020-Nov-20 |
|
185 KB |
1139 |
Lidocaine Hydrochloride IP + Diltiazem Hydrochloride IP Gel (Phase III) |
M/s. Abbott India Ltd |
FDC |
2020-Nov-20 |
|
286 KB |
1140 |
2-Deoxy-D-glucose |
M/s Dr. reddy's laboraotories limited |
New Drugs |
2020-Nov-16 |
|
2313 KB |
1141 |
Daclatasvir dihydrochloride IP eq. to Daclatasvir + Sofosbuvir film coated tablet with or without Nitazoxanide in combination with standard of care in adult patients with moderate Covid-19 (Phase IIB) |
M/s. Mylan Laboratories Ltd. |
FDC |
2020-Nov-13 |
|
3097 KB |
1142 |
AS012 |
M/s. Sun Pharma |
GCT |
2020-Nov-13 |
|
506 KB |
1143 |
Pregabalin IP (as prolonged release form) + Mecobalamin IP + Nortriptyline HCl film coated bilayered tablet (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2020-Nov-06 |
|
3209 KB |
1144 |
Pioglitazone IP + Vildagliptin (as sustained release form) Film coated bilayered tablet (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2020-Nov-06 |
|
3024 KB |
1145 |
Amino Acid + Glucose 7.5% with Electrolytes and Vitamin B1 Injection (BFLUID) (1000 ml Bag each) (Phase III) |
M/s. Otsuka Pharmaceuticals India Pvt. Ltd |
FDC |
2020-Nov-05 |
|
4216 KB |
1146 |
inebilizumab |
M/s. Medpace |
GCT |
2020-Nov-03 |
|
506 KB |
1147 |
Mycobacterium w (Heat KilledInjection |
M/s Cadila Pharmaceuticals Limited |
Vaccine |
2020-Oct-27 |
|
394 KB |
1148 |
SARS-CoV-2 (Covid-19) Vaccine |
M/s Biological E Ltd. |
Vaccine |
2020-Oct-27 |
|
1184 KB |
1149 |
Saxagliptin + Dapagliflozin Film coated tablets (Phase IV) |
M/s. Astrazeneca Pharma India Ltd |
FDC |
2020-Oct-26 |
|
2849 KB |
1150 |
Whole Virion, Inactivated Corona Virus Vaccine,BBV152 |
M/s Bharat Biotech International Limited |
Vaccine |
2020-Oct-23 |
|
1793 KB |
1151 |
Ketorolac Tromethamine 30mg |
M/s Troikaa Pharmaceuticals Ltd |
SND |
2020-Oct-23 |
|
3039 KB |
1152 |
Gam COVID Vac Combined vector vaccine component one and component two |
M/s Dr Reddys Laboratories Limited |
Vaccine |
2020-Oct-22 |
|
1928 KB |
1153 |
Chlorthalidone IP + Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium film coated tablets (Phase III) |
M/s. Mascot Health Series Pvt. Ltd |
FDC |
2020-Oct-20 |
|
2804 KB |
1154 |
Insulin Glargine |
M/s. Novo Nordisk |
GCT |
2020-Oct-19 |
|
518 KB |
1155 |
SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment) |
M/s Biological E Ltd. |
Vaccine |
2020-Oct-16 |
|
561 KB |
1156 |
Intramuscular Injection of Paracetamol 500 mg/2ml |
M/s Troikaa Pharmaceuticals Ltd |
SND |
2020-Oct-16 |
|
2812 KB |
1157 |
Bemcentinib |
M/s. IQVIA |
GCT |
2020-Oct-16 |
|
440 KB |
1158 |
Betamethasone Dipropionate USP + Clotrimazole USP + Gentamicin Sulfate USP Cream (Phase III) |
M/s. AGIO Pharmaceuticals Ltd |
FDC |
2020-Oct-16 |
|
2397 KB |
1159 |
Sodium Copper Chlorophyllin |
M/s IDRS labs. Pvt. Ltd |
New Drugs |
2020-Oct-14 |
|
2955 KB |
1160 |
M/s Synokem Pharmaceuticals Ltd |
Iguratimod Tables |
SND |
2020-Oct-12 |
|
1087 KB |
1161 |
LIB003 with Evolocumab |
M/s. Medpace |
GCT |
2020-Oct-09 |
|
302 KB |
1162 |
Pantoprazole Sodium IP Aspirin IP Capsules |
M/s. Alkem Laboratories Ltd |
FDC |
2020-Oct-07 |
|
664 KB |
1163 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrochloride Hydrate IP eq. to Teneligliptin tablets (Phase III) |
M/s. Pure & Cure Pvt. Ltd |
FDC |
2020-Oct-06 |
|
2943 KB |
1164 |
Nertrasudil + Latanoprost |
M/s Ajanta Pharma Limited |
New Drugs |
2020-Oct-06 |
|
2686 KB |
1165 |
Acotiamide Hydrochloride hydrate SR Tablet 300mg |
M/s Mascot Health Series Pvt ltd |
SND |
2020-Oct-06 |
|
3185 KB |
1166 |
Iguratimod tablets 25 mg |
M/s. Ajanta pharma |
New Drugs |
2020-Oct-05 |
|
12792 KB |
1167 |
Follicle-Stimulating Hormone and Human Chorionic Gonadotropin |
M/s. Sanzyme |
New Drugs |
2020-Oct-05 |
|
1997 KB |
1168 |
Teriparatide solution for injection prefilled pen20 micrograms/ 80microliters, subcutaneous injection |
M/s Intas Pharmaceuticals Limited |
rDNA |
2020-Oct-05 |
|
478 KB |
1169 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP uncoated bilayered tablets (Phase III) |
M/s. Zuventus Healthcare Ltd |
FDC |
2020-Sep-25 |
|
2608 KB |
1170 |
Osimertinib Vs Savolitinib |
M/s. AsraZeneca |
GCT |
2020-Sep-24 |
|
494 KB |
1171 |
SAR442168(Multiple Sclerosis) |
M/s. Sanofi |
GCT |
2020-Sep-24 |
|
498 KB |
1172 |
Amivantamab & Carboplatin |
M/s. Johnson & Johnson |
GCT |
2020-Sep-24 |
|
494 KB |
1173 |
lasmiditan (Migraine) |
M/s. Eli Lilly |
GCT |
2020-Sep-23 |
|
502 KB |
1174 |
Lasmiditan |
M/s. Eli Lilly |
GCT |
2020-Sep-23 |
|
502 KB |
1175 |
oral Etrasimod |
M/s. IQVIA |
GCT |
2020-Sep-22 |
|
392 KB |
1176 |
Ticagrelor SR Tablets 120mg/180mg |
M/s Exemed pharmaceuticals |
SND |
2020-Sep-21 |
|
3334 KB |
1177 |
Pegfilgrastim 6mg/0.6ml subcutaneous injection |
M/s. Lupin Limited |
rDNA |
2020-Sep-19 |
|
634 KB |
1178 |
Lumasiran |
M/s. Medpace |
GCT |
2020-Sep-18 |
|
1801 KB |
1179 |
Ipilimumab (r-DNAorigin) Injection, 50mg/10mL(5mg/mL) |
M/s Bristol-Myers Squibb India Pvt. Ltd |
rDNA |
2020-Sep-17 |
|
652 KB |
1180 |
Metformin Hydrochloride + Doxycycline Hyclate gel (Phase II) |
M/s. Dr. Reddyâs Laboratories Ltd |
FDC |
2020-Sep-14 |
|
3020 KB |
1181 |
Desidustat |
M/s. Cadila healthcare |
New Drugs |
2020-Sep-14 |
|
285 KB |
1182 |
Reversible Inhibition of Sperm under Guidance (RISUG) |
M/s. IcubedG Ideas Pvt ltd |
New Drugs |
2020-Sep-14 |
|
227 KB |
1183 |
PNB-001 |
M/s. Biosphere clinical research pvt ltd |
New Drugs |
2020-Sep-09 |
|
10107 KB |
1184 |
Gepotidacinrevised |
M/s. PPD(Revised) |
GCT |
2020-Sep-07 |
|
502 KB |
1185 |
Osimertinib Versus lazertinib |
M/s. J&J |
GCT |
2020-Sep-07 |
|
1456 KB |
1186 |
Bosutinib tab |
M/s. MSN labs |
New Drugs |
2020-Sep-04 |
|
292 KB |
1187 |
HRF-10071 tab |
M/s. Lambda |
New Drugs |
2020-Sep-04 |
|
226 KB |
1188 |
Semaglutide (T2diabetes) |
M/s. Novo Nordisk |
GCT |
2020-Sep-03 |
|
508 KB |
1189 |
Teriflunomide |
M/s. IQVIA |
GCT |
2020-Aug-31 |
|
414 KB |
1190 |
Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin + Pioglitazone Hydrochloride eq. to Pioglitazone film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals |
FDC |
2020-Aug-31 |
|
3333 KB |
1191 |
SAR442168 to Placebo |
M/s. Sanofi |
GCT |
2020-Aug-31 |
|
500 KB |
1192 |
Epinephrine Sublingual tab |
M/s. Lambda therapeutic |
New Drugs |
2020-Aug-26 |
|
202 KB |
1193 |
M/s Biocon Biologics India LimitedItolizumab Injection |
M/s Biocon Biologics India Limited |
rDNA |
2020-Aug-25 |
|
525 KB |
1194 |
2'0 Methyl Antisense Oligonucleotide |
M/s. DART |
New Drugs |
2020-Aug-25 |
|
290 KB |
1195 |
Evenamide |
M/s. Clinirx GCT |
GCT |
2020-Aug-21 |
|
272 KB |
1196 |
Capmatinib |
M/s. Novartis |
GCT |
2020-Aug-21 |
|
261 KB |
1197 |
Ranibizumab Solution for Injection10 mg/ml, 0.23ml vial |
M/s Sun Pharmaceutical Industries Limited |
rDNA |
2020-Aug-21 |
|
195 KB |
1198 |
nWhole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152D) |
M/s Bharat Biotech International Limited |
Vaccine |
2020-Aug-20 |
|
264 KB |
1199 |
PF-06826647n |
M/s. Pfizer |
GCT |
2020-Aug-20 |
|
509 KB |
1200 |
dimethyl Fumarate |
M/s. Cliantha |
GCT |
2020-Aug-20 |
|
500 KB |
1201 |
Ligelizumab |
M/s. Novartis |
GCT |
2020-Aug-20 |
|
509 KB |
1202 |
Coagulation Factor VIII (Recombinant) rFVIII, Plasma/Albumin Free Method; OctocogAlfa |
M/s Baxalta BioscienceIndiaPvt.ltd |
rDNA |
2020-Aug-19 |
|
182 KB |
1203 |
Thymosin a-1 for Injection 1.6mg |
M/s Gufic biosciences Limited |
SND |
2020-Aug-19 |
|
2970 KB |
1204 |
Evobrutinib |
M/s. IQVIA |
GCT |
2020-Aug-18 |
|
403 KB |
1205 |
oral Semaglutide |
M/s. Novo Nordisk |
GCT |
2020-Aug-18 |
|
505 KB |
1206 |
Bilastine tablet 40mg |
M/s Exemed Pharmaceuticals |
SND |
2020-Aug-17 |
|
4275 KB |
1207 |
Bilastine Tablet 40 mg |
M/s Exemed Pharmaceuticals |
SND |
2020-Aug-17 |
|
4257 KB |
1208 |
Fluticasone Furoate + Oxymetazoline hydrochloride IP nasal spray (Phase III) |
M/s. Cadila Healthcare Ltd |
FDC |
2020-Aug-13 |
|
3016 KB |
1209 |
Adjuvant Durvalumab |
M/s. AstraZeneca |
GCT |
2020-Aug-13 |
|
378 KB |
1210 |
C21n |
M/s. QED |
GCT |
2020-Aug-11 |
|
613 KB |
1211 |
Typhoid Vi Conjugate Vaccine I.P.n |
M/s Cadila Healthcare Limited |
Vaccine |
2020-Aug-11 |
|
295 KB |
1212 |
Niclosamide IM depot Injection |
M/s Daewoong Pharmaceuticals India Pvt Ltd |
SND |
2020-Aug-10 |
|
2410 KB |
1213 |
Gemcitabine revised |
M/s. AstraZeneca |
GCT |
2020-Aug-07 |
|
775 KB |
1214 |
Azelnidipine 8 mg plus Metoprolol Succinate ER 50 mg tab and Azelnidipine 16 mg plus Metoprolol Succinate ER 50 mg tab |
M/s. Ajanta pharma |
New Drugs |
2020-Aug-07 |
|
13899 KB |
1215 |
DFV890 |
M/s. Novarti |
GCT |
2020-Aug-05 |
|
487 KB |
1216 |
Otilimab |
M/s. PPD |
GCT |
2020-Aug-05 |
|
325 KB |
1217 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as gastro resistant pellets) hard gelatin capsules (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2020-Aug-04 |
|
3280 KB |
1218 |
Azelnidipine IP + Olmesartan Medomoxil IP film coated tablet (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2020-Aug-04 |
|
2918 KB |
1219 |
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2020-Aug-03 |
|
2002 KB |
1220 |
Capaivasertib+Abiraterone |
M/s. AstraZeneca |
GCT |
2020-Jul-31 |
|
331 KB |
1221 |
TRC041266 |
M/s. Torrent pharma |
New Drugs |
2020-Jul-29 |
|
10239 KB |
1222 |
PF-06865571 |
M/s. Pfizer |
GCT |
2020-Jul-29 |
|
377 KB |
1223 |
Bepotastine Besilate + Ketorolac Tromethamine IP + Benzalkonium Chloride IP (as preservative) per ml Ophthalmic Solution (Phase III) |
M/s. Ajanta Pharma Ltd |
FDC |
2020-Jul-28 |
|
3761 KB |
1224 |
Adalimumab(40mg/0.8 mL) Pre-filledsyringe |
M/s Cadila Healthcare Limited |
rDNA |
2020-Jul-28 |
|
175 KB |
1225 |
Inosine Pranobex 500 mg |
M/s. Themis Medicare ltd |
New Drugs |
2020-Jul-28 |
|
11600 KB |
1226 |
Desidustat tab |
M/s. Cadila Healthcare |
New Drugs |
2020-Jul-27 |
|
11490 KB |
1227 |
PF-06826647 |
M/s. pfizer |
GCT |
2020-Jul-23 |
|
260 KB |
1228 |
Secukinumabd |
M/s. Novartis |
GCT |
2020-Jul-22 |
|
257 KB |
1229 |
Erenumab |
M/s. Novartis |
GCT |
2020-Jul-20 |
|
497 KB |
1230 |
Netarsudil Ophthalmic sol 0.02%`w/v |
M/s. Sun pharma |
New Drugs |
2020-Jul-20 |
|
13846 KB |
1231 |
Perampanel |
M/s. PPD |
GCT |
2020-Jul-16 |
|
305 KB |
1232 |
S (-) Metoprolol Succinate IH + Efonidipine Hydrochloride Ethanolate IH modified release uncoated bilayered tablets (Phase III) |
M/s. Zuventus Healthcare Ltd |
FDC |
2020-Jul-13 |
|
1595 KB |
1233 |
Trenexamic Acid |
M/s. Ethicare |
GCT |
2020-Jul-13 |
|
257 KB |
1234 |
Druvalumab |
M/s AstraZeneca Pharma India Limited |
rDNA |
2020-Jul-13 |
|
515 KB |
1235 |
Pregabalin ER |
M/s. Cliantha |
GCT |
2020-Jul-13 |
|
194 KB |
1236 |
dInsulinGlargineInjection 100IU/ml |
M/s M .J. Biopharm Pvt.Ltd |
rDNA |
2020-Jul-10 |
|
734 KB |
1237 |
InsulinaspartMix30 |
M/s BioGenomics Limited |
rDNA |
2020-Jul-10 |
|
633 KB |
1238 |
Typhoid Vi Conjugate Vaccine I.P.1 |
M/s Cadila Healthcare Limited |
Vaccine |
2020-Jul-10 |
|
566 KB |
1239 |
dlnsulin Glargine 100U/mL |
M/s Stelis Biopharma Private Limited |
rDNA |
2020-Jul-10 |
|
177 KB |
1240 |
lnsulin Glargine 100U/mL |
M/s Bio Genomics Limited |
rDNA |
2020-Jul-10 |
|
526 KB |
1241 |
Efonidipine Hydrochloride Ethanolate + Chlorthalidone IP uncoated bilayered tablets (Phase III) |
M/s. Zuventus Healthcare Ltd |
FDC |
2020-Jul-06 |
|
4512 KB |
1242 |
Tocilizumab Injection[180mg/mL PrefilledSyringes(162mg/0.9mL) |
M/s Cipla Limited |
rDNA |
2020-Jul-03 |
|
755 KB |
1243 |
InsulinGlargineInjection 100IU/ml |
M/s Genesys Biologics Pvt. Ltd |
rDNA |
2020-Jul-03 |
|
168 KB |
1244 |
Dacomitinib tab 15 rm |
M/s. Pfizer products |
New Drugs |
2020-Jul-02 |
|
234 KB |
1245 |
Novel Corona Virus 2019-nCoV Vaccine |
M/s Cadila Healthcare Limited |
Vaccine |
2020-Jul-02 |
|
1665 KB |
1246 |
SCD411 And Eylea |
M/s. PPD |
GCT |
2020-Jul-02 |
|
502 KB |
1247 |
Lorlatinib tab 25 rmg |
M/s. Pfizer products India pvt ltd |
New Drugs |
2020-Jul-02 |
|
241 KB |
1248 |
Gemcitabine |
M/s. AstraZeneca |
GCT |
2020-Jul-02 |
|
367 KB |
1249 |
Fitusiran |
M/s. Sanofi |
GCT |
2020-Jul-02 |
|
475 KB |
1250 |
ct Umifenovir Hcl cap |
M/s. Hetero |
New Drugs |
2020-Jul-02 |
|
1833 KB |
1251 |
Gepotidacin |
M/s. PPD |
GCT |
2020-Jul-02 |
|
483 KB |
1252 |
VIB4920 |
M/s. Siro |
GCT |
2020-Jul-01 |
|
318 KB |
1253 |
Somapacitan |
M/s. Novo Nordisk |
GCT |
2020-Jun-30 |
|
493 KB |
1254 |
Pirfenidone 267 mg tab |
M/s. Shilpa Medicare ltd |
New Drugs |
2020-Jun-26 |
|
1675 KB |
1255 |
Whole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152) |
M/s Bharat Biotech International Limited |
Vaccine |
2020-Jun-26 |
|
330 KB |
1256 |
Naftifine Hydrochloride Gel 2% |
M/s. Hetero labs ltd |
New Drugs |
2020-Jun-25 |
|
232 KB |
1257 |
Insulin Human 4units, 8units and 12units single-use cartridge Inhalation Powder (Recombinant human insulin) |
M/s Cipla Limited |
rDNA |
2020-Jun-25 |
|
404 KB |
1258 |
Topiroxostat tablets 20 mg/40mg/60 mg |
M/s. Precise biopharma pvt ltd |
New Drugs |
2020-Jun-25 |
|
248 KB |
1259 |
Dienogest (Ph IV) |
M/s. Jagsonpal pharmaceuticals ltd |
New Drugs |
2020-Jun-25 |
|
254 KB |
1260 |
PF-06480605 |
M/s. Pfizer |
GCT |
2020-Jun-24 |
|
377 KB |
1261 |
Hydrocorticosone Acetate |
M/S. Novotech |
GCT |
2020-Jun-24 |
|
379 KB |
1262 |
Acodiamide Hydrochloride 300 mg |
M/s Synokem Pharmaceuticals Ltd |
SND |
2020-Jun-23 |
|
1873 KB |
1263 |
Lipoprotein |
M/s. Novartis |
GCT |
2020-Jun-19 |
|
674 KB |
1264 |
Sphaeranthus Indicus Extract |
M/s. Piramal Enterprises ltd |
New Drugs |
2020-Jun-16 |
|
2203 KB |
1265 |
Umifenovir |
Dr. Tapas K. Kundu |
New Drugs |
2020-Jun-16 |
|
2588 KB |
1266 |
Tocilizumabconcentrate for solution for IV infusion |
M/s Dr. Reddyâs Laboratories Limited |
rDNA |
2020-Jun-15 |
|
380 KB |
1267 |
Measles and Rubella vaccine (Live) |
M/s Indian Immunological Limited |
Vaccine |
2020-Jun-12 |
|
288 KB |
1268 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P. |
M/s Cadila Healthcare Limited |
Vaccine |
2020-Jun-10 |
|
275 KB |
1269 |
Benidipine Hydrochloride + Chlorthalidone IP Film coated tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2020-Jun-08 |
|
273 KB |
1270 |
Yellow Fever Vaccine (live) I.P. |
M/s Serum Institute of India Pvt. Ltd. |
Vaccine |
2020-Jun-04 |
|
220 KB |
1271 |
Hepcidin Mimetic PTG-300 |
M/s. JSS Medical |
GCT |
2020-Jun-04 |
|
496 KB |
1272 |
Colloidal silver BP 50 ppm |
M/s. Nanz Med Sciences pharma pvt ltd |
New Drugs |
2020-May-29 |
|
12437 KB |
1273 |
BDB001 |
M/s. George Clinical |
GCT |
2020-May-29 |
|
236 KB |
1274 |
IIIM-290 |
M/s. Indian Institute of Integrative medicine-CSIR |
New Drugs |
2020-May-28 |
|
942 KB |
1275 |
Azacitidine |
M/s. Novartis |
GCT |
2020-May-26 |
|
250 KB |
1276 |
Ulinastatin for Injection |
Bharat Serums and Vaccines |
SND |
2020-May-26 |
|
1431 KB |
1277 |
Favipiravir & Umifenovir |
M/s. Glenmark pharma |
New Drugs |
2020-May-25 |
|
12027 KB |
1278 |
Nafamostat Mesilate for inj |
M/s. Sun pharma |
New Drugs |
2020-May-25 |
|
11361 KB |
1279 |
2-Deoxy-D-Glucose (2-DG) |
M/s. Dr. Reddyâs laboratories |
New Drugs |
2020-May-21 |
|
240 KB |
1280 |
NitazoxanideTablet 500 mgHydroxychloroquine Tablet 200 mg |
JSS Medical Research |
SND |
2020-May-20 |
|
1361 KB |
1281 |
Pegylated interferon alfa-2b |
M/s Cadila Healthcare Limited |
rDNA |
2020-May-11 |
|
511 KB |
1282 |
Tocilizumab |
M/s JSS Medical Research India Pvt.Ltd |
rDNA |
2020-May-08 |
|
222 KB |
1283 |
NitazoxanideTabet 500 mg and Hydroxychloroquine Tablet 200 mg |
Dr.Reddyâs Laboratories |
SND |
2020-May-07 |
|
1456 KB |
1284 |
Dutasteride topical |
M/s Shilpa Medicare Limited |
SND |
2020-May-01 |
|
371 KB |
1285 |
Dustasteride Topical solution 0.01% w/v, 0.02% w/v and 0.005% w/v |
Shilpa Medicare |
SND |
2020-May-01 |
|
679 KB |
1286 |
BCG vaccine |
M/s Haffkine Institute |
Vaccine |
2020-May-01 |
|
219 KB |
1287 |
Sotagliflozin |
M/s. Covance |
GCT |
2020-Apr-28 |
|
534 KB |
1288 |
PIK3CA |
M/s. Novartis |
GCT |
2020-Apr-27 |
|
296 KB |
1289 |
Favipiravir |
M/s. Glenmark pharma |
New Drugs |
2020-Apr-26 |
|
2366 KB |
1290 |
Mycobacterium w (Heat Killed) Injection2 |
M/s Cadila Pharmaceuticals Limited |
Vaccine |
2020-Apr-22 |
|
235 KB |
1291 |
Mycobacterium w (Heat Killed) Injection1 |
M/s Cadila Pharmaceuticals Limited |
Vaccine |
2020-Apr-22 |
|
235 KB |
1292 |
Remdesevir (GS-5734) for inj 100 mg |
M/s. ICMR- Bhosari, Pune |
New Drugs |
2020-Apr-19 |
|
1914 KB |
1293 |
Mycobacterium w (Heat Killed) Injection |
M/s Cadila Pharmaceuticals Limited |
Vaccine |
2020-Apr-15 |
|
209 KB |
1294 |
VPM1002(recombinant BCG) vaccine |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2020-Apr-12 |
|
207 KB |
1295 |
Itolizumab Injection |
M/s Biocon Biologics India Limited |
rDNA |
2020-Apr-09 |
|
511 KB |
1296 |
S.C. Secukinumab |
M/s. Novartis |
GCT |
2020-Apr-07 |
|
360 KB |
1297 |
Osimertinib |
M/s. AstraZeneca |
GCT |
2020-Apr-07 |
|
399 KB |
1298 |
VIS649 |
M/s. George Clinical |
GCT |
2020-Mar-30 |
|
375 KB |
1299 |
CPI-613 |
M/s. JSS Medical |
GCT |
2020-Mar-20 |
|
498 KB |
1300 |
lumasiran |
M/s. Medpace |
GCT |
2020-Mar-20 |
|
493 KB |
1301 |
Concizumab |
M/s. Novo Nordisk |
GCT |
2020-Mar-20 |
|
497 KB |
1302 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium +Cilnidipine IP Film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2020-Mar-19 |
|
309 KB |
1303 |
Apremilast 60 mg Tablet 60 mg Tablet |
M/sSynokem |
SND |
2020-Mar-16 |
|
1831 KB |
1304 |
Zika Virus Vaccine (Adsorbed), Zika Virus Vaccine (Adsorbed) |
M/s Bharat Biotech International Limited |
Vaccine |
2020-Mar-16 |
|
221 KB |
1305 |
5-aminolevulinic Acid |
M/s. ClinSync |
GCT |
2020-Mar-13 |
|
384 KB |
1306 |
vaporized cannabinoids |
Dr. Rajendra Achyut Badwe |
New Drugs |
2020-Mar-13 |
|
225 KB |
1307 |
Acotiamide Sustained 300 mg Tablet 300 mg Tablet |
M/sExemed Pharmaceuticals |
SND |
2020-Mar-11 |
|
2037 KB |
1308 |
Acotiamide Sustained 300 mg Tablet 300 mg t |
M/sAkums |
SND |
2020-Mar-11 |
|
1819 KB |
1309 |
DE-109 |
M/s.Excel Life Science |
GCT |
2020-Mar-09 |
|
258 KB |
1310 |
Intravenous Secukinimab |
M/s. Novartis |
GCT |
2020-Mar-09 |
|
497 KB |
1311 |
Oral Pharmacokinetics and Safety of TRC041266 Powder with TRC4186 Tablet |
M/s Torrent pharma |
New Drugs |
2020-Mar-09 |
|
195 KB |
1312 |
Glycopyrrolate IP eq. to Glycopyrronium + Arformoterol Tartrate eq. to Arformoterol Inhalation solution (Phase III) |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2020-Mar-09 |
|
303 KB |
1313 |
Bilastine + Montelukast Sodium IP eq. to Montelukast Film coated tablets |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2020-Mar-09 |
|
288 KB |
1314 |
Secukinumab |
M/s. Novartis |
GCT |
2020-Mar-09 |
|
497 KB |
1315 |
Canagliflozin + Metformin HCl Film coated tablets (Phase IV) |
M/s. Johnson & Johnson Pvt. Ltd |
FDC |
2020-Mar-09 |
|
216 KB |
1316 |
Medroxyprogesterone Acetate SR tablet30 mg 30 mg Tablet |
M/sSynokem |
SND |
2020-Mar-09 |
|
1570 KB |
1317 |
M/s Biological E Limited |
Hepatitis B Vaccine (rDNA) |
Vaccine |
2020-Mar-03 |
|
572 KB |
1318 |
Bevacizumab (r-DNAorigin) drug product100mg/4ml& 400mg/16m |
M/s Dr. Reddys Laboratories Limited |
rDNA |
2020-Mar-02 |
|
648 KB |
1319 |
Cefpodoxime Proxetil 200/400 mgTablet |
M/sSun Pharma |
SND |
2020-Mar-02 |
|
2025 KB |
1320 |
Inactivated Hepatitis A vaccine |
M/s Biological E. Limited |
Vaccine |
2020-Feb-28 |
|
281 KB |
1321 |
Selpercatinib |
M/s. Eli Lilly |
GCT |
2020-Feb-27 |
|
491 KB |
1322 |
ZYBK2 |
M/s Cadila Healthcare |
New Drugs |
2020-Feb-26 |
|
206 KB |
1323 |
zelnidipine 8 mg plus Telmisartan 40 mg and Azelnidipine 16 mg plus Telmisartan 40mg tab versus Azelnidipine tab 16 mg and Telmisartan tab 40 mg |
M/s. Ajanta pharma |
New Drugs |
2020-Feb-26 |
|
376 KB |
1324 |
Adalimumab injection |
M/s Enzene Biosciences Ltd |
rDNA |
2020-Feb-25 |
|
177 KB |
1325 |
Cabozantinib or Vandetanib |
M/S. Eli Lilly |
GCT |
2020-Feb-25 |
|
419 KB |
1326 |
Estradiol Valerate 4mg SR Table |
M/s Synokem Pharmaceuticals Ltd |
SND |
2020-Feb-24 |
|
1773 KB |
1327 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) hard gelatin capsules (Phase III) |
M/s. Torrent Pharmaceuticals Ltd |
FDC |
2020-Feb-22 |
|
248 KB |
1328 |
Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) Vaccine (Adsorbed) |
M/s Sanofi Healthcare India Private Limited |
Vaccine |
2020-Feb-21 |
|
308 KB |
1329 |
Recombinant GrowthHormone(ALT-P1) |
M/s Accutest Research Laboratories (I) Pvt.Ltd |
rDNA |
2020-Feb-21 |
|
385 KB |
1330 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III) |
M/s. Hetero Labs Ltd |
FDC |
2020-Feb-20 |
|
318 KB |
1331 |
Evenamide (NW-3509)2 |
M/s. CliniRx |
GCT |
2020-Feb-19 |
|
269 KB |
1332 |
AR-301 |
M/s. Pharm-Olam |
GCT |
2020-Feb-18 |
|
251 KB |
1333 |
Evenamide2 |
M/s. CliniRx |
GCT |
2020-Feb-18 |
|
379 KB |
1334 |
Bedaquiline Tablets 100mg |
M/s. Doctors Without Borders |
GCT |
2020-Feb-17 |
|
255 KB |
1335 |
Bedaquiline, Delamanid |
M/s. Doctors Without Borders |
GCT |
2020-Feb-17 |
|
360 KB |
1336 |
Tropifexor (LJN452) & licogliflozin |
M/s. Novartis |
GCT |
2020-Feb-14 |
|
429 KB |
1337 |
Dienogest (Visanne®) |
M/s Bayer Pharmaceutical Private Limited |
New Drugs |
2020-Feb-14 |
|
196 KB |
1338 |
Typhoid Conjugate Vaccine (Monovalent) |
M/s Biological E Limited |
Vaccine |
2020-Feb-12 |
|
289 KB |
1339 |
Insulin Injection, Biphasic Isophane IP /Ph. Eur. 100 IU/ml in 3 ml cartridge (containing 30 % human insulin soluble injection and 70 % human insulin isophane suspension) |
M/s M.J. Biopharm Pvt. Ltd |
rDNA |
2020-Feb-07 |
|
517 KB |
1340 |
Recombinant Human Thrombopoietin Injection |
M/s Eris LifesciencesLimited |
rDNA |
2020-Feb-04 |
|
175 KB |
1341 |
Ramucirumab Injection |
M/s Reliance Life Sciences Pvt. Ltd |
rDNA |
2020-Jan-30 |
|
185 KB |
1342 |
Hydroxychloroquine Sulfate Tablet 200mg/300 mg |
IPCA Laboratories |
SND |
2020-Jan-28 |
|
788 KB |
1343 |
Goserelin 10.8mg Injection1 |
M/s. Klinera |
GCT |
2020-Jan-27 |
|
1460 KB |
1344 |
Hydrocortisone Acetate Suppositories, 25 Mg |
M/s. Raptim |
GCT |
2020-Jan-27 |
|
303 KB |
1345 |
INTP1- Granulocyte Colony Stimulating Factor (Filgrastim) |
M/s Intas Pharmaceuticals |
rDNA |
2020-Jan-24 |
|
525 KB |
1346 |
Ipatasertib |
M/s. Roche Products |
GCT |
2020-Jan-21 |
|
505 KB |
1347 |
Inactivated Therapeutic Tuberculosis Vaccine |
M/s Cadila Healthcare Limited |
Vaccine |
2020-Jan-20 |
|
185 KB |
1348 |
Inactivated Therapeutic Tuberculosis Vaccine.RUTI Vaccine |
M/s Cadila Healthcare Limited |
Vaccine |
2020-Jan-20 |
|
185 KB |
1349 |
Fingolimod capsule |
M/s Sun pharma |
New Drugs |
2020-Jan-16 |
|
2608 KB |
1350 |
Mepolizumab Powder for Solution for Injection |
M/s GlaxoSmithKline PharmaceuticalsLimited |
rDNA |
2020-Jan-15 |
|
378 KB |
1351 |
Remogliflozin Etabonate + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film coated tablets (Phase III) |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2020-Jan-14 |
|
302 KB |
1352 |
Glimepiride IP + Voglibose IP + Metformin HCl IP (as ER) uncoated bilayered tablet (Phase IV) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2020-Jan-14 |
|
242 KB |
1353 |
Silodosin + Solifenacin Succinate Ph. Eur. Capsule (Phase III) |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2020-Jan-14 |
|
337 KB |
1354 |
Mirabegron + Solifenacin Succinate tablets (Phase III) |
M/s. Hetero Labs Ltd |
FDC |
2020-Jan-13 |
|
232 KB |
1355 |
Ivabradin Tablet |
M/s. Synokem Pharma Ltd |
SND |
2020-Jan-09 |
|
2543 KB |
1356 |
sacubitril/valsartan |
M/s. Novartis |
GCT |
2020-Jan-08 |
|
251 KB |
1357 |
Liraglutide injection(r-DNA) |
M/s Levim Biotech LLP |
rDNA |
2020-Jan-07 |
|
247 KB |
1358 |
Bilastine + Montelukast Sodium IP eq. to Montelukast uncoated tablet (Phase III) |
M/s. Exemed Pharmaceuticals |
FDC |
2020-Jan-07 |
|
297 KB |
1359 |
Goserelin 10.8mg Injection |
M/s. Lambda |
GCT |
2020-Jan-07 |
|
381 KB |
1360 |
BevacizumabInjection 100 mg/4mL |
M/s Enzene Biosciences Limited |
rDNA |
2020-Jan-07 |
|
250 KB |
1361 |
Brimonidine Tartrate 0.1% Ophthalmic Solution |
M/s. Cliantha |
GCT |
2020-Jan-03 |
|
325 KB |
1362 |
Selonsertib |
M/s. Klinera |
GCT |
2020-Jan-03 |
|
1460 KB |
1363 |
PF-06741086 |
Pfizer |
GCT |
2019-Dec-31 |
|
493 KB |
1364 |
Evenamide(NW-3509/008/II/2019) |
Clinirx |
GCT |
2019-Dec-31 |
|
375 KB |
1365 |
Remogliflozin Etabonate Vildagliptin film coated tablet |
M/s. Glenmark Pharmaceuticals Ltd |
FDC |
2019-Dec-30 |
|
1222 KB |
1366 |
Hydrocortisone Acetate |
Raptim |
GCT |
2019-Dec-27 |
|
358 KB |
1367 |
Trastuzumabbio |
M/s Biocad India Private Limited |
rDNA |
2019-Dec-26 |
|
3401 KB |
1368 |
Ripasudil HCl Hydrate eq. To Ripasudil Timolol Maleate IP Eq. To to Timolol eye drops |
M/s. Ajanta Pharma Ltd |
FDC |
2019-Dec-26 |
|
1008 KB |
1369 |
Cephalexin extended release Clavulanate Potassium tablet |
M/s. Sun Pharma Laboratories Ltd |
FDC |
2019-Dec-26 |
|
1016 KB |
1370 |
Vedolizumab |
M/s Takeda Pharmaceutical India Pvt.Ltd |
Vaccine |
2019-Dec-26 |
|
349 KB |
1371 |
Ceftazidime |
Pfizer |
GCT |
2019-Dec-23 |
|
321 KB |
1372 |
Goserelin 3.6 mg Injection |
Lambda |
GCT |
2019-Dec-23 |
|
495 KB |
1373 |
Triamcinolone acetonide IP Lignocaine HCl IP Gel |
M/s. Abbott Healthcare Pvt. Ltd |
FDC |
2019-Dec-19 |
|
712 KB |
1374 |
GSK2831781 |
George Clinical |
GCT |
2019-Dec-18 |
|
502 KB |
1375 |
Ceftazidime-Avibactam |
Pfizer |
GCT |
2019-Dec-18 |
|
489 KB |
1376 |
Lipidol |
M/s. DispoSurgicals |
SND |
2019-Dec-11 |
|
3028 KB |
1377 |
Evenamide(nw-3509) |
CliniRx |
GCT |
2019-Dec-10 |
|
509 KB |
1378 |
Evenamide(NW-3509/006/III/2019) |
CliniRx |
GCT |
2019-Dec-10 |
|
509 KB |
1379 |
Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze Dried) |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2019-Dec-10 |
|
193 KB |
1380 |
Prohance® (Gadoteridol 279.3 mg/mllnjection |
M/s Accutest Research Laboratories(l) Pvt. Ltd |
New Drugs |
2019-Dec-09 |
|
2667 KB |
1381 |
Dalbavancin |
M/sGufic Biosciences Limited |
New Drugs |
2019-Dec-06 |
|
2754 KB |
1382 |
opivacaine Hydrochloride USP eq. to anhydrous Ropivacaine hydrochloride Dextrose IP per ml injection |
M/s. Neon Laboratories Ltd |
FDC |
2019-Dec-04 |
|
959 KB |
1383 |
Azelnidipine Olmesartan Medoxomil IP tablets |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Dec-04 |
|
1260 KB |
1384 |
Benidipine HCl Chlorthalidone IPTelmisartan IP Film coated bilayered tablets |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2019-Dec-02 |
|
876 KB |
1385 |
Rosuvastatin IP Teneligliptin Film coated tablet |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Dec-02 |
|
1099 KB |
1386 |
Recombinant Insulin Aspart |
M/s BioGenomics Limited |
rDNA |
2019-Nov-30 |
|
1342 KB |
1387 |
SB3 |
IQVIA |
GCT |
2019-Nov-29 |
|
249 KB |
1388 |
Bevacizumab |
M/s Cadila Healthcare Limited |
rDNA |
2019-Nov-29 |
|
549 KB |
1389 |
International Centre for Genetic Engineering and Biotechnology CampusBivalent (JAIVAC-2: PfMSPFu24 +PfF2/ Alhydrogel) P. falciparum malaria vaccine |
Multi Vaccines Development Program, |
Vaccine |
2019-Nov-29 |
|
167 KB |
1390 |
Baricitinib eli lily |
Eli Lilly |
GCT |
2019-Nov-27 |
|
509 KB |
1391 |
TRUNCATE â TB (tuberculosis) |
M/s. National Institute of Tuberculosis and Respiratory Diseases (NITRD) |
New Drugs |
2019-Nov-25 |
|
3884 KB |
1392 |
Moroctocogalfa |
M/s Pfizer Products India PrivateLimited |
rDNA |
2019-Nov-22 |
|
177 KB |
1393 |
Lenvatinib Capsules 4 mg and 10 mg |
Eisai Pharmaceuticals India Private Limited |
SND |
2019-Nov-22 |
|
330 KB |
1394 |
Trastuzumab aur |
M/s Aurobindo Biologics |
rDNA |
2019-Nov-22 |
|
213 KB |
1395 |
Azilsartan KamedoxomilChlorthalidone IP tablet |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Nov-19 |
|
654 KB |
1396 |
Etanercept Lupin |
M/s Lupin Limited |
rDNA |
2019-Nov-19 |
|
140 KB |
1397 |
Ticagrelor 120/180 mg SR Tablet |
Synokem Pharmaceuticals Limited |
SND |
2019-Nov-18 |
|
2652 KB |
1398 |
Diptheria,Tetanus, Pertussis (Whole cell),Hepatitis B, Poliomyelitis (inactivated) and Haemophilus Influenzae Type b conjugate Vaccine (Adsorbed) [DTwPHepB-IPV-Hib vaccine (Adsorbed |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2019-Nov-14 |
|
207 KB |
1399 |
AUR101 |
M/s. Aurigene Discovery Technologies Limited |
New Drugs |
2019-Nov-14 |
|
3310 KB |
1400 |
Desidustat Tablet versus Epoetin alfa Injection |
M/s. Cadila Healthcare Limited |
New Drugs |
2019-Nov-14 |
|
2558 KB |
1401 |
Recombinant Hepatitis E Vaccine, Single Human Dose |
M/s Cadila Healthcare Limited |
Vaccine |
2019-Nov-11 |
|
266 KB |
1402 |
Zileuton Ointment 1.25% and 5.0% |
Dr. Reddys Laboratories Limited |
SND |
2019-Nov-08 |
|
702 KB |
1403 |
InsulinGlargine |
M/s Eli Lilly and Company (India)Pvt. Ltd |
rDNA |
2019-Nov-07 |
|
275 KB |
1404 |
LNP023 |
Novartis |
GCT |
2019-Nov-06 |
|
366 KB |
1405 |
Iodixanol |
Wipro |
GCT |
2019-Nov-06 |
|
2023 KB |
1406 |
Avanafil tablets 100 mg & 200 mg |
M/s.Zydus Healthcare |
New Drugs |
2019-Nov-06 |
|
1223 KB |
1407 |
FEIBA |
Baxalta |
GCT |
2019-Nov-06 |
|
403 KB |
1408 |
Etrasimod( IQVIA RDS) |
IQVIA |
GCT |
2019-Nov-06 |
|
513 KB |
1409 |
Etrasimod( IQVIA) |
IQVIA |
GCT |
2019-Nov-06 |
|
502 KB |
1410 |
Concizumab Prophylaxis |
Novo-Nordisk |
GCT |
2019-Nov-06 |
|
508 KB |
1411 |
Inotuzumab |
Pfizer |
GCT |
2019-Nov-06 |
|
370 KB |
1412 |
Etrasimod |
IQVIA |
GCT |
2019-Nov-06 |
|
485 KB |
1413 |
CT-P13 |
PPD |
GCT |
2019-Nov-06 |
|
471 KB |
1414 |
Inactivated Hepatitis A Vaccine (Adsorbed) I.P.6nov |
M/s Cadila Healthcare Limited |
Vaccine |
2019-Nov-06 |
|
262 KB |
1415 |
LNP023(Rituximab) |
Novartis |
GCT |
2019-Nov-06 |
|
260 KB |
1416 |
GSK3196165 |
IQVIA |
GCT |
2019-Nov-05 |
|
284 KB |
1417 |
Ruxolitinib |
Novartis |
GCT |
2019-Nov-05 |
|
310 KB |
1418 |
Apremilast Film Coated 10/10/30mg Tablets |
Synokem Pharmaceuticals Ltd |
SND |
2019-Oct-31 |
|
2755 KB |
1419 |
Trastuzumabnn |
M/s Intas Pharmaceuticals Limited |
rDNA |
2019-Oct-31 |
|
176 KB |
1420 |
Spironolactone Topical Cream 5% |
Alkem Laboratories Ltd |
SND |
2019-Oct-31 |
|
1495 KB |
1421 |
Tenofovir Alafenamide, Emtricitabine and Bictegravir |
M/s.Hetero lab |
New Drugs |
2019-Oct-30 |
|
2682 KB |
1422 |
Sofosbuvir 400 mg Tablet |
Virchow Biotech |
SND |
2019-Oct-29 |
|
2627 KB |
1423 |
Peginterferonbeta-1a |
M/s Reliance Life Sciences Pvt Ltd |
rDNA |
2019-Oct-28 |
|
144 KB |
1424 |
Typhoid Vi conjugate VaccineRa |
M/s Ra (Biologicals) Panacea Biotec Ltd |
Vaccine |
2019-Oct-21 |
|
276 KB |
1425 |
Cilnidipine IP Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2019-Oct-15 |
|
609 KB |
1426 |
Benidipine HCl IPTelmisartan IP Film coated tablets |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2019-Oct-04 |
|
641 KB |
1427 |
Azelnidipine Telmisartan tablets |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Oct-04 |
|
624 KB |
1428 |
Methylcobalamin Nasal spray 500 mcg |
Torrent Pharma |
SND |
2019-Sep-30 |
|
284 KB |
1429 |
Typhoid Vi conjugate Vaccine30sep |
M/s Bharat Biotech International Limited |
Vaccine |
2019-Sep-30 |
|
185 KB |
1430 |
Certican / Zortress(everolimus EVR) |
Novartis |
GCT |
2019-Sep-27 |
|
312 KB |
1431 |
Tirzepatide1 |
Eli Lilly |
GCT |
2019-Sep-23 |
|
313 KB |
1432 |
QL1205 Versus Lucentis |
Kendle |
GCT |
2019-Sep-19 |
|
304 KB |
1433 |
Bupivacaine Hydrochloride IP eq. to anhydrous Bupivacaine Hydrochloride Fentanyl Citrate IP Eq. to Fentanyl injection |
M/s. Troikaa Pharmaceuticals Ltd |
FDC |
2019-Sep-18 |
|
672 KB |
1434 |
AT-10 (2-oxoclopidogrel bisulfate |
M/s. IPCA |
New Drugs |
2019-Sep-18 |
|
2845 KB |
1435 |
HP-hMG and Menopur® |
M/s.Bharat Serum |
New Drugs |
2019-Sep-18 |
|
2143 KB |
1436 |
Inactivated Hepatitis A vaccine (Adsorbed) I.P. |
M/s Indian Immunological Limited |
Vaccine |
2019-Sep-17 |
|
187 KB |
1437 |
Rabies Vaccine, Human, I.P. |
M/s Cadila Healthcare Limited |
Vaccine |
2019-Sep-17 |
|
187 KB |
1438 |
Brazikumab |
Parexel |
GCT |
2019-Sep-17 |
|
393 KB |
1439 |
evenamide or placebo |
CliniRx |
GCT |
2019-Sep-16 |
|
273 KB |
1440 |
Ribociclib plus goserelin acetate |
Novartis |
GCT |
2019-Sep-16 |
|
434 KB |
1441 |
Meningococcal Conjugate Vaccine |
Sanofi |
GCT |
2019-Sep-16 |
|
510 KB |
1442 |
semaglutide versus placebo |
Novo-Nordisk |
GCT |
2019-Sep-16 |
|
477 KB |
1443 |
Leuprolide acetate |
M/s.Bharat Serum |
New Drugs |
2019-Sep-12 |
|
2291 KB |
1444 |
Netarsudil Ophthalmic solution 0.02% |
M/s.Ajanta Pharma |
New Drugs |
2019-Sep-09 |
|
3055 KB |
1445 |
MYL-1701P and Eylea |
Mylan |
GCT |
2019-Sep-09 |
|
299 KB |
1446 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Sep-04 |
|
710 KB |
1447 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP + Chlorthalidone IP Tablets (Phase III Clinical Trial |
M/s. Ajanta Pharma Ltd |
FDC |
2019-Sep-03 |
|
705 KB |
1448 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Cilnidipine IP film coated tablet (Phase III Clinical Trial) |
M/s. Hetero Labs Ltd |
FDC |
2019-Sep-03 |
|
697 KB |
1449 |
Mirikizumab |
Eli Lilly |
GCT |
2019-Aug-18 |
|
625 KB |
1450 |
Azelnidipine IP + Chlorthalidone IP Uncoated Tablet (Phase III Clinical Trial) |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Aug-14 |
|
617 KB |
1451 |
Tranexamic acid |
M/s.Dr.M.S. Gopalakrishan |
New Drugs |
2019-Aug-14 |
|
1667 KB |
1452 |
Menopausal Gonadotropin |
M/s.Sanzyme Pvt Ltd |
New Drugs |
2019-Aug-14 |
|
2618 KB |
1453 |
baloxavir marboxil |
Roche |
GCT |
2019-Aug-13 |
|
492 KB |
1454 |
k0706 |
Sun Pharma |
GCT |
2019-Aug-13 |
|
592 KB |
1455 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (10-Valent) |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2019-Aug-13 |
|
259 KB |
1456 |
traconazole |
PPD |
GCT |
2019-Aug-08 |
|
1373 KB |
1457 |
Mirikizumab (UC) |
Eli Lilly |
GCT |
2019-Aug-08 |
|
625 KB |
1458 |
Semaglutide (SOUL) |
Novo-Nordisk |
GCT |
2019-Aug-08 |
|
2366 KB |
1459 |
Filgotinib (rheumatoid Arthritis) |
Klinera |
GCT |
2019-Aug-06 |
|
519 KB |
1460 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial) |
M/s. Cipla Ltd |
FDC |
2019-Aug-05 |
|
531 KB |
1461 |
Tigilanol Tiglate |
Excel Life Sciences |
GCT |
2019-Aug-02 |
|
368 KB |
1462 |
Capivasertib + Paclitaxel versus placebo |
AstraZeneca |
GCT |
2019-Aug-02 |
|
228 KB |
1463 |
HD204 to Avastin® |
IQVIA |
GCT |
2019-Jul-31 |
|
513 KB |
1464 |
Baricitinib |
EliLilly |
GCT |
2019-Jul-31 |
|
500 KB |
1465 |
Oral Baricitinib |
Eli Lilly |
GCT |
2019-Jul-31 |
|
316 KB |
1466 |
Aceclofenac Topical ointment 1.5% w/wIII |
M/s Panacea Biotech Ltd |
SND |
2019-Jul-26 |
|
2285 KB |
1467 |
Beclomethasone |
M/s.Cipla ltd |
New Drugs |
2019-Jul-26 |
|
1765 KB |
1468 |
IVIEW-1201 |
Excel Life Sciences |
GCT |
2019-Jul-23 |
|
264 KB |
1469 |
Ulipristal acetate tablet 30mgIII |
M/s Synokem Pharmaceuticals Ltd |
SND |
2019-Jul-23 |
|
2555 KB |
1470 |
Sertaconazole Nitrate + Terbinafine HCl cream (Phase III Clinical Trial) |
M/s. Trikona Pharmaceuticals Pvt. Ltd |
FDC |
2019-Jul-16 |
|
643 KB |
1471 |
Ribiciclib |
Novartis |
GCT |
2019-Jul-15 |
|
289 KB |
1472 |
INTP24 against Avastin® in |
INTAS |
GCT |
2019-Jul-15 |
|
468 KB |
1473 |
Nonacog Alfa(recombinant coagulation factor IX |
M/s Pfizer Products India Private Limited |
rDNA |
2019-Jul-12 |
|
115 KB |
1474 |
PMZ-1620 |
M/s.Pharmazz |
New Drugs |
2019-Jul-12 |
|
320 KB |
1475 |
Adenosine IP + Minoxidil IP Topical solution (Phase II Clinical Trial) |
M/s. Dr. Reddyâs Laboratories Ltd |
FDC |
2019-Jul-09 |
|
626 KB |
1476 |
Benidipine Hydrochloride + Metoprolol Succinate eq. to Metoprolol tartrate IP Film coated tablet (Phase III Clinical Trial) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2019-Jul-09 |
|
357 KB |
1477 |
Benidipine Hydrochloride JP + Chlorthalidone IP Film coated tablets (Phase III Clinical Trial |
M/s. Synokem Pharmaceuticals Pvt. Ltd |
FDC |
2019-Jul-09 |
|
580 KB |
1478 |
Lenalidomide |
Dr. Prafulla Parikh |
New Drugs |
2019-Jul-08 |
|
267 KB |
1479 |
Osimertinib in Combination with Savolitinib |
AstraZeneca |
GCT |
2019-Jul-05 |
|
492 KB |
1480 |
Golimumab |
M/s Reliance Life Sciences Pvt Ltd |
rDNA |
2019-Jul-02 |
|
114 KB |
1481 |
Biphasic Isophane Insulinm |
M/s Wockhardt Limited |
rDNA |
2019-Jul-02 |
|
187 KB |
1482 |
RabiesHumanMonoclonalAntibody |
M/s Serum Institute of IndiaPvt.Ltd |
rDNA |
2019-Jul-01 |
|
142 KB |
1483 |
Isophane Insulin |
M/s Serum Institute of IndiaPvt.Ltd |
rDNA |
2019-Jul-01 |
|
337 KB |
1484 |
Biapenem 300 mg inj |
M/s. BDR Pharma |
New Drugs |
2019-Jun-26 |
|
368 KB |
1485 |
Saroglitazar tablet 4mg II |
M/s Cadila Healthcare Ltd |
SND |
2019-Jun-26 |
|
2058 KB |
1486 |
Sulbactam-ETX2514 |
Medpace |
GCT |
2019-Jun-25 |
|
427 KB |
1487 |
Rifapentine plus Isoniazid |
ICMR |
GCT |
2019-Jun-24 |
|
259 KB |
1488 |
Recombinant Hepatitis E Vaccine |
M/s Wockhardt Limited |
Vaccine |
2019-Jun-17 |
|
155 KB |
1489 |
Ropivacaine Readyfusor 2mg/mlIII |
M/s Cipla Ltd |
SND |
2019-Jun-17 |
|
2629 KB |
1490 |
IQVIA |
insulin glargine 300 U/mL |
GCT |
2019-Jun-17 |
|
213 KB |
1491 |
Acotiamide ER tablet 300 tabletIII |
M/s Hetero labs Ltd |
SND |
2019-Jun-17 |
|
2090 KB |
1492 |
Toujeo 300 Units/ml |
M/s IQVIA RDS india Pvt ltd |
GCT |
2019-Jun-17 |
|
486 KB |
1493 |
Oral Galactose |
M/s. Dr. Abhijieet Saha |
New Drugs |
2019-Jun-03 |
|
252 KB |
1494 |
Vi-capsular Polysaccharide-CRM197 Conjugate Typhoid Vaccine |
M/s. Biological E Limited |
Vaccine |
2019-May-17 |
|
284 KB |
1495 |
Semaglutide (NN9535-4352) |
NovoNordisk |
GCT |
2019-May-16 |
|
429 KB |
1496 |
Typhoid Vi Conjugate Vaccine |
M/s Cadila Healthcare Limited |
Vaccine |
2019-May-06 |
|
280 KB |
1497 |
Curcumin (Biocurcumax cap) as an adjunct drug to standard therapy [(Artesunate) + (Sulfadoxine-Pyrimethamine) tablet] |
M/s. National Institute of Malaria Research |
New Drugs |
2019-May-06 |
|
238 KB |
1498 |
Pneumococcal polysaccharide conjugate vaccine (14-valent) |
M/s. Biological E Limited |
Vaccine |
2019-May-06 |
|
283 KB |
1499 |
2Ã-Methyl-Phosphorothioate Anti Sense Oligoribonucleotide for treating patients with Duchenne Muscular Dystrophy |
M/s. Muscular Dystrophy patientsâ Welfare Society |
New Drugs |
2019-May-06 |
|
231 KB |
1500 |
Cetuximab |
M/s Enzene Biosciences Limited |
rDNA |
2019-May-03 |
|
182 KB |
1501 |
Xlucane versus Lucentis® |
Kendle |
GCT |
2019-May-02 |
|
443 KB |
1502 |
Durvalumab |
AstraZeneca |
GCT |
2019-May-01 |
|
427 KB |
1503 |
Neoadjuvant/adjuvantDurvalumab |
AstraZeneca |
GCT |
2019-May-01 |
|
427 KB |
1504 |
Rituximab Biosimilar (DRL_RI) with MabThera® |
Parexel |
GCT |
2019-Apr-29 |
|
434 KB |
1505 |
METREXASSIST⢠|
Crystal Life |
GCT |
2019-Apr-26 |
|
194 KB |
1506 |
Phenobarbital Sodium Injection |
CBCC |
GCT |
2019-Apr-26 |
|
191 KB |
1507 |
FDC of Daclatasvir Dihydrochloride Eq. to Daclatasvir 60mg Sofosbuvir 400mg film coated tablets (Phase IV) |
M/s. Mylan Laboratories Ltd |
FDC |
2019-Apr-23 |
|
1031 KB |
1508 |
C.O.M.B.A.T |
M/s.Girish Chinnaswamy |
New Drugs |
2019-Apr-18 |
|
222 KB |
1509 |
Sodium Fusidate eq. To Fusidic acid 2% w/w (Sofinox gel) |
M/s Apex Laboratories Pvt. Ltd |
SND |
2019-Apr-16 |
|
3105 KB |
1510 |
esidustat vs Darbepoetin |
M/s. Cadila Healthcare |
New Drugs |
2019-Apr-16 |
|
295 KB |
1511 |
Saroglitazar 2mg & 4mg Tablet |
M/s Cadila Healthcare Ltd |
SND |
2019-Apr-16 |
|
2767 KB |
1512 |
Tacrolimus lipid tablet 3mg |
M/s Intas Pharmaceuticals Ltd. |
SND |
2019-Apr-15 |
|
2677 KB |
1513 |
Rivaroxaban tablets 2.5mg (Xarelto®) |
M/s Bayer Pharmaceuticals Pvt. Ltd |
SND |
2019-Apr-15 |
|
2579 KB |
1514 |
Oral Nafithromycin vs oral Moxifloxacin |
M/s. Wockhardt |
New Drugs |
2019-Apr-15 |
|
417 KB |
1515 |
TRC160334 |
M/s. Torrent pharma |
New Drugs |
2019-Apr-15 |
|
295 KB |
1516 |
Typhoid Conjugate vaccineApril11 |
M/s Bharat Biotech International Limited |
Vaccine |
2019-Apr-14 |
|
301 KB |
1517 |
Biphasic Isophane insulin |
M/s Wockhardt Limited, Research Centre |
rDNA |
2019-Apr-10 |
|
109 KB |
1518 |
Fitusira |
PPD |
GCT |
2019-Apr-10 |
|
419 KB |
1519 |
SB12 and Soliris |
PPD |
GCT |
2019-Apr-08 |
|
202 KB |
1520 |
SAR341402 Mix 70/30 to NovoMix®3 |
Sanofi |
GCT |
2019-Apr-04 |
|
337 KB |
1521 |
Typhoid Conjugate vaccineTCV |
M/s Bharat Biotech International Limited |
Vaccine |
2019-Mar-28 |
|
299 KB |
1522 |
Typhoid Conjugate vaccine |
M/s Bharat Biotech International Limited |
Vaccine |
2019-Mar-28 |
|
301 KB |
1523 |
Pharmacokinetic and Pharmacodynamic |
M/s Amgen Technology Pvt Ltd |
GCT |
2019-Mar-26 |
|
476 KB |
1524 |
Pharmacokinetics of Murepavadin |
M/s Convance India Pharmaceuticals Services Pvt ltd |
GCT |
2019-Mar-25 |
|
248 KB |
1525 |
Ipatasertib in Combination with Paclitaxel |
M/s Roche Products India Private Limited |
GCT |
2019-Mar-21 |
|
194 KB |
1526 |
IMU-131 HER2/neu |
M/s PPD Pharmaceutical Development India Pvt ltd |
GCT |
2019-Mar-21 |
|
427 KB |
1527 |
Inactivated Japanese Encephalitis Vaccine |
M/s Bharat Biotech International Limited |
Vaccine |
2019-Mar-13 |
|
451 KB |
1528 |
Trastuzumab powder for concentrate for solution for intravenous infusion |
M/s. Cliantha Research Limited |
rDNA |
2019-Mar-13 |
|
120 KB |
1529 |
Inactivated poliomyelitis vaccine 12March |
M/s. Biological E Limited |
Vaccine |
2019-Mar-12 |
|
149 KB |
1530 |
10-valent Pneumococcal Conjugate Vaccine |
M/s Serum Institute of India Pvt. Ltd |
Vaccine |
2019-Mar-11 |
|
322 KB |
1531 |
Etanercept |
M/s. Lupin Limited |
rDNA |
2019-Mar-08 |
|
103 KB |
1532 |
Cetilistat |
M/s. Hetero labs |
New Drugs |
2019-Mar-04 |
|
394 KB |
1533 |
Octenidine Dihydrochloride |
M/s. Ajanta |
New Drugs |
2019-Mar-04 |
|
318 KB |
1534 |
Bibrocathol 2% Eye ointment |
M/s. Ursha pharma |
New Drugs |
2019-Mar-03 |
|
303 KB |
1535 |
Norethisterone CR tablet 15mg |
M/s Synokem Pharmaceuticals Ltd |
SND |
2019-Mar-01 |
|
2068 KB |
1536 |
Probiotic Supplementation lactic acid bacteria and Bifidobacteria, namely, L. Plantarum DSM24730, L. paracasei DSM 24733, L. delbrueckii subsp. Bulgaricus DSM 24734, L. acidophilus DSM24735, B. longam, DSM24736, B. Infantis DSM 24737, B. breve DSM 24732, and S. thermophilus DSM 24731 which is to be reconstituted with MCT oil drop with Medium Chain Triglyceride (MCT) oil |
ICMR, HQ, New Delhi |
SND |
2019-Mar-01 |
|
2042 KB |
1537 |
Teneligliptin and Sitagliptin |
M/s. Dr. Sujoy Ghosh |
New Drugs |
2019-Feb-26 |
|
247 KB |
1538 |
secukinumab SUNSHINE |
Novartis |
GCT |
2019-Feb-25 |
|
570 KB |
1539 |
Edoxaban tosylate |
IQVIA RDS |
GCT |
2019-Feb-22 |
|
220 KB |
1540 |
Secukinumab SUNRISE |
Novartis |
GCT |
2019-Feb-22 |
|
570 KB |
1541 |
iGlarLixi versus premixed |
Sanofi |
GCT |
2019-Feb-22 |
|
321 KB |
1542 |
Durvalumab in combination |
AstraZeneca |
GCT |
2019-Feb-20 |
|
423 KB |
1543 |
Liquid ROTAVAC 5CM (Live Attenuated Rotavirus Vaccine) |
M/s Bharat Biotech International Limited |
Vaccine |
2019-Feb-20 |
|
277 KB |
1544 |
Inactivated poliomyelitis vaccine |
M/s. Biological E Limited |
Vaccine |
2019-Feb-20 |
|
488 KB |
1545 |
Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil Cilnidipine film coated bilayaered tablet (Phase III) |
M/s. Synokem Pharmaceuticals Pvt.Ltd |
FDC |
2019-Feb-19 |
|
1652 KB |
1546 |
Alfuzosin Hydrochloride IP (extended release form) Tadalafil IP film coated tablets (Phase III) |
M/s. Akums Drugs & Pharmaceuticals Ltd |
FDC |
2019-Feb-19 |
|
1141 KB |
1547 |
Evaluation of Vitamin D Supplementation in affecting the outcome of newly Diagnosed patients with Lymphoma |
M/s. Dr. Aranab Bhattacharjee |
New Drugs |
2019-Feb-18 |
|
217 KB |
1548 |
Tacrolimus lipid suspension 4mg/vial |
M/s Intas Pharmaceuticals Ltd |
SND |
2019-Feb-15 |
|
1294 KB |
1549 |
Oxaceprol tablet 600mg |
M/s Synokem Pharmaceuticals Ltd |
SND |
2019-Feb-15 |
|
1358 KB |
1550 |
Baricitinib SLE |
PPD |
GCT |
2019-Feb-11 |
|
581 KB |
1551 |
Ivermectin Lotion,0.5% |
Cliantha |
GCT |
2019-Feb-08 |
|
223 KB |
1552 |
Bepotastine besilate JP Montelukast Sodium IP tablets (Phase III) |
M/s. Windlas Biotech Pvt. Ltd |
FDC |
2019-Feb-08 |
|
1067 KB |
1553 |
Ofatumumab toterability |
Novartis |
GCT |
2019-Feb-08 |
|
195 KB |
1554 |
Durvalumab Monotherapy |
AstraZeneca |
GCT |
2019-Feb-08 |
|
355 KB |
1555 |
Beclomethasone Dipropionate |
Axis |
GCT |
2019-Feb-08 |
|
581 KB |
1556 |
Natalizumab |
M/s Reliance Life Sciences Pvt. Ltd. |
rDNA |
2019-Feb-04 |
|
105 KB |
1557 |
Follitropin delta |
M/s Ferring Pharmaceuticals Pvt. Ltd |
rDNA |
2019-Feb-01 |
|
330 KB |
1558 |
Phase 3 Relamorelin |
Parexel |
GCT |
2019-Jan-31 |
|
413 KB |
1559 |
15-Valent Pneumococcal Conjugate Vaccine (PCV15) |
M/s Tergene Biotech Private Limited |
Vaccine |
2019-Jan-31 |
|
322 KB |
1560 |
Benidipine Hydrochloride IP Telmisartan IP Film coated tablets (Phase III) |
M/s. Synokem Pharmaceuticals Pvt. Ltd. |
FDC |
2019-Jan-29 |
|
1695 KB |
1561 |
Rotavirus Vaccine |
M/s Indian Council of Medical Research (ICMR) |
Vaccine |
2019-Jan-29 |
|
321 KB |
1562 |
JHL1101 |
IQVIA |
GCT |
2019-Jan-29 |
|
498 KB |
1563 |
Measles and Rubella Vaccine (Live) |
M/s Indian Immunological Limited |
Vaccine |
2019-Jan-29 |
|
320 KB |
1564 |
efficacy ART-123 |
Asiatic |
GCT |
2019-Jan-28 |
|
439 KB |
1565 |
Relamorelin gastroparesis |
Parexel |
GCT |
2019-Jan-28 |
|
238 KB |
1566 |
Mirabegron (in extended release) Solifenacin Succinate Film coated bilayered tablets (Phase III) |
M/s. Windlas Biotech Pvt.Ltd. |
FDC |
2019-Jan-26 |
|
1117 KB |
1567 |
SHP640 |
Baxalta |
GCT |
2019-Jan-23 |
|
196 KB |
1568 |
Teriflunomide tab 14 mg |
M/s. Sanofi-Syntholabo(I) pvt ltd |
New Drugs |
2019-Jan-17 |
|
428 KB |
1569 |
HRF-4467 |
M/s. Lambad Therapeutic Research Ltd |
New Drugs |
2019-Jan-14 |
|
228 KB |
1570 |
PNB028 |
M/s. Lambad Therapeutic Research Ltd |
New Drugs |
2019-Jan-14 |
|
266 KB |
1571 |
Itraconazole |
J&J |
GCT |
2019-Jan-11 |
|
1378 KB |
1572 |
Prednisone delayed Release Tablet 5 mg |
M/s Ajanta Pharma Ltd. |
SND |
2019-Jan-11 |
|
2670 KB |
1573 |
M/s Reliance Life Sciences Pvt Ltd. |
Panitumumab |
rDNA |
2019-Jan-11 |
|
1313 KB |
1574 |
Durvalumab as Consolidation therapy |
AstraZeneca |
GCT |
2019-Jan-10 |
|
1497 KB |
1575 |
Dexamethasone Sodium Phosphate |
Clinirx |
GCT |
2019-Jan-10 |
|
1600 KB |
1576 |
Relamorelin |
Parexel |
GCT |
2019-Jan-10 |
|
1680 KB |
1577 |
Enbrel娉 (Etanercept |
Lupin |
GCT |
2019-Jan-10 |
|
1379 KB |
1578 |
Single dose Del Nido vs multi dose StThomas II Cardioplegia |
M/s. Dr. Aravind K. |
New Drugs |
2019-Jan-06 |
|
235 KB |
1579 |
CPL-2009-0031 tablet 140 mg of Cadila Pharmaceutical Ltd |
M/s. Cadila Pharmaceutials Ltd |
New Drugs |
2018-Dec-24 |
|
222 KB |
1580 |
CPL-2009-0031 tablet 140 mg |
M/s. Cadila Pharmaceutials Ltd |
New Drugs |
2018-Dec-24 |
|
277 KB |
1581 |
PMZ-2010 |
M/s. Pharmazz India Pvt Ltd |
New Drugs |
2018-Dec-24 |
|
283 KB |
1582 |
Denosumab (120 mg/1.7 mL) |
M/s Intas Pharmaceuticals Ltd |
rDNA |
2018-Dec-20 |
|
352 KB |
1583 |
LNP3794 in apatients |
M/s. Lupin |
GCT |
2018-Dec-13 |
|
1411 KB |
1584 |
Crizanlizumab |
M/s. Novartis |
GCT |
2018-Dec-12 |
|
1410 KB |
1585 |
Dupilumab |
M/s. Sanofi |
0 |
2018-Dec-06 |
|
1781 KB |
1586 |
Ifetroban |
M/s. JSS Medical |
GCT |
2018-Dec-05 |
|
1415 KB |
1587 |
Herceptin® or TX05 |
Fermish |
GCT |
2018-Nov-30 |
|
1438 KB |
1588 |
Ivabradine Tablets |
M/s Sun Pharma Laboratories Limted |
SND |
2018-Nov-30 |
|
2291 KB |
1589 |
TX05 |
Fermish |
GCT |
2018-Nov-30 |
|
1595 KB |
1590 |
CT-P16 |
PPD |
GCT |
2018-Nov-30 |
|
1586 KB |
1591 |
Ligelizumab (QGE031) |
Novartis |
GCT |
2018-Nov-26 |
|
1614 KB |
1592 |
Semaglutide |
Novo Nordisk |
GCT |
2018-Nov-26 |
|
1601KB |
1593 |
Aztreonam-Avibactam (Atm-Avi) |
Pfizer |
GCT |
2018-Nov-26 |
|
1491 KB |
1594 |
Selinexor (KPT-330 |
Excel Life Sciences |
GCT |
2018-Nov-26 |
|
1592 KB |
1595 |
tropifexor (LJN452) and cenicriviroc (CVC) |
Novartis |
GCT |
2018-Nov-26 |
|
1460 KB |
1596 |
ZS (sodium zirconium cyclosilicate |
AstraZeneca |
GCT |
2018-Nov-26 |
|
1636 KB |
1597 |
NexoBrid |
Apothecaries |
GCT |
2018-Nov-26 |
|
1513 KB |
1598 |
Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% |
Cliantha |
GCT |
2018-Nov-26 |
|
1449 KB |
1599 |
PXL01 |
Kentron |
GCT |
2018-Nov-26 |
|
1568 KB |
1600 |
ligelizumab (QGE031) |
Novartis |
GCT |
2018-Nov-26 |
|
1696 KB |
1601 |
Coversin |
Medpace |
GCT |
2018-Nov-26 |
|
1489 KB |
1602 |
Cefepime-Tazobactam vs. Meropenem |
Wockhardt |
GCT |
2018-Nov-26 |
|
1484 KB |
1603 |
Pembrolizumab (KEYTRUDA®) |
M/s MSD Pharmaceuticals Private Limited |
rDNA |
2018-Nov-22 |
|
1343 KB |
1604 |
Azelnidipine tab 8 mg / 16 mg |
M/s Synokem Pharmaceuticals ltd |
New Drugs |
2018-Nov-22 |
|
287 KB |
1605 |
Epinephrine plus Vasopressin |
Dr Medha R |
New Drugs |
2018-Nov-22 |
|
226KB |
1606 |
Azacitidine 100 mg |
M/s Dr Reddys |
New Drugs |
2018-Nov-22 |
|
280 KB |
1607 |
ENZ110 (similar biologic of Romiplostim) |
M/s. Enzene Biosciences Ltd |
rDNA |
2018-Nov-06 |
|
1326 KB |
1608 |
Saroglitazar Magnesium |
M/s Cadila Healthcare Ltd |
SND |
2018-Nov-02 |
|
17176 KN |
1609 |
BevacizumabM/s. Intas |
M/s. Intas Pharmaceuticals Ltd |
rDNA |
2018-Oct-23 |
|
1366 KB |
1610 |
Bevacizumabbio |
M/s. Intas Pharmaceuticals Ltd |
rDNA |
2018-Oct-23 |
|
1366 KB |
1611 |
VELPANAT |
M/s. Natco |
New Drugs |
2018-Oct-22 |
|
197 KB |
1612 |
Azelnidipine |
M/s. Hetero |
New Drugs |
2018-Oct-22 |
|
371 KB |
1613 |
FDC of Efonidipine Hydrochloride Ethanolate + Metoprolol Succinate IP (as extended release) (20 mg+25mg & 20mg+50mg) Film coated tablets. |
M/s Ajanta Pharma Ltd |
FDC |
2018-Oct-16 |
|
17177 KB |
1614 |
Pegfilgrastim (ZRC-3128) |
M/s Cadila Healthcare Limited |
rDNA |
2018-Oct-11 |
|
1409 KB |
1615 |
Doxycycline |
Dr. Suma T K |
New Drugs |
2018-Oct-10 |
|
225 KB |
1616 |
Bedaquiline, Delamanid, Linezolid and Clofazimine |
Dr. Srikanth Prasad Tripathy |
New Drugs |
2018-Oct-05 |
|
218 KB |
1617 |
fecombinant human follicle stimulating hormone (r-h-FSH) |
M/s. Intas Pharmaceuticals Ltdr |
rDNA |
2018-Oct-04 |
|
1407 KB |
1618 |
recombinant human follicle stimulating hormone (r-h-FSH) |
M/s. Intas Pharmaceuticals Ltd |
rDNA |
2018-Oct-04 |
|
1407 KB |
1619 |
Tulobuterol Transdermal |
M/s. Zuventus Healthcare Ltd |
New Drugs |
2018-Oct-01 |
|
239 KB |
1620 |
Enterogermina |
M/s. Sanofi-Synthelabo (I) Ltd |
New Drugs |
2018-Oct-01 |
|
179 KB |
1621 |
Desidustat ZYAN1 |
M/s. Cadila Healthcare Ltd |
New Drugs |
2018-Oct-01 |
|
236 KB |
1622 |
Nexagon® (NEXAGON) |
Excel Life Sciences Pvt Ltd |
GCT |
2018-Sep-29 |
|
1530 KB |
1623 |
Tapentadol nasal spray 225mg/ml |
M/s Torrent Pharmaceuticals Ltd |
SND |
2018-Sep-28 |
|
966 KB |
1624 |
Nitazoxanide 500 mg Tablets |
Axis Clinicals |
GCT |
2018-Sep-17 |
|
1696 KB |
1625 |
Efpeglenatide |
Sanofi |
GCT |
2018-Sep-17 |
|
444 KB |
1626 |
Edoxaban |
Medpace |
GCT |
2018-Sep-17 |
|
1794 KB |
1627 |
LCZ696 |
Novartis |
GCT |
2018-Sep-17 |
|
1762 KB |
1628 |
Osilodrostat (LCI699 |
Novartis |
GCT |
2018-Sep-17 |
|
1794 KB |
1629 |
KAF156 |
Novartis |
GCT |
2018-Sep-17 |
|
1902 KB |
1630 |
Aztreonam-Avibactam (ATM-AVI Pfizer |
Pfizer |
GCT |
2018-Sep-17 |
|
2029 KB |
1631 |
Granexin Gel |
JSS Medical |
GCT |
2018-Sep-17 |
|
545 KB |
1632 |
Esmolol Hydrochloride 14.00% w/w topical gel |
M/s Novalead Pharma Pvt Ltd. |
GCT |
2018-Sep-10 |
|
1298 KB |
1633 |
FDC of Daclatasvir dihydrochloride eq to Daclatasvir 60mg + Sofosbuvir 400mg film coated tablets |
M/s Natco Pharma Ltd |
FDC |
2018-Sep-05 |
|
1246 KB |
1634 |
Clostridium Botulinum Type-A Toxin Haemagglutinin complex injection 300 units |
M/s Nestle Skin Health India Private Limited |
SND |
2018-Sep-04 |
|
1737 KB |
1635 |
Dalfampridine |
M/s. Sun pharma lab ltd |
New Drugs |
2018-Aug-30 |
|
124 KB |
1636 |
Apremilast Tablets 10/20/30mg Phase IV . |
M/s Glenmark Pharmaceuticals Ltd |
SND |
2018-Aug-24 |
|
1708 KB |
1637 |
FDC of Metoprolol Succinate ER + Cilnidipine +Telmisartan (25mg + 10mg + 40mg & 50mg + 10mg + 40mg) Tablets |
M/s Ajanta Pharma Ltd |
FDC |
2018-Aug-21 |
|
1300 KB |
1638 |
FDC of Metoprolol Tartrate IP + Ivabradine HCL eq to Ivabradine (25mg+5mg & 50mg+5mg) Film coated tablets |
M/s Ajanta Pharma Ltd |
FDC |
2018-Aug-21 |
|
1316 KB |
1639 |
EG12014 |
Psi CRO |
GCT |
2018-Aug-18 |
|
1782 KB |
1640 |
Paracetamol Injection 500mg/2ml for IM route Phase III |
M/s Troikaa Pharmaceuticals Ltd. |
SND |
2018-Aug-17 |
|
1960 KB |
1641 |
Pilot study on Paracetamol Injection for IM route Pilot study |
M/s Troikaa Pharmaceuticals Ltd. |
SND |
2018-Aug-17 |
|
1593 KB |
1642 |
Bilastine 20 mg |
Meriarin i India Private Limited |
New Drugs |
2018-Aug-13 |
|
312 KB |
1643 |
Magnesium sulfate |
Dr. Chanchal Kumar |
New Drugs |
2018-Aug-08 |
|
116 KB |
1644 |
Dolutegravir (Phase IV) |
M/s. Mylan lab |
New Drugs |
2018-Jul-30 |
|
78.6 KB |
1645 |
Brolucizumab |
Novartis |
GCT |
2018-Jul-18 |
|
1822 KB |
1646 |
Scrub Typhus INTREST |
Syngene |
GCT |
2018-Jul-18 |
|
1820 KB |
1647 |
5-aminolevulinic acid hydrochloride |
Clinsync |
GCT |
2018-Jul-18 |
|
1854 KB |
1648 |
Nitazoxanide 500 mg Tablets |
M/s Axis Clinicals |
GCT |
2018-Jul-18 |
|
1696 KB |
1649 |
Aztreonam-Avibactam (ATM-AVI |
Pfizer |
GCT |
2018-Jul-18 |
|
2029 KB |
1650 |
Ticagrelor |
Quintiles |
GCT |
2018-Jul-18 |
|
1672 KB |
1651 |
Tagrisso (Osimertinib) |
M/s. AstraZeneca Pharma (I) Ltd |
New Drugs |
2018-Jul-16 |
|
137 KB |
1652 |
Kyprolis (Carfilzomib) |
M/s. Amgen Technology Pvt Ltd |
New Drugs |
2018-Jul-16 |
|
184 KB |
1653 |
Efonidipine Hydrochloride Ethanolate 20mg + Telmisartan IP 40mg film coated Tablets (Phase-III) |
M/s Ajanta Pharma Limited |
FDC |
2018-Jul-12 |
|
1,008 KB |
1654 |
Tadalafil + Dapoxetine (20mg +60mg, 20mg+30mg, 10mg+30mg) film coated tablets (Phase-III). |
M/s. Ajanta Pharma Ltd |
FDC |
2018-Jul-12 |
|
949 KB |
1655 |
Metoprolol Succinate ER + Chlorthalidone + Telmisartan (50mg+12.5mg+40mg, 25mg+12.5mg+40mg)film coated tablets (Phase-III) |
M/s Ajanta Pharma Limited |
FDC |
2018-Jul-12 |
|
1,027 KB |
1656 |
Azilsartan Medoxomil + Chlorthalidone (40mg+25mg,40mg+12.5mg 40mg+6.25mg) Tablets (Phase-III). |
M/s MSN Laboratories Private Limited |
FDC |
2018-Jul-12 |
|
1,118 KB |
1657 |
Alcaftadine 0.25% w/v + Ketoroloc Tromethamine 0.4% w/v Eye drops (Phase-III). |
M/s Ajanta Pharma Limited |
FDC |
2018-Jul-12 |
|
1,163 KB |
1658 |
Pregabalin IP (As Prolonged Release) 75mg + Etoricoxib IP 60mg uncoated bilayered tablets (Phase-III). |
M/s Sun Pharma Laboratories Limited |
FDC |
2018-Jul-12 |
|
1,195 KB |
1659 |
Cinacalcet Hydrochloride |
Amgen |
GCT |
2018-Jul-11 |
|
1,710 KB |
1660 |
Efpeglenatide |
M/s Sanofi-Synthelabo |
GCT |
2018-Jul-11 |
|
444 KB |
1661 |
emaglutide 2.4 mg CT/18/000019 |
M/s Novo Nordisk India Pvt. Ltd |
GCT |
2018-Jul-11 |
|
1,708 KB |
1662 |
Semaglutide 2.4 mg |
M/s Novo Nordisk India Pvt. Ltd |
GCT |
2018-Jul-11 |
|
1,722 KB |
1663 |
Enzalutamide |
M/s. Astellas Pharma India Pvt Ltd |
New Drugs |
2018-Jul-05 |
|
98.6 KB |
1664 |
Delamanid |
Dr. Arun Kowale |
New Drugs |
2018-Jul-05 |
|
82 KB |
1665 |
Azelnidipine tab 16 mg |
M/s. Ajanta Pharma Ltd |
New Drugs |
2018-Jul-05 |
|
130 KB |
1666 |
Calcipotriol/AKVANO 50 µg/g cutaneous solution |
M/s Cadila Pharmaceuticals Ltd. |
SND |
2018-Jun-29 |
|
1,737,836 KB |
1667 |
Permission for conducting a Phase rB/IlA 'clinical study entitled , "A Phase IS /IrA, multi-center , open-label clinical trial to evaluate the safety, to lerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis " |
M/s . Cadila Health care Limited |
New Drugs |
2018-Jun-12 |
|
97KB |
1668 |
Permission for conducting A Phase 3 clinical trial titled "ATLAS- INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, With Inhibitory Antibodies to Factor VIII or IX |
M/s. PPD Pharmaceutical Development India Pvt. Ltd. |
GCT |
2018-Jun-12 |
|
143KB |
1669 |
Permission for conducting a clinical study entitle d, "A multicentric , Randomized , double blind , parallel group, comparative, Phase 3 clinical study to evaluate the efficacy, Safety and Tolerability of Azelnidipine Tablets 16 mg verus Amlodipine Tablets 10 mg in subjects with essential hypertension " |
M/s Ajanta Pharma Lim ited |
New Drugs |
2018-Jun-11 |
|
128KB |
1670 |
Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB" |
Dr. Arun Kowale, B.J . Medical College, & Sassoon General Hospitals |
New Drugs |
2018-Jun-11 |
|
76KB |
1671 |
Ivermectin topical lotion 0.5% w/w |
M/s Ajanta Pharma Ltd. |
SND |
2018-Jun-08 |
|
1,858,593 KB |
1672 |
Darunavir Tablet 800mg |
M/s Cipla Ltd. |
SND |
2018-Jun-05 |
|
143KB |
1673 |
qHPV Vaccine |
M/s. Serum Institute Of India Pvt. Ltd |
Vaccine |
2018-May-22 |
|
1862 KB |
1674 |
Permission for conducting a clinical study entitled , "A multicenter Phase-4 , Open-label, Single-arm, Safety and Efficacy Study of Enzalutarnide in Indian Patients with Progressive Metastatic Castration -Resistant Prostate Cancer (mCRPC) Previously Treated with Docetaxel-Based Chemotherapy" |
M/ s . Astellas Pharma India Pvt . Ltd |
New Drugs |
2018-May-11 |
|
105KB |
1675 |
Canakinumab |
Novartis |
GCT |
2018-May-10 |
|
1877 KB |
1676 |
Paliperidone Palmitate |
J&J |
GCT |
2018-May-08 |
|
1757 KB |
1677 |
Rigosertib |
JSS |
GCT |
2018-May-08 |
|
1688 KB |
1678 |
Torsemide Extended Release |
M/s Syngene |
GCT |
2018-May-01 |
|
568KB |
1679 |
Emicizumab |
M/s Roche |
GCT |
2018-May-01 |
|
371KB |
1680 |
NexoBrid |
M/s Apothecaries |
GCT |
2018-May-01 |
|
302KB |
1681 |
QAW039 |
M/s Novartis |
GCT |
2018-May-01 |
|
570KB |
1682 |
Baricitinib |
M/s Eli Lilly |
GCT |
2018-May-01 |
|
300KB |
1683 |
Exenatide |
M/s AstraZeneca |
GCT |
2018-May-01 |
|
373KB |
1684 |
Rilpivirine |
M/s J&J |
GCT |
2018-May-01 |
|
577KB |
1685 |
MB02 (Bevacizumab Biosimilar Drug) |
M/s Kendle |
GCT |
2018-May-01 |
|
573KB |
1686 |
YLB113 |
M/s Lupin |
GCT |
2018-May-01 |
|
299KB |
1687 |
AMG 334 |
M/s Novartis |
GCT |
2018-May-01 |
|
392KB |
1688 |
SCY 078 |
M/s Syngene |
GCT |
2018-May-01 |
|
242KB |
1689 |
Pimodivir15 |
Quintiles |
GCT |
2018-Apr-25 |
|
1640 KB |
1690 |
Pimodivir |
Quintiles |
GCT |
2018-Apr-25 |
|
1718 KB |
1691 |
ASN100 |
Pharmolam |
GCT |
2018-Apr-19 |
|
1753 KB |
1692 |
MEDI-551 |
AstraZeneca |
GCT |
2018-Apr-17 |
|
1763 KB |
1693 |
Regorafenib |
M/s. Bayer Pharmaceuticals Pvt Ltd |
New Drugs |
2018-Apr-16 |
|
140KB |
1694 |
Fluticasone Propionate 100 mcg and Salmeterol 50 mcg |
Amneal |
GCT |
2018-Apr-12 |
|
1750 KB |
1695 |
QVM149 |
Novartis |
GCT |
2018-Apr-05 |
|
1804 KB |
1696 |
Lenvatinib |
M/s. Eisai Pharmaceuticals Pvt Ltd. |
New Drugs |
2018-Mar-06 |
|
143KB |
1697 |
Sofosbuvir / Velpatasvir FDC |
M/s Mylan Laboratories Ltd |
New Drugs |
2018-Feb-28 |
|
100KB |
1698 |
Februric (Febuxostat) |
M/s. Ajanta Pharma Ltd. |
New Drugs |
2018-Feb-20 |
|
103KB |
1699 |
Pirfenidone |
M/s. Cipla Ltd. |
New Drugs |
2018-Jan-24 |
|
100KB |
1700 |
Anagliptin |
M/s. MSN laboratories Pvt Ltd |
New Drugs |
2018-Jan-18 |
|
162KB |
1701 |
Verapamil ER |
M/s Dr. C. Padmapriyadarsini |
New Drugs |
2018-Jan-10 |
|
193KB |
1702 |
Heptral |
M/s. Akums Drugs and Pharmaceuticals Ltd. |
New Drugs |
2018-Jan-08 |
|
105KB |
1703 |
Spironolactone cream 5% |
M/s AlkemLaboratories |
SND |
2018-Jan-05 |
|
926KB |
1704 |
BIO-11006 |
M/s. Cliantha |
GCT |
2017-Dec-18 |
|
565 KB |
1705 |
LUBT010 |
M/s. Lupin |
GCT |
2017-Dec-15 |
|
371 KB |
1706 |
Ataluren |
M/s. Medpace |
GCT |
2017-Dec-15 |
|
269 KB |
1707 |
ribociclib with endocrine |
M/s. Novartis |
GCT |
2017-Dec-01 |
|
423 KB |
1708 |
ABP 798 |
M/s. PRA |
GCT |
2017-Dec-01 |
|
340 KB |
1709 |
Selinexor (KPT-330) |
M/s. Excel Life Sciences |
GCT |
2017-Dec-01 |
|
445 KB |
1710 |
Nintedanib Systemic Sclerosis |
M/s. Boehringer |
GCT |
2017-Dec-01 |
|
404 KB |
1711 |
Lorlatinib (PF-06463922) |
M/s. Pfizer |
GCT |
2017-Nov-22 |
|
470 KB |
1712 |
SB11 |
M/s. Quintiles |
GCT |
2017-Nov-22 |
|
282 KB |
1713 |
Dapagliflozin 5 and 10 mg |
M/s. PRA |
GCT |
2017-Nov-22 |
|
447 KB |
1714 |
Dinutuximab and Irinotecan |
M/s. Novotech |
GCT |
2017-Nov-22 |
|
456 KB |
1715 |
Canagliflozin in Children |
M/s. J&J |
GCT |
2017-Nov-22 |
|
439 KB |
1716 |
Povidone-Iodine Nail Solution |
M/s. JSS |
GCT |
2017-Nov-22 |
|
103 KB |
1717 |
Atezolizumab compared with chemotherapy |
M/s. Roche |
GCT |
2017-Nov-22 |
|
109 KB |
1718 |
CLS-TA Sapphire |
M/s. Excel Life Sciences |
GCT |
2017-Nov-08 |
|
100 KB |
1719 |
Selinexor |
M/s. Excel Life Sciences |
GCT |
2017-Nov-08 |
|
448 KB |
1720 |
Bempedoic Acid (ETC-1002) |
M/s. Quintiles |
GCT |
2017-Oct-18 |
|
582 KB |
1721 |
LJN452 |
M/s. Novartis |
GCT |
2017-Oct-11 |
|
367 KB |
1722 |
Atezolizumab(ANTI-PD-L1Antibody) |
M/s. Roche |
GCT |
2017-Sep-29 |
|
907 KB |
1723 |
Ticagrlor |
M/s. Astra Zeneca |
GCT |
2017-Sep-28 |
|
1115 KB |
1724 |
Deferasirox Formulation(Granules) |
M/s. Novartis |
GCT |
2017-Sep-28 |
|
842 KB |
1725 |
LCZ696 on NT Pro BNP |
M/s. Novartis |
GCT |
2017-Sep-21 |
|
1117 KB |
1726 |
QAW039 sept |
M/s. Novartis |
GCT |
2017-Sep-20 |
|
1132 KB |
1727 |
Ixekizumab |
M/s. Eli Lilly |
GCT |
2017-Sep-20 |
|
1165 KB |
1728 |
Alpelisib |
M/s. Novartis |
GCT |
2017-Sep-20 |
|
861 KB |
1729 |
PEGylated factor |
M/s. Baxalta |
GCT |
2017-Sep-15 |
|
1154 KB |
1730 |
Abemaciclib |
M/s. Eli Lilly |
GCT |
2017-Sep-14 |
|
1210 KB |
1731 |
RSV |
M/s. Kendle |
GCT |
2017-Sep-13 |
|
868 KB |
1732 |
Apixaban |
M/s. BMS |
GCT |
2017-Sep-13 |
|
1104 KB |
1733 |
Empagliflozin 10mg |
M/s. Quintiles |
GCT |
2017-Aug-17 |
|
1138 KB |
1734 |
Empagliflozin |
M/s. Quintiles |
GCT |
2017-Aug-15 |
|
1228 KB |
1735 |
LY900014 (Insulin Lispro) |
M/s. Eli Lilly |
GCT |
2017-Aug-09 |
|
1115 KB |
1736 |
QMF149 150-80 microgram |
M/s. Novartis |
GCT |
2017-Jul-30 |
|
1039 KB |
1737 |
Canagliflozin |
M/s. Novo Nordisk |
GCT |
2017-Jul-30 |
|
1121 KB |
1738 |
ovidone -Iodine |
M/s. JSS |
GCT |
2017-Jul-30 |
|
1133 KB |
1739 |
SPI-2012 |
M/s. Spectrum |
GCT |
2017-Jul-30 |
|
876 KB |
1740 |
Dulaglutide |
M/s. Eli Lilly |
GCT |
2017-Jul-30 |
|
985 KB |
1741 |
LNP1892 |
M/s. Lupin |
GCT |
2017-Jul-30 |
|
1018 KB |
1742 |
Dapagliflozin PC D1699C00001 |
M/s. Astra Zeneca |
GCT |
2017-Jul-30 |
|
1064 KB |
1743 |
Eltrombopag |
M/s. Novartis |
GCT |
2017-Jul-30 |
|
867 KB |
1744 |
MOD-4023 |
M/s. JSS |
GCT |
2017-Jul-30 |
|
1274 KB |
1745 |
Ribociclib |
M/s. Novartis |
GCT |
2017-Jul-30 |
|
846 KB |
1746 |
SAIT101 vs Rituximab |
M/s. Quintiles |
GCT |
2017-Jul-30 |
|
1353 KB |
1747 |
ANF-Rho |
M/s. Amneal |
GCT |
2017-Jul-30 |
|
1125 KB |
1748 |
Safety Study of Atezolizumab |
M/s. Roche |
GCT |
2017-Jul-30 |
|
814 KB |
1749 |
Filgotinib combined phase |
M/s. Klinera |
GCT |
2017-Jul-28 |
|
1008 KB |
1750 |
sFilgotinib |
M/s. Klinera |
GCT |
2017-Jul-28 |
|
1171 KB |
1751 |
Filgotinib Rheumatoid |
M/s. Klinera |
GCT |
2017-Jul-28 |
|
842 KB |
1752 |
Filgotinib Crohn |
M/s. Klinera |
GCT |
2017-Jul-28 |
|
1203 KB |
1753 |
LNP3794 |
M/s. Lupin |
GCT |
2017-Jul-28 |
|
819 KB |
1754 |
Filgotinib Administered |
M/s. Klinera |
GCT |
2017-Jul-27 |
|
196 KB |
1755 |
Tenofovir Alafenamide |
M/s. Klinera |
GCT |
2017-Jul-21 |
|
1111 KB |
1756 |
LY900014 |
M/s. Eli Lilly |
GCT |
2017-Jul-21 |
|
1048 KB |
1757 |
Filgotinib |
M/s Klinera |
GCT |
2017-Jul-20 |
|
198 KB |
1758 |
Dapagliflozin |
M/s. Astra Zeneca |
GCT |
2017-Jul-12 |
|
1168 KB |
1759 |
CLS-TA |
M/s.Excel Life |
GCT |
2017-Jul-03 |
|
59 KB |
1760 |
Ribociclib LEE011 |
M/s. Novartis |
GCT |
2017-Jun-30 |
|
831 KB |
1761 |
Selonsertib NASH |
M/s. Klinera |
GCT |
2017-Jun-30 |
|
1326 KB |
1762 |
Filgotinib safety |
M/s. Klinera |
GCT |
2017-Jun-30 |
|
1238 KB |
1763 |
Pemafibrate |
M/s. Quintiles |
GCT |
2017-Jun-30 |
|
1356 KB |
1764 |
Masitinib vs Placebo |
M/s. Apothecaries |
GCT |
2017-Jun-30 |
|
807 KB |
1765 |
Bedaquiline |
M/s. Johnson & Johnson |
GCT |
2017-Jun-27 |
|
152 KB |
1766 |
Daprodustat |
M/s. PPD |
GCT |
2017-Jun-20 |
|
183 KB |
1767 |
aprodustat |
M/s. PPDD |
GCT |
2017-Jun-20 |
|
227 KB |
1768 |
Oral Semaglutide versus |
M/s. Novo Nordisk |
GCT |
2017-Jun-12 |
|
192 KB |
1769 |
LCZ696 |
M/s. Novartis |
GCT |
2017-Jun-08 |
|
145 KB |
1770 |
SAIT101 |
M/s. Quintiles |
GCT |
2017-May-24 |
|
148 KB |
1771 |
Alphanate® |
M/s. Sectrum |
GCT |
2017-Mar-19 |
|
139 KB |
1772 |
TK-112690 |
M/s. RA Chem Pharma |
GCT |
2017-Mar-17 |
|
172 KB |
1773 |
Ofatumumab safety |
M/s.Novartis |
GCT |
2017-Mar-15 |
|
186 KB |
1774 |
Etrolizumab PhaseII/III |
M/s. Roche |
GCT |
2017-Mar-15 |
|
204 KB |
1775 |
Ofatumumab |
M/s.Novartis |
GCT |
2017-Mar-15 |
|
188 KB |
1776 |
Clindamycin phosphate |
M/s. Cliantha |
GCT |
2017-Mar-15 |
|
178 KB |
1777 |
Pradaxa Capsules |
M/s. Boehringer |
GCT |
2017-Mar-15 |
|
155 KB |
1778 |
Etrolizumab |
M/s. Roche |
GCT |
2017-Mar-15 |
|
207 KB |
1779 |
DE-117 |
M/s. Covance |
GCT |
2017-Mar-08 |
|
200 KB |
1780 |
Lixisenatide |
M/s. Sanofi |
GCT |
2017-Feb-27 |
|
204 KB |
1781 |
QVA149 |
Novartis |
GCT |
2017-Jan-17 |
|
294 KB |
1782 |
Aclidinium |
M/s. Parexel |
GCT |
2017-Jan-09 |
|
229 KB |
1783 |
Nintedanib oral |
M/s. Boehringer |
GCT |
2017-Jan-07 |
|
197 KB |
1784 |
Sarizotan |
M/s. CliniRx |
GCT |
2017-Jan-04 |
|
142 KB |
1785 |
FIASP |
M/s. Novo Nordisk |
GCT |
2017-Jan-03 |
|
143 KB |
1786 |
CBT124 |
M/s. Cipla Biotec |
GCT |
2017-Jan-03 |
|
222 KB |
1787 |
Avelumab |
M/s. Pfizer |
GCT |
2017-Jan-03 |
|
150 KB |
1788 |
Insulin Degludec |
M/s. Novo Nordisk |
GCT |
2017-Jan-03 |
|
156 KB |
1789 |
LY2835219 |
M/s. Eli Lilly |
GCT |
2017-Jan-03 |
|
295 KB |
1790 |
Palbociclib |
M/s. Pfizer |
GCT |
2017-Jan-03 |
|
178 KB |
1791 |
Sofosbuvir Velpatasvir |
Klinera |
GCT |
2016-Dec-30 |
|
158 KB |
1792 |
Cardiovascular safety of Oral Semaglutide |
Novo Nordisk |
GCT |
2016-Dec-29 |
|
216 KB |
1793 |
MYL-14020 |
Cliantha |
GCT |
2016-Nov-10 |
|
280 KB |
1794 |
Vedolizumab IV |
PPD |
GCT |
2016-Nov-10 |
|
152 KB |
1795 |
Budesonide |
I C Bio |
GCT |
2016-Nov-10 |
|
150 KB |
1796 |
Dexamethasone sodium |
CliniRx |
GCT |
2016-Oct-31 |
|
141 KB |
1797 |
Pegylated Interferon @-2a |
Roche |
GCT |
2016-Oct-27 |
|
143 KB |
1798 |
BCD-055 |
Biocad |
GCT |
2016-Sep-21 |
|
148 KB |
1799 |
NC0195-0092 |
Novo Nordisk |
GCT |
2016-Sep-21 |
|
130 KB |
1800 |
Liraglutide |
Novo Nordisk |
GCT |
2016-Sep-21 |
|
136 KB |
1801 |
QAW039 |
Novartis |
GCT |
2016-Sep-15 |
|
128 KB |
1802 |
Oral Semaglutide |
Novo Nordisk |
GCT |
2016-Aug-29 |
|
133 KB |
1803 |
GS-5745 |
Klinera |
GCT |
2016-Aug-23 |
|
138 KB |
1804 |
RFB002 |
Novartis |
GCT |
2016-Aug-12 |
|
135 KB |
1805 |
Semaglutide IGlar SGT2i |
Novo Nordisk |
GCT |
2016-Aug-11 |
|
160 KB |
1806 |
Trimcinolone Acetonide |
Excel Life Sciences |
GCT |
2016-Aug-11 |
|
173 KB |
1807 |
Rivaroxaban |
AIIMS |
GCT |
2016-Aug-09 |
|
148 KB |
1808 |
MEDI4736 aug |
AstraZeneca |
GCT |
2016-Aug-08 |
|
211 KB |
1809 |
MEDI4736 |
AstraZeneca |
GCT |
2016-Aug-04 |
|
189 KB |
1810 |
Ceritinib |
Novartis |
GCT |
2016-Aug-04 |
|
144 KB |
1811 |
INC280 |
Novartis |
GCT |
2016-Aug-02 |
|
2112 KB |
1812 |
QMF149 |
Novartis |
GCT |
2016-Jun-21 |
|
225 KB |
1813 |
Indacaterol |
Novartis |
GCT |
2016-Jun-21 |
|
277 KB |
1814 |
BIASP-30 |
Novo Nordisk |
GCT |
2016-May-25 |
|
198 KB |
1815 |
Insulin Aspart |
Novo Nordisk |
GCT |
2016-May-25 |
|
195 KB |
1816 |
NW-3509A |
Clinirx |
GCT |
2016-May-25 |
|
153 KB |
1817 |
Insulin degludec may |
Novo Nordisk |
GCT |
2016-May-24 |
|
216 KB |
1818 |
Lopinavir/Ritonavir |
BJMC Pune (Dr. Sandhya Khadse) |
GCT |
2016-May-24 |
|
144 KB |
1819 |
MDR-TB Drugs |
National Institute for Research in TB |
GCT |
2016-May-24 |
|
151 KB |
1820 |
B1695502 |
Boehringer |
GCT |
2016-May-23 |
|
225 KB |
1821 |
Sofosbuvir |
Klinera |
GCT |
2016-May-23 |
|
143 KB |
1822 |
RLX030 |
Novartis |
GCT |
2016-May-18 |
|
190 KB |
1823 |
Clindamycin |
Amneal |
GCT |
2016-May-17 |
|
189 KB |
1824 |
Semaglutide 2016 |
Novo Nordisk |
GCT |
2016-May-11 |
|
256 KB |
1825 |
Masitinib |
Maya Clinicals |
GCT |
2016-May-09 |
|
178 KB |
1826 |
Carbetocin RTS |
Dr. Shivaprasad |
GCT |
2016-Apr-25 |
|
1542 KB |
1827 |
YLB113 |
Kendle |
GCT |
2016-Mar-15 |
|
184 KB |
1828 |
Insulin degludec |
Novo Nordisk |
GCT |
2016-Mar-10 |
|
245 KB |
1829 |
BYL719 |
Novartis |
GCT |
2016-Mar-03 |
|
189 KB |
1830 |
Nintedanib |
Boehringer |
GCT |
2016-Jan-18 |
|
204 KB |
1831 |
Pregabali |
Pfizer |
GCT |
2016-Jan-08 |
|
182 KB |
1832 |
Pregabalin |
Pfizer |
GCT |
2016-Jan-06 |
|
182 KB |
1833 |
Alirocumab |
Sanofi |
GCT |
2015-Dec-29 |
|
191 KB |
1834 |
CT P10 |
PPD |
GCT |
2015-Dec-28 |
|
186 KB |
1835 |
QGE031 S.c |
Novartis |
GCT |
2015-Dec-17 |
|
191 KB |
1836 |
QGE031 CQGE031B2201 |
Novartis |
GCT |
2015-Dec-17 |
|
166 KB |
1837 |
FG-3019s |
Excel Life Science |
GCT |
2015-Dec-09 |
|
190 KB |
1838 |
Roxadustat |
AstraZeneca |
GCT |
2015-Dec-03 |
|
187 KB |
1839 |
Roxadustat Anemia |
AstraZeneca |
GCT |
2015-Dec-03 |
|
190 KB |
1840 |
GENA-05 |
Max Neeman |
GCT |
2015-Nov-17 |
|
160 KB |
1841 |
Subcutaneous Secukinumab |
Novartis |
GCT |
2015-Nov-17 |
|
221 KB |
1842 |
Dydrogesterone |
Abbott |
GCT |
2015-Nov-17 |
|
178 KB |
1843 |
Pregabalin as adjunctive |
Pfizer |
GCT |
2015-Oct-26 |
|
171 KB |
1844 |
Linaclotide |
Axis |
GCT |
2015-Sep-28 |
|
225 KB |
1845 |
LCZ696 NYHA |
Novartis |
GCT |
2015-Sep-20 |
|
204 KB |
1846 |
LCZ696 Paradigm |
Novartis |
GCT |
2015-Aug-27 |
|
235 KB |
1847 |
RanibizumAB |
Novartis |
GCT |
2015-Aug-18 |
|
173 KB |
1848 |
Moroctocog alfa |
Pfizer |
GCT |
2015-Aug-18 |
|
166 KB |
1849 |
Steroids in Iga |
George Clinical |
GCT |
2015-Aug-17 |
|
181 KB |
1850 |
Canagloflozin |
J&J |
GCT |
2015-Aug-17 |
|
209 KB |
1851 |
Insulin Aspart BIAsp |
Novo-Nordisk |
GCT |
2015-Aug-12 |
|
201 KB |
1852 |
Salmeterol |
Novartis |
GCT |
2015-Aug-11 |
|
193 KB |
1853 |
Masitinib Lymphoma |
Maya Clinicals |
GCT |
2015-Jul-10 |
|
189 KB |
1854 |
LEE011 NSAI |
Novartis |
GCT |
2015-Jul-07 |
|
182 KB |
1855 |
Octafibrin |
Max Neeman |
GCT |
2015-Jun-10 |
|
170 KB |
1856 |
ACTG 5288 |
YRG Care |
GCT |
2015-May-11 |
|
170 KB |
1857 |
Dabigatran etexilate dual |
Boehringer |
GCT |
2015-May-05 |
|
239 KB |
1858 |
Clindamycin 1% |
Cliantha |
GCT |
2015-May-01 |
|
215 KB |
1859 |
Bococizumab PF-04950615) |
Pfizer |
GCT |
2015-Apr-24 |
|
368 KB |
1860 |
LEE011 with Lerozole |
Novartis |
GCT |
2015-Apr-24 |
|
184 KB |
1861 |
Bococizumab |
Pfizer |
GCT |
2015-Apr-24 |
|
369 KB |
1862 |
Masitinib |
Maya Clinicals |
GCT |
2015-Apr-17 |
|
210 KB |
1863 |
Masitinib Folfiri |
Maya Clinicals |
GCT |
2015-Apr-17 |
|
209 KB |
1864 |
Rituximab |
Pfizer |
GCT |
2015-Apr-16 |
|
190 KB |
1865 |
Dabigatran Etexilate |
Boehringer |
GCT |
2015-Apr-16 |
|
255 KB |
1866 |
Chemotherapy |
Dr. ShaileshTata Memorial |
GCT |
2015-Apr-16 |
|
178 KB |
1867 |
Dabigatran |
St. John's Research |
GCT |
2015-Apr-16 |
|
197 KB |
1868 |
Fibrinogen |
Max Neeman |
GCT |
2015-Apr-16 |
|
182 KB |
1869 |
2 PARALLEL Masitinib |
Maya Clinicals |
GCT |
2015-Apr-15 |
|
213 KB |
1870 |
Chemoradiation |
Tata Memorial |
GCT |
2015-Apr-09 |
|
162 KB |
1871 |
Ticagelor |
AstraZeneca |
GCT |
2015-Mar-05 |
|
189 KB |
1872 |
QGE031 |
Novartis |
GCT |
2015-Feb-24 |
|
183 KB |
1873 |
Isoniazid |
B. J. Medical |
GCT |
2015-Feb-23 |
|
172 KB |
1874 |
Tiotropium |
Boehringer |
GCT |
2015-Feb-20 |
|
265 KB |
1875 |
Nifedipine Daga |
Memorial |
GCT |
2015-Feb-09 |
|
165 KB |
1876 |
Labetalol |
Govt Medical College |
GCT |
2015-Feb-09 |
|
162 KB |
1877 |
DS-5565 |
INC Research |
GCT |
2015-Feb-09 |
|
178 KB |
1878 |
Nifedipine Daga |
Memorial |
GCT |
2015-Feb-09 |
|
165 KB |
1879 |
LY2963019 |
Eli Lilly |
GCT |
2015-Jan-16 |
|
200 KB |
1880 |
NNC0195-0092 |
Novo-Nordisk |
GCT |
2015-Jan-16 |
|
188 KB |
1881 |
Insulin Detemir |
Novo-Nordisk |
GCT |
2015-Jan-16 |
|
181 KB |
1882 |
Pasireotidestudy |
Novartis |
GCT |
2015-Jan-15 |
|
171 KB |
1883 |
Pasireotide |
Novartis |
GCT |
2015-Jan-15 |
|
173 KB |
1884 |
Mifepristone and Misoprotol |
Fortis |
GCT |
2015-Jan-15 |
|
163 KB |
1885 |
Mifepristone |
PGIMER |
GCT |
2015-Jan-15 |
|
160 KB |
1886 |
LCI699 |
Novartis |
GCT |
2015-Jan-15 |
|
173 KB |
1887 |
LY2605541 |
Eli Lilly |
GCT |
2014-Sep-12 |
|
200 KB |
1888 |
Octafibrin GCT/64/14 |
Max Neeman |
GCT |
2014-Sep-12 |
|
197 KB |
1889 |
Antidepressant |
National Institute of Mental Helath |
GCT |
2014-Sep-12 |
|
149 KB |
1890 |
Semaglutide 2014 |
Novo-Nordisk |
GCT |
2014-Sep-12 |
|
198 KB |
1891 |
Alglucosidase Alfa |
Sanofi |
GCT |
2014-Sep-03 |
|
164 KB |
1892 |
Dabigatran BI 655075 |
Boehringer |
GCT |
2014-Aug-27 |
|
223 KB |
1893 |
Ranibizumab VEGF |
Novartis |
GCT |
2014-Aug-13 |
|
180 KB |
1894 |
Ranibizumab CRVO |
Novartis |
GCT |
2014-Aug-12 |
|
180 KB |
1895 |
Ranibizumab Brilliance |
Novartis |
GCT |
2014-Aug-12 |
|
191 KB |
1896 |
Afatinib for Patients |
Boehringer |
GCT |
2014-Aug-11 |
|
172 KB |
1897 |
Rituximab RTXM83 |
Cliantha |
GCT |
2014-Aug-11 |
|
185 KB |
1898 |
Afatinib BiBW 2992 |
Boehringer |
GCT |
2014-Aug-11 |
|
189 KB |
1899 |
Trastuzumab |
Siro |
GCT |
2014-Aug-11 |
|
216 KB |
1900 |
Alglucosidase |
Sanofi |
GCT |
2014-Aug-08 |
|
171 KB |
1901 |
Pregabalin Adjunctive |
Pfizer |
GCT |
2014-Jul-25 |
|
188 KB |
1902 |
Herpes Zoster |
GSK |
GCT |
2014-Jul-25 |
|
169 KB |
1903 |
Paclitaxel |
Pfizer |
GCT |
2014-Jul-24 |
|
178 KB |
1904 |
Eravacycline |
PSiCRO |
GCT |
2014-Jul-23 |
|
197 KB |
1905 |
UT-15C Phase III |
PRA |
GCT |
2014-Jul-22 |
|
189 KB |
1906 |
UT-15C |
PRA |
GCT |
2014-Jul-22 |
|
176 KB |
1907 |
Dapagliflozin 10mg |
BMS |
GCT |
2014-Jul-22 |
|
201 KB |
1908 |
Bevacizumab AVASTIN |
Cliantha |
GCT |
2014-Jul-21 |
|
178 KB |
1909 |
Pasireotide LAR |
Novartis |
GCT |
2014-Jul-15 |
|
163 KB |
1910 |
LDK378 |
Novartis |
GCT |
2014-Jul-15 |
|
219 KB |
1911 |
FactorVIII |
Max Neeman |
GCT |
2014-Jul-14 |
|
122 KB |
1912 |
Ifetroban Injection |
Max Neeman |
GCT |
2014-Jul-14 |
|
192 KB |
1913 |
Baricitinib in Patients |
Eli Lilly |
GCT |
2014-Jul-11 |
|
222 KB |
1914 |
Adalimumab |
Novartis |
GCT |
2014-Jun-26 |
|
179 KB |
1915 |
Cyclosporine |
Aurobindo |
GCT |
2014-Jun-24 |
|
190 KB |
1916 |
Fluocinolone acetonide intravitreal |
Excel Life |
GCT |
2014-Jun-20 |
|
174 KB |
1917 |
Ranibizumab 0.5 mg |
Novartis |
GCT |
2014-Jun-09 |
|
188 KB |
1918 |
Everolimus with reduced calcineurin |
Novartis |
GCT |
2014-May-29 |
|
256 KB |
1919 |
Fosaprepitant |
MSD |
GCT |
2014-May-28 |
|
191 KB |
1920 |
Sitagliptin |
Novo-Nordisk |
GCT |
2014-May-23 |
|
213 KB |
1921 |
Liraglutide Sitagliptin |
Novo-Nordisk |
GCT |
2014-May-23 |
|
181 KB |
1922 |
NOVA22007 |
Chiltern |
GCT |
2014-May-15 |
|
191 KB |
1923 |
QAW039 on FEV1 |
Novartis |
GCT |
2014-May-08 |
|
184 KB |
1924 |
Clindamycin benzoyal peroxide |
Cliantha |
GCT |
2014-May-05 |
|
265 KB |
1925 |
Pasireotide S.C |
Novartis |
GCT |
2014-May-02 |
|
173 KB |
1926 |
BCD-020 |
BIOCAD |
GCT |
2014-May-02 |
|
223 KB |
1927 |
Ciprodex |
Cliantha |
GCT |
2014-Apr-22 |
|
212 KB |
1928 |
Enbrel |
Quintiles |
GCT |
2014-Apr-09 |
|
194 KB |
1929 |
Exenatide |
Parexel |
GCT |
2014-Apr-09 |
|
174 KB |
1930 |
Daclizumab |
Biogen Idec |
GCT |
2014-Apr-09 |
|
186 KB |
1931 |
Remicade |
Quintiles |
GCT |
2014-Apr-09 |
|
215 KB |
1932 |
Ceftazidime CAZ AVI |
AstraZeneca |
GCT |
2014-Apr-09 |
|
200 KB |
1933 |
BCD-021 |
BIOCAD |
GCT |
2014-Apr-01 |
|
214 KB |
1934 |
Buparlisib |
Novartis |
GCT |
2014-Apr-01 |
|
182 KB |
1935 |
Liraglutide versus sulphonylurea |
Novo-Nordisk |
GCT |
2014-Mar-24 |
|
211 KB |
1936 |
Insulin Degludec versus insulin glargine |
Novo-Nordisk |
GCT |
2014-Mar-24 |
|
277 KB |
1937 |
BCD-022 |
BIOCAD |
GCT |
2014-Mar-20 |
|
217 KB |
1938 |
tolerability of Secukinumab |
Novartis |
GCT |
2014-Mar-06 |
|
176 KB |
1939 |
Everolimus RADOO1 |
Novartis |
GCT |
2014-Feb-14 |
|
192 KB |
1940 |
Everolimus alone |
Novartis |
GCT |
2014-Feb-14 |
|
183 KB |
1941 |
SAR236553 |
Sanofi |
GCT |
2014-Feb-03 |
|
681 KB |
1942 |
subcutaneous Secukinumab |
Novartis |
GCT |
2014-Jan-31 |
|
166 KB |
1943 |
Afatinib |
Boehringer |
GCT |
2014-Jan-31 |
|
225 KB |
1944 |
Sofosbuvir plus ribavirin |
Klinera |
GCT |
2014-Jan-29 |
|
291 KB |
1945 |
Everolimus |
Novartis |
GCT |
2014-Jan-28 |
|
243 KB |
1946 |
Fluocinolone |
Excel Life |
GCT |
2014-Jan-28 |
|
292 KB |
1947 |
FLU D-QIV |
GSk |
GCT |
2014-Jan-06 |
|
278 KB |
1948 |
FIAsP 2014 |
Novo-Nordisk |
GCT |
2014-Jan-03 |
|
279 KB |
1949 |
FIAsP Insulin |
Novo-Nordisk |
GCT |
2014-Jan-03 |
|
280 KB |
1950 |
Tenofovir Disoproxil |
Klinera |
GCT |
2014-Jan-01 |
|
303 KB |
1951 |
Tenofovir Alafenamide TAF |
M/s. Klinera |
GCT |
2013-Dec-27 |
|
314 KB |
1952 |
olasertib |
M/s. Boehringer |
GCT |
2013-Dec-26 |
|
289 KB |
1953 |
Diclofenac Gel |
M/s. Amneal Pharma |
GCT |
2013-Dec-11 |
|
370 KB |
1954 |
Baricitinib LY3009104 |
M/s. Eli Lilly |
GCT |
2013-Dec-11 |
|
348 KB |
1955 |
BEZ235 |
M/s. Novartis |
GCT |
2013-Oct-21 |
|
846 KB |
1956 |
TechnologyMG145 |
M/s. Amgen |
GCT |
2013-Oct-21 |
|
1410 KB |
1957 |
Producttrastuzumab |
M/s. Roche |
GCT |
2013-Sep-13 |
|
926 KB |
1958 |
LAF237 |
M/s. Novartis |
GCT |
2013-Sep-13 |
|
293 KB |
1959 |
Liraglutide sc Injection |
M/s. Novo Nordisk |
GCT |
2013-Sep-11 |
|
306 KB |
1960 |
Human rh FV III |
M/s. Max Neeman |
GCT |
2013-Sep-03 |
|
301 KB |
1961 |
Fesoterodine |
M/s. Pfizer |
GCT |
2013-Sep-03 |
|
305 KB |
1962 |
Lixisenatid Subcutaneous |
M/s. Sanofi |
GCT |
2013-Aug-30 |
|
382 KB |
1963 |
Octefibrin |
M/s. Max Neeman |
GCT |
2013-Aug-30 |
|
290 KB |
1964 |
CP-690,550 |
M/s. Pfizer |
GCT |
2013-Aug-30 |
|
296 KB |
1965 |
Tenofovir |
M/s. Klinera |
GCT |
2013-Aug-30 |
|
342 KB |
1966 |
ART-123 |
M/s. Asiatic |
GCT |
2013-Aug-20 |
|
303 KB |
1967 |
Paliperidone Palmitate Prolonged Release Suspension for Injection 25mg/50mg/75mg/100mg and 150mg (Pre-filled Syringes) |
M/s Johnson and Johnson Limited, |
SND |
2010-Jul-07 |
|
193 KB |